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ABSTRACT
DEPARTMENT OF BIOLOGY AND BIOCHEMISTRY,
BRUNEL UNIVERSITY, UXBRIDGE,
ENGLAND, U.K.
HARMANJEET RAMNI JAMNADASS
Ph.D., 1995
IDENTIFICATION AND CHARACTERISATLON OF AN EXTRACHROMOSOMAL
ELEMENT FROM A MULTIDRUG-RESISTANT ISOLATE OF TRYPANOSOMA BRUCEI
BRUCE!
Drug rcsistancc togcther with difficulties involved in the development of new tiypanocides are a
major problem in the present control of African tiypanosomiasis. DNA based diagnostics for drug resistance
ould o ercome problems in the identification of drug-resistant populations and contribute to effective
control mcasurcs. However, this requires a detailed knowledge of the mode of action and the mechanisms by
hich U) panosomes can overcome the toxic effects of tzypanocides. In this study, a search for molecular
diffcrenccs bet ecn a multidrug-resisiant isolate of Trypanosoma brucei brucei, CP 547, and a reference
drug-sensitive population, ILTat 1.4, led to the identification of a 6.6 kbp extrachromosomal element in the
multidrug-rusislant population. In light of the involvement of extrachromosomal elements in drug resistance
in Leishmana spp. and cancer cells, the idenWication of the 6.6 kbp element warranted its characterisation.
Several different approaches sere attempted before a sequence which hybridised to the 6.6 kbp
element sas eventually isolated. This sequence is represented by a 108 bp repeat sequence which forms long
arrays of tandem repeats. Since N/a III is the sole restriction enzyme that cuts within the repeat, it has been
referred to as an N/a III repeal The repeat is flanked by a 5 bp spacer sequence. However, a unique 5 bp
direct repeat flanking two complete, and one partial copy of the N/a III repeat may signif' the transposition of
these sequences. Hybridisation ith the N/a III repeat revealed the presence of 'higher' hybridising elements
hich also appear to be predominantly composed of long tandem arrays of the N/a Ill repeal Through
exploitation of the p01) merase chain reaction using arbitrary primers (AP-PCR), additional sequences were
identified i,hich aic associated with some of the 6.6 kbp and 'higher' hybridising elements.
The 6.6 kbp element and some of the 'higher' hybridising elements display features of circular DNA
molecules. The 6.6 kbp element also displays some level of size and sequence heterogeneity within different
populations of the same trypanosome isolate. The copy number of the 6.6 kbp element is also not stable and
appears to be directly affected by the application of selective drug pressure, but a direct association between
the presence of the element and the expression of multidrug resistance could not be determined.
The N/a III repeat family represents a newly identified repetitive family specific to members of the
Trypanozoon subgenus. This repeat family, representing about 5% of the parasite genome, is dispersed

through all size classes of chromosomes, in addition to its presence on the extrachromosomal elements.
Transcriptional studies of the N/a III repeats have revealed that their transcription is developmentally
regulated, since heterogeneous transcripts ranging from greater than 10 kb to smaller than 300 bp are present
in the actively dividing long slender bloodstream and insect stage procyclic forms of the parasite but not nondividing, stumpy bloodstream forms. Lastly, the N/a III repeat lacks an open reading frame and transcripts do
not appear to have a spliced leader sequence at the 5' end. Furthermore, there is almost an equal
representation of polyadenylatcd and non-polyadenlyated transcripts.
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CHAPTER 1

INTRODUCTION

1.1

Introduction to salivarian trypanosomes

1.1.1 General
Members of the genus Trypanosoma, within the order Kinetoplastida, are all
parasitic organisms. Amongst them are the salivarian trypanosomes, some of which live
within the bloodstream and tissue spaces of their mammalian hosts (Mulligan, 1970).
These parasites have developed a remarkable mechanism of antigenic variation enabling
them to escape destruction by the host's immune system (Brigden eta!., 1976; Boothroyd,
1985; Donelson and Rice Ficht, 1985; Borst, 1986; Pays and Steinert, 1988; Cross, 1990;
Donelson, 1989; Hajduk eta!., 1992).
Gruby (1943), a Hungarian, is credited with providing the generic name,
Trypanosoma, to parasites of amphibians. However, Timothy Lewis' discovery of a
trypanosome in the blood of rats in India (Lewis, 1878), termed T !ewisi, helped the
veterinary surgeon Griffith Evans (1880) to recognise the parasite which he discovered in
the blood of Indian horses and camels suffering from the disease Surra. Evans' work
gave the first indication that these organisms were capable of causing disease.
Subsequent investigations contributed to the realisation that there are many different
species of trypanosomes, some that are pathogenic and others which are not. The
identification of all the species is by no means complete as new species are still being
identified (Majiwa eta!., 1993) The success of the genus Trypanosoma in general is
apparent from the findings that they have adapted to a variety of hosts ranging from
mammals, reptiles and birds to plants.
African trypanosomes have received most of the attention since they cause
potentially fatal diseases in both man and animals. In some instances, the reservoir for

African trypanosomes are the wild game animals of Africa, but these parasites do not
always appear to have a deleterious effect on these animals. However, man and his
domestic animals do succumb to trypanosome infections, although there are livestock
(Bos taurus breeds, e.g. the N'Dama, Baoule', Muturu etc) which are more resistant to the
pathogenic effects of trypanosomiasis than the Bos indicusZebu cattle. The typical
course of a pathogenic infection is a relapsing parasitaemia and eventual death, caused by
the combined effects of anaemia and loss of ability to sustain recurrent infections due to
haemopoetic and lymphoid exhaustion.

1.1.2 Biology
The taxonomic classification of the African trypanosomes based on Hoare (1970,
1972) is outlined in Table 1. The classification of trypanosomes is based on
morphological and biological criteria (Hoare 1964). Morphologically, characterisation is
based on the parasite size, motility, whether there is a free flagellum, and the size of the
flagellum. Biological characterisation is based on the site of development of the parasite
in the vector, the host specificity, and the clinical course of the disease produced.
Recently, immunological and biochemical techniques have been used to characterise
trypanosomes. These studies used monoclonal antibodies to detect antigenic
characteristics. Other techniques were used to detect isoenzyme polymorphisms,
repetitive DNA sequences, polymorphism of restriction fragment lengths, polymerase
chain reaction (PCR) products and karyotypes (Godfrey, 1987; Majiwa eta!., 1986a;
Moser eta!, 1989; Paindavoine eta!., 1989).
The family Trypanosomatidae is divided into two major sections (Table 1);
salivaria and stercoraria. This division is based on whether the developmental cycle of
the parasite in the vector takes place in the anterior part of the alimentary tract and
transmission is by inoculation, or whether it takes place in the posterior region of the gut
and the transmission is by faecal contamination.
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TABLE 1:

PROTOZOA

Phylum

Subphylum

SARCOMASTIGOPHORA

Super cuss

MASTIGOPHORA

Class

ZOOMASTIGOPHORA

Order

KINETOPLASTIDA

Suborder

TRYPANOSOMATLNA

Family

TRYPANOSOMATIDAE
TRYPANOSOMA

genus

Salivaria

Stercoraria

Sections

I

I

I

I

Nannomonas

Subgenera Wegatrvponum Herpasosoma Schi,.ampunum Duttonella

Species

I
T. titeileri

I

T. lewiss

I

II

ri

Trypanozoon Pycnomonas

T.cruci T.virzx T. uniforme T. congolense T. simiae

T. brucci

T. evansi

Subspecies

1

I

I

T. e. evansi

T. suis

T. equiperdum

T. e. equinum

I

1

T. b. gwnbiense T. b. brucei T. b. rhodesiense

Figure 1
The life cycle of Trypanosoma brucei (simplified from Vickerman, 1985). The
parasite proliferates in the mammalian host in the "long slender" form, which
displays an extraordinary capacity for changing its surface antigen coat. Long
slender bloodstream forms give rise to the less active "stumpy" trypanosomes,
which are believed to initiate the infection of the tsetse fly. After ingestion by
the insect, the parasites transform into large "procyclic" forms that multiply in
the midgut of the fly. Mature procyclics subsequently migrate towards the
salivary glands and differentiate into the non-dividing "metacyclics" form. At
this stage, the parasite has resumed the synthesis of variable surface antigens and
has recovered its infectivity to the mammalian host.

EPJMAST!GOTE

Tsetse Salivary Glands
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—

J

•(( METI4C}PCLIC

Endocyios.s

Migration

Injection

M,IochondrI& r.9tssOfl

PRO VENTRICULAR

Mnochon&s& r.p.ssjc,

I

I'ROCYCLIC ,

Ingestion

STUMPY

SG os1
Endoc1os*s
c.as.s

Tsetse Midgut

Mnochondrtal actIvi&hon

Mammalian Bloodstream

The principal paThogens of livestock in sub-Saharan Africa belong to three
different sub-genera (Fiennes, 1950; Mulligan, 1970): Trypanosoma brucei brucei, 7'.

evans! and 7'. equlperdlim (subgenus T,ypanozoon) (Plimmer and Bradford, 1899; Bruce
et aL, 1914), 1. congolense and 7'. simiae (subgenus Nannomonas) (Broden, 1904) and 7'.
vivax (subgenus Duttonella) (Ziemann, 1905). When examining the blood of livestock
from sub-Saharan Africa, other non-pathogenic species such as 7'. theileri, 7'.
melophagium (subgenus Megatrypanum) (Hoare, 1964), which are stercorarian, and 7'.

suis (subgenus Pycnomonas) (Hoare, 1964) are also encountered.
The principal agent responsible for transmission of trypanosomes occurring in
livestock confined to Africa is the tsetse fly, belonging to the genus Glossina (Mulligan,
1970). Trypanosomes are digenetic, undergoing distinct developmental stages in the two
hosts; the tsetse fly and the definitive host. Among these pathogenic trypanosomes, two
species, Trypanosoma evansi, T. equiperdum and sometimes T. vivax, are not transmitted
by the tsetse fly, but by non-cyclical, mechanical transmission (Gardiner and Mahmoud,
1992). The agents responsible for mechanical transmission are flies belonging to the
family Tabanidae (Dine eta!., 1989).
The salivarian species found in domestic livestock have a similar cyclical pattern
of development in the vector: trypanosomes ingested with blood transform into
epimastigote forms, which eventually give rise to the infective metacyclics
(metatrypanosomes).
Unlike many parasites, trypanosomes have a relatively simple life cycle
(Vickerman, 1974). The life cycle of 7' bruce! is drawn schematically in Figure 1. In the
mammalian bloodstream, T. b. bruce! is pleomorphic, consisting of long slender, dividing
forms, intermediate forms, and non-dividing short-stumpy forms. All these forms have
the variable surface glycoprotein (VSG) surface coat. The slender forms rely on aerobic
glycolysis, excreting pyruvate as the sole end product, for energy generation. When a
tsetse fly bites an infected mammal, trypanosomes ingested with a blood meal by the fly
differentiate and multiply in the tsetse midgut as noninfectious procyclic forms. The
glycoprotein surface coat is replaced by the procyclin coat, and the procyclic forms
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change from anaeroic to aerobic growth. Procyclic forms migrate to the salivary glands
where, attached to the epithelial cells, they multiply as a distinct morphological stage, the
epimastigote. After cessation of division, the epimastigote starts to express the VSG coat
once more (Tetley eta!., 1987), and this expression leads to detachment and maturation
as non-dividing, infective, metacyclic trypomastigotes. The infected tsetse fly, on biting
a mammalian host, passes mature metacyclics in saliva to the host, resulting in the
initiation of an infection. Shortly after being deposited in the skin, tiypanosomes begin
to multiply by binary fission of the long slender forms, and undergo a variety of
additional morphological and metabolic changes (Vickerman, 1985).
Trypanosoma congolense can produce a pathogenic form of African
trypanosomiasis in ruminants but is non-infective for humans (Mulligan, 1970). This
species goes through a similar life cycle like T. brucei. However, epimastigotes attach
and form metacyclics in the proboscis and not in the salivary glands. The Duttonella
subgenus is represented by monomorphic tiypanosomes which are parasitic chiefly in
wild and domestic ruminants. These parasites have the least complex insect cycle. They
develop solely in the mouthparts of the Glossina; the parasites ingested with the blood
meal attach to the wall of the proboscis and transform to elongated trypomastigotes and
then into epimastigotes which eventually give rise to infective metacyclic forms. All
these trypanosome species are found throughout the tsetse infested areas with mixed
infections being common in the field (Stephen, 1970). A summary of the characteristics
of the trypanosomes of veterinary importance is given in Table 2 (Food and Agricultural
Organisation [FAO], 1986).

1.2

Economic importance of trypanosomiasis in domestic livestock in Africa.

1.2.1 General
In Africa, the disease caused by the major animal pathogenic tiypanosomes can
be acute or chronic, depending on the susceptibility of the mammalian host species, and
is generally characterised by intermittent fever, wasting, anaemia and infertility. In
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susceptible species, if left untreated, the disease is usually fatal. There are, however,
certain indigenous breeds of cattle in West and Central Africa which can better tolerate
exposure to trypanosomiasis (Murray eta!,. 1982). In these cattle, even though mortality
is reduced, infection is often accompanied by losses in productivity in areas of high tsetse
challenge (Stephen, 1986).
There are as many forms of trypanosomiasis as there are specific trypanosomes
(Table 3). Each species of trypanosome may infect several species of animals with
different effects and degrees of severity resulting in the clinical signs varying in different
mammalian species. Moreover, the clinical picture is often complicated further by the
presence of mixed infections within one host.
According to a 1992 report by Winrock international, 65-7O% of the woñds
livestock population resides in developing countries, yet they provide only 30% of the
world's meat output. The estimated production of animal protein from livestock farming
in Africa per 1,000 hectares is almost 1/77 of that in Europe and 1/8 of that in Latin
America (FAO, 1975). This condition was expected to deteriorate even further as
Africa's human population increased by twice the rate of food production between 1980
and 1985. Presently, Africa has the highest population growth rate in the world, which is
estimated to be expanding at 3.2% per annum. There is, therefore, a continually
increasing need for significant improvements in food productivity in the developing
world.
Trypanosomiasis has had profound adverse effects on agriculture in Africa.
According to the Food and Agricultural Organisation of the United Nations, (FAO)
(1975) and the International Livestock Centre for Africa (ILCA) (1985), trypanosomiasis
has been the most significant factor limiting extension of the cattle producing areas of
Africa. It has been estimated that 31 species and subspecies of the tsetse fly are
distributed over 37 countries lying between latitudes 15°C North to 25°C South across
the African continent. Their habitat includes approximately 7 million square kilometres
of savannah and light woodland with good rainfall, suitable for agricultural development
(Finelle, 1974). Currently, of a total population of approximately 160 million cattle in
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Table 3:

The occurrence of pathogenic African trypanosomes of veterinary
Importance (FAO, 1986).

Trypanosome
species

Domestic
animal
affected

Reservoir
hosts

Experimental
hosts

T. congolense

Cattle
Horses
Dogs
Sheep
Goats
Pigs

Wild game
species

Rats
Mice
Rabbits
Guinea-pigs

T. simiae

Pigs

Warthog
Bushpigs

Rabbits
Monkeys

T. vivax

Cattle
Sheep
Goats

Wild game
species

None
(mice for
West African

wild game
species

Rats
Mice
Guinea-pigs
Rabbits

Stocks
T. brucei brucei

Horses
Dogs
Sheep
Goats
Cattle
Pigs

T. b. evansi

Camels
Cattle
Water Buffalo
Horses
Dogs

7'. b. equiperdum

Horses

Rats
Mice
Guinea-pigs
Pigs
Rabbits
None
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None

Africa, only about 50 million are located in the tsetse-infested subhumid/humid zone, Of
these, only 5% are the more resistant Bos taurus breeds and their crosses. Where cattle
are exposed to trypanosomiasis, severe losses occur in livestock productivity due to poor
growth, weight loss, lower milk yield, reduced traction capability, infertility and abortion
(McDowell, 1977; FAO/WHO 1982). Thus in 1963, Africas annual loss in meat
production due to trypanosomiasis was estimated to be US $5 billion (Gyening, 1990).
The agricultural production of Africa cannot even today sustain the existing
population. This is shown by the facts that in 1983/1985, it was estimated that 35% of
the population of sub-Saharan Africa was malnourished and 26% severely malnourished
(The African Trypanotolerant Livestock Network [ATLNJ, 1987). This is a reflection of
poor economic growth and low levels of agricultural productivity. Recent projections
indicate that in sub-Saharan Africa the deficits for meat and milk production will reach 1.7% and -0.8% per annum, respectively, by the year 2,000. Meeting these deficits
through imports would cost an estimated US$15 billion annually (Mc Namara, 1990;
Winrock, 1992), which Africa cannot afford.

1.2.2 Control of trypanosomiasis
Presently, there are three main approaches to the control of animal
trypanosomiasis:
i)

Combating the vector by control or eradication of tsetse fly populations.

ii)

Reducing the affects of the disease through the use of trypanotolerant cattle.

iii)

Combating the disease in the mammalian host through chemotherapy and/or

chemoprophylaxis.

1.2.2a Tsetse fly control
Control of tsetse flies is based on the use of insecticides, the restriction of their
hosts and habitats, and extensive utiuisation of traps. The oldest and traditional method of
control has been selective bush clearing. With the expanding human populations within
Africa, there has been a growing need for arable land for either settlement or cultivation.
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Clearance of vegetation creates an adverse environment for tsetse. In addition, workers
have also been encouraged to destroy game to decrease the reservoir for tiypanosomes
(Jordan, 1974). Both methods are clearly non-sustainable and environmentally
dangerous approaches, and are now discouraged.
Modern strategies for tsetse control can be either chemical or non-chemical.
Chemical control is divided into two distinct categories: (i) the use of residual
insecticides which kill tsetse by contact and are active over a period of weeks or months
and (ii) the use of non-persistent insecticides with no detectable residual effect but which
require repeated application. Due to the toxic nature and the environmental damage
caused by the three commonly used residual insecticides, dichorodipheny\ tñc'thoethane
(DDT), dieldrin and endosulfan (toxic to fish), non-residual insecticides such as the
synthetic pyrethroids (Spielberger eal., 1979) are now eneca((j useci.
these insecticides is by aerial-spraying programs and dipping and spraying cattle. With
advances in the production of ultra-low volume aerosols (IJLV), very low doses of
insecticide are applied using aircraft and helicopters (MacLannan eta!., 1967; Takken et
a!., 1986).
The selective application of insecticides in tsetse control programmes
unfortunately suffers from the eventual major drawback of reinvasion of areas allegedly
freed from tsetse (Hadaway, 1977). In addition, the insecticides can produce
environmental pollution and unwanted ecological effects (Koeman eta!., 1971).
Furthermore, the application of insecticides is not suited to all ecological zones. Areas of
high rainfall and dense vegetation tend to limit the feasibility and efficacy of insecticide
application (Jordan, 1974).
Of the non-chemical approaches, use has been made of traps and screens. In the
past these were used for tsetse population surveys. With improvements in terms of both
simplicity and greater catching efficiency, and with the incorporation of chemical
attractants and insecticides, traps and screens can now be used to complement other
control methods such as aerial spraying (Vale, 1980, 1988; Jordan, 1985).
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A sterile insect release technique (SIT) has also been investigated. This method
has been employed with limited success in areas of Tanzania and Nigeria (Williamson et
a!., 1983). Failure to completely eradicate the fly has been attributed to immigration of
flies from surrounding areas. Enormous costs are involved in implementing the SIT,
making it prohibitive in most of Africa, and furthermore, the density of the target
population must be low for SIT to be effective.

1.2.2b Trypanotolerance (Genetic resistance):
Trypanotolerance, the heritable ability of some bovidae to remain productive in
the face of trypanosome challenge, offers a sustainable means of reducing the impact of
trypanosomiasis on cattle productivity (ATLN, 1987).
Investigations have shown that increased resistance of wild animals to the illeffects of trypanosome infections may be related to their innate ability to control the level
of parasitaemia (Murray eta!., 1982). Comparative studies have shown the possible
involvement of the immune system in the control of parasitaemia; phagocyctic cells from
wild animals are superior to those of susceptible cattle breeds in engulfment and
subsequent destruction (phagocytosis) of antibody-sensitised trypanosomes (Rurangirwa
eta!., 1986). This ability is also possessed by the trypanotolerant cattle (Murray eta!.,
1982). It has been shown both in the field and experimentally that trypanotolerant cattle
are capable of resisting the pathogenic effects of trypanosomiasis to varying extents
(Murray et a!., 1982; Nantulya el a!., 1986); they remain productive despite the infection,
and often spontaneously recover from infections (Nantulya eta!., 1984, 1986).
A search for genetic markers for the trypanotolerant trait, which might be used
quantitatively in the breeding of trypanotolerant livestock, is in progress at ILRAD
(Teale, 1993). Identification of the genes responsible (providing these are not too many)
should help in breeding programmes to select for more productive trypanotolerant cattle.
The possibility of transfecting the genes for trypanotolerance into more productive cattle
breeds is a possibility on the basis of the success in transfer of the chioramphenicol
acetyltransferase structural gene into the bovine genome (Biery eta!., 1988).
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I .2,2c Chemotherapy of African trypanosom iasis:
In areas where the tsetse populations have posed difficulties in being eliminated,
chemotherapy may be the preferred means for controlling trypanosomiasis in domestic
livestock at the present time.
The first application of chemotherapy to bovine trypanosomiasis was brought
about by observations of Plimmer and Thompson (1908), that mice infected with T b.
brucei or T. evansi were cured by administration of tartar emetic (potassium antimonyl
tartrate). Early in the 1940s, several other types of veterinary trypanocidal drugs,
belonging to the chemical classes of acid naphthylamines, diamidines, quinaldines and
phenanthridines, were put to use.
Chemotherapy of trypanosomiasis in domestic livestock is at present dependent
on a relatively small number of synthetic compounds: homidium (Et1idium,
Novidium'), a phenanthridine; isometamidium (Samorin ), Trypamidium), a
phenanthridine aromatic amidine; diminazene (Berenil (', Veriben( ), an aromatic
di amidine; qui napyrami ne (Trypacide), a quinoline pyrimidine; surami n (Naganol(),
a naphthylamine suiphonic acid derivative; and a relatively new drug melarsomine
(Cymelarsan). Melarsomine (Raynaud eta!., 1989) is an arsenical which is used
against only T. evansi infections in camels. Besides melarsomine, all these compounds
have been on the market for a minimum of 30 years, primarily because of the costs
involved in developing a new drug for a relatively small trypanocide market (Goodwin,
1978); $80 million is required to make a new drug commercially available (Williamson,
1980a, b) deters pharmaceutical companies since returns expected on new trypanocidal
drugs would be low due to problems of limited resources and foreign exchange in
developing countries. However, there is an urgent need for new trypanocidal drugs as the
extensive use of available drugs for the control of bovine trypanosomiasis has resulted in
the appearance of drug resistance in T congolense, T. vivax and T. brucei in many parts
of Africa (Peregrine, 1994). Furthermore, because of the close chemical relationships
between trypanocides (Leach and Roberts, 1981), the development of resistance to
individual compounds often appears to be associated with cross-resistance to others
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(Whiteside, 1961; Williamson, 1970). In some areas, drug resistance has become so
prevalent that some drugs have been withdrawn from general use (e.g., homidium in
northern Nigeria [Aliu, 1981]). However, despite these problems, chemoprophylaxis and
chemotherapy can be effective and economically justified if managed in an efficient
manner (Blaser eta!., 1977; Leach and Roberts, 1981).
Data regarding the generic name, compound class, trade name, route of
administration, spectrum of activity and the species of animal for which the veterinary
trypanocides are used is shown in Table 4 (from Peregrine, 1994).

Phena n th rid ines
Homidium and isometamidium
The phenanthridinium salts phenidium and dimidium were demonstrated as
having high levels of tryanocidal activity in 1938 (Browning eta!., 1938). Subsequently,
an improved substitute, homidium, was introduced in 1952 (Watkins and Woolfe, 1952)
followed by the introduction of isometamidium in 1960 (Berg, 1960). These drugs have
been used for the treatment and prophylaxis of infections of T congolense, T vivax, and
other species of trypanosomes in domestic ruminants (Wragg eta!., 1958) throughout
Africa, and have profoundly benefited the African cattle industry (Williamson, 1970).
However, like other trypanocides, resistance of various strains of 7'. vivax and T.

congolense to isometamidium has been reported across Africa (ATLN, 1987). In some
cases the strains that were resistant to isometamidium were also resistant to other
trypanocides such as homidium, diminazene and quinapyramine (ROttcher and
Schillinger, 1985; SchOnefeld eta!., 1987). However, some investigations have failed to
establish the presence of isometamidium resistance, even in areas where the drug has
been used for about 20 years (Trail eta!., 1985).
Mode of action
Newton eta! (1964) studied the effects of homidium on non-parasitic
kinetoplastids such as Crithidia oncopelti. Homidium was found to irreversibly inhibit
multiplication of these kinetoplastids. Evidence suggests that homidium probably
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prevents DNA replication by intercalating between adjacent base pairs and destroying the
double helix, thereby preventing DNA polymerase from functioning (Newton, 1974).
Similarly, isometamidium has been shown to be capable of binding to DNA (Kinabo and
Bogan, 1987), and inhibiting RNA polymerase (Richardson, 1973) and DNA polymerase
(Marcus eta!., 1982), resulting in the inhibition of incorporation of nucleic acid
precursors into DNA and RNA (Lantz and van Dyke, 1972). These findings suggest that
the primary action of isometamidium is blockade of nucleic acid synthesis. Additional
studies have indicated that isometamidium also interacts with other intracellular
molecules (Bacchi eta!., 1980; Bacchi, 1981; Shapiro and England, 1990) suggesting that
its trypanocidal activity may be due to a combination of inhibitory action on several
target molecules. Recent investigations (Zilberstein eta!., 1993) indicate that
isometamidium is transported across the trypanosome plasma membrane via a protein
carrier.

Diminazene aceturate
Diminazene aceturate was introduced as a trypanocide for domestic livestock in
1955 (Jensch, 1955) and subsequently became the most commonly used therapeutic agent
for trypanosomiasis in domestic livestock (Williamson, 1976). The relative success of
diminazene has been due to a number of factors: a higher therapeutic index than other
trypanocides in most livestock species (Fairclough, 1963a, b; Williamson, 1970), activity
against tiypanosomes that are resistant to other trypanocides used in cattle (Williamson,
1970), and a low incidence of diminazene resistance despite extensive usage of the
compound (Williamson, 1976). Although the incidence of resistance to diminazene is
much lower in comparison to other trypanocides, significant levels of resistance have
been reported across Africa (Mamman eta!., 1993). Whether such resistance is a result
of cross-resistance induced by other drugs, such as quinapyramine, is however, not clear
(Leach and Roberts, 1981).
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Mode of action
Diminazene binds to trypanosomal kDNA (MacAdam and Williamson, 1972;
Newton and Burnett, 1972). The binding occurs via specific interaction with sites rich in
adenine-thymine base pairs (Newton, 1972; Lane eta!., 1991). The molecule binds with
higher affinity to 5' -AATF- 3' than to 5' -TFAA- 3' regions of DNA (Hu

eta!.,

1992). It

has been shown that binding to the double stranded DNA occurs via the minor groove
(Gresh and Pullman, 1984; Hu eta!., 1992) via electrostatic and hydrogen bonding at
specific sites (Gresh and Pullman, 1984; Lane

eta!.,

1991). Through this interaction in

trypanosomes, diminazene inhibits kDNA replication (Brack and Delain, 1975). Shapiro
and Englund (1990) have shown that diminazene specifically inhibits mitochondrial type
II topoisomerase in viable trypanosomes. Thus, inhibition of DNA replication may occur
via this interaction. Although diminazene selectively fragments kinetoplast DNA, it is
not established whether it is the primary target for diminazene in vivo (Newton, 1980).
When exposed to diminazene, diverse changes are observed in the structure and
function of trypanosomatids. These alterations include aggregation and loss of ribosomes
(Wallis, 1966), modification of lysosomes and cytoplasmic membrane (MacAdam and
Williamson, 1972), inhibition of basic amino acid transport (Gutteridge, 1966), inhibition
of DNA and RNA polymerases (Waring, 1965; Marcus

eta!.,

1982), and interference

with polyamine uptake, synthesis and function (Bacchi, 1981; Bitonti

eta!.,

1986).

To date, there is no published information on the molecular basis of resistance to
diminazene in trypanosomes. In studies with the closely related diamidine, pentamidine,
Damper and Patton (1976a, b) concluded that the drug appears to be actively transported
into trypanosomes via a carrier-mediated process that is substrate specific, concentrative
and energy coupled. They also concluded that alteration in pentamidine transport is the
primary mechanism responsible for pentamidine resistance in trypanosomes (Damper and
Patton, 1976a). Drug efflux and drug metabolism were not shown to play a role in drug
resistance (Damper and Patton 1976b).
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Quhiapyramine
Quinapyramine was first described by Curd and Davey (1949, 1950). Two salts
of quinapyramine are used as trypanocides; the chloride and the dimethylsulphate. Both
salts have a broad spectrum of activity, being active against T. evansi, T. equiperdum, T.
b. bruce! (Curd and Davey, 1950; Leach, 1961), T. congolense and T. vivax (Davey,
1950). This drug was shown to be more active against trypanosomes affecting livestock
such as T. congolense and T. vivax, than other species (Davey, 1957).
Between 1950 and 1970, quinapyramine was widely used in Africa as a
therapeutic and prophylactic agent in cattle (Fiennes, 1953; Ruchel, 1975). However, this
appeared to lead to the rapid development of quinapyramine resistance in trypanosomes
of domestic livestock (Wilson, 1949; Unsworth, 1954), which often appeared to be
associated with concomitant cross-resistance to isometamidium, homidium and
diminazene (Whiteside, 1960; Mwambu and Mayende, 1971a, b). In 1976
quinapyramine ceased to be manufactured for the control of trypanosomiasis in cattle
(Holmes and Scott, 1982) due to the ease with which resistance appeared to develop
apparent concomitant-cross resistance to other trypanocides (Leach and Roberts, 1981)
and because of drug toxicity (Davey, 1957). However, the compound was reintroduced
onto some African markets in the 1980s for use in camels only.
Mode of

Action

Although quinapyramine has been marketed as a trypanocide for approximately
40 years, very little is known about its mechanism of action. In experimental studies with
the trypanosomatid flagellate Crithidia oncopelli, quinapyramine appeared to inhibit
growth by aggregating and inactivating ribosomes (Newton, 1962, 1963, 1966). The
compound has also been shown to inhibit synthesis of RNA from exogenous purines, but
not from purines synthesized de novo (Waring, 1965; Newton, 1966). In T. b. brucei,
quinapyramine appears to interfere with polyamine metabolism (Bacchi eta!, 1979,
198 1), although the molecular basis of this inhibition is unclear.
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Suramin
Suramin was first produced by Bayer in 1916 and is still used extensively for the
treatment of trypanosomiasis in horses and camels (Apted, 1980). Suramin has been
shown to be ineffective against T. congolense and T. vivax infections of cattle (Ruchel,
1975), but is efficacious against infections with trypanosomes of the subgenus
Trypanozoon (Leach and Roberts, 1981).
Mode of Action
Suramin complexes with serum proteins and enters trypanosomes by endocytosis
(Fairlamb and Bowman, 1977, 1980). In in vitro studies, several enzymes of T. b. brucei
appear to be very sensitive to inhibition by suramin. Two characterised enzymes
involved in the glycolytic pathway, glycerol-phosphate oxidase and NAD-linked
glycerol-3-phosphate dehydrogenase, have been shown to be particularly sensitive to
suramin (Fairlamb and Bowman, 1977; Fairlamb, 1981). Two enzymes involved in
pyrimidine biosynthesis in T. b. brucei are also inhibited by suramin; dihydrofolate
reductase (Jaffe eta!., 1972) and thymidine kinase (Chello and Jaffe, 1972). Suramin
may also act by interfering with either ribosomal or lysosomal function, thus resulting in
retardation of protein synthesis (Williamson and MacAdam, 1965). Finally, the
compound is extremely anionic and binds readily to plasma proteins, a property which is
thought to account for the drug's prophylactic activity (Dewey and Wormall, 1946).

Melarsom inc
Melarsomine is an arsenical, patented in 1985, and is effective against members
of the subgenus Tiypanozoon, where it is limited for use against T. evansi infections in
camels (Raynaud et a!., 1989).
Mode of action
In view of the short duration of trypanocidal levels in camel plasma, melarsomine
is regarded as a therapeutic product (Zelleke eta!., 1989). The drug inhibits the
metabolism of the cell by inhibition of trypanothione reductase, an enzyme which is
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central to the regulation of the thiol/disuiphide redox balance in the parasite and which is
absent in the mammalian host (Fairlamb eta!., 1989).

1.2.3 Problem of trypanocidal drug resistance
Drug resistance in trypanosomes can be defined as the ability of a trypanosome
strain to survive, despite the administration of recommended drug doses (ROttcher and
Schillinger, 1985). From its earliest days, the development of chemotherapy for bovine
trypanosomiasis has been accompanied by the development of drug resistance
(Williamson, 1979). Resistance to almost all the available drugs has now been described
and has been observed in all species of pathogenic Trypanosoma (Leach and Roberts,
1981; Pinder and Authie 1984; ROttcher and Schillinger, 1985; SchOnefeld eta!., 1987;
Mbwambo eta!., 1988). Recent reports have shown that drug resistance in African
trypanosomes is an increasing and significant problem over Africa (Table 5, Peregrine,
1994). It is therefore important to define the various forms of drug resistance which can
occur since the success of chemotherapy might be determined by the factors that are
responsible for such drug resistance. Resistance can occur as follows;

1.2.3a Acquired drug resistance
The term acquired resistance is used to describe cases where a resistant strain or
cell line emerges from a population that was previously drug sensitive. Conditions under
which acquired drug resistance develops in the field are all thought to be derived
principally from underdosing; that is, the concentration of the trypanocide in the animal's
body is below levels that are required to eliminate an infection, thus facilitating the
selection of a drug-resistant sub-population (Whiteside, 1962; Leach and Roberts, 1981).
Sub-therapeutic drug levels may occur because of incorrect dosage, irregular treatment
with prophylactics, or stopping the usage of a prophylactic whilst animals are still at risk
(Davey, 1950, 1957; Whiteside, 1960).
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Table 5:

(From Peregrine, 1994) Reports of resistance to standard recommended

doses of diminazene, homidium, isometamidium and quinapyramine in
cattle.
Reference

Countiy

Tiypanosome
species

Resistance to

Nigeria

7.. congotense

h,i

Jones-Davies and Folkers, 1966

Nigeria

7.. vivax

d

Jones-Davies, 1967

Nigeria

7'. congolense

d,h,i

Na'Isa, 1967

Nigeria

7'. congolense

d

MacLennan and Jones-Davies, 1967

Chad

7'. V ' Vax

d

Graber, 1968

Nigeria

7'. congolense

d

Jones-Davies, 1968

Nigeria

7.. congolense
7'. vivax

d,h,i,q
d,h,q

Gray and Roberts, 1971
"

Uganda

T. VI VaX

d

Mwambu and Mayende, 1971

Sudan

7' congolense

h,i

Abde) Gadir et a)., }972

Zimbabwe

7'. congo/ense

I

Lewis and Thomson, 1974

Kenya

T. congolense

d,h,i,q

Gitatha, 1979

Nigeria

T. VI VaX

d,h,j

Ilemobade, 1979

Sudan

7.. congolense
7.. bruceilT. vivax

h
h

Abdel Gadir et a)., 1981
"
"

Côte d'Ivoire T. congolense
T. vivax

h,i
h,i

KUpper and Wolters, 1983
"
"
"

Tanzania

7'. congolense

d

Njau et a)., 1983

Burkina Faso 7.. congolense

i

Pinder and Authie, 1984

Kenya

T. vivax

d,h,i,q

ROttcher and Schillinger, 1985

Kenya

T. V1WJX

d,h,i,q

Schönefeld et a!., 1987

Somalia

T. vivax

h,i,q

SchOnefeld et a!., 1987

Tanzania

T. congolense

d

Mbwambo et a!., 1988

Somalia

T. congolense

d,i

Ainanshe et al., 1992

Burkina Faso T. congolense

d,h,i,q

Clausen eta!., 1992

Sudan

T. congolense
T. brucei
T.vivax

d,h,i
d,h,i
h

Mohamed-Ahmed et a!., 1992

Ethiopia

T. congolense

d,h,i

Codjia et al., 1993

d = diminazene; h = homidium; i = isometamidium; q = quinapyramine
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1.2.3b Cross resistance
Cross-resistance occurs when, in addition to developing resistance to the selective
agent, drug resistance also develops against other drugs. The development of crossresistance in trypanosomes to many of the drugs used for treatment can be expected
because of the close chemical relationship between most of the trypanocides (Leach and
Roberts, 1981). Common receptor sites or molecules involved in the transport of
trypanocides into trypanosomes, and modifications to those sites during the development
of resistance, may be important factors in the development of cross-resistance
(Williamson, 1970; Fairlamb eta!., 1992).
Most of the present information on the problems of cross-resistance with
trypanocides has been interpreted from field data of Whiteside (1961) (Table 6).
However, recent investigations conducted by Ndoutamia eta!. (1993) have confirmed,
under controlled laboratory conditions, the ease with which resistance to quinapyramine
in T. congolense can be generated, and that such trypanosomes display the crossresistance profile observed in the field (Whiteside, 1960; Mwambu and Mayende, 1971a,
b).
Investigations on cross-resistance in the field led Whiteside (1960, 1962) to
advise the use of"sanative pairs", an example of which is homidium and diminazene,
since neither of these appear to produce cross-resistance to each other.

1.2.3c Natural resistance
Natural resistance of a trypanosome strain or species to a drug is that variation in
drug sensitivity shown by a trypanosome that is not dependent on previous exposure to
the drug concerned. In this case, the feature responsible for resistance is an integral
property of the species that has arisen through the processes of evolution, in which all
organisms develop mechanisms for survival and seif-propogation. For instance, it is
believed that in West Africa, the initial appearance of resistance to both homidium and
diminazene in T. vivax (Jones-Davies and Folker, 1966a, b; Jones-Davies 1967a, b)
probably reflected the level of natural resistance of these populations
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Table 6:

The cross-resistance patterns of drugs used in cattle trypanosomiasis
(after Whiteside, 1961)

Trypanosomes
resistant to

Quinapyramine
Homidium
Metamidium*
Diminazene

Response of trypanosomes to:
Quinapyramine

Homidium Metamidium Diaminazene

R
+
+
0

4±

R
4*

0

+
+
R
0

R:
direct resistance
+:
Cross-resistance to curative dose
++: Cross-resistance to higher dose
0:
No cross-resistance
*:
A mixture of phenanthridines that contained 45% isometamidium
(Kinabo and Bogan, 1988).
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4*

0
0
R

1.2.4 Factors that may contribute to the apparent resistance phenotype
1.2.4a Depressed immune status of the host
It is known that an antibody response by the host to the surface antigens of
trypanosomes facilitates the rapid elimination of parasites following drug treatment (De
Gee eta!., 1983). The trypanocidal effect of DL-alpha-difluormethyl-ornithine (DFMO)
(Eflornithine(R), Merrrel Dow Company), an ornithine decarboxylase inhibitor, was
greatly reduced in immunosuppressed mice (De Gee eta!., 1983). Since depressed
immune responses resulting from other, unrelated parasitic infections or malnutrition are
frequent occurrences in tropical livestock (Holmes eta!., 1974; Griffin eta!., 1981), the
response to treatment should be considered in relation to the immune status of the host.

1.2.4b Extravascular trypanosomes resisting treatment
Members of the subgenus Trypanozoon such as T. brucei and T. evansi (Jennings
eta!., 1979) and also T. vivax (Whitelaw eta!., 1988) can invade body compartments
other than the vascular system. Depending on the drug used, in some of these
extravascular sites the typanocidal level may be low or nonexistent. They may therefore
represent sites of escape from chemotherapy (Whitelaw eta!., 1985, 1988) and account
for some cases of apparent drug resistance.

1.2.5 Stability of drug resistance
Field studies carried out by Knowles (1927) demonstrated that suramin resistance
remained stable for one year or longer in T evansi infected horses. Laboratory
investigations also demonstrated that there was little if any change in the drug sensitivity
of a multidrug-resistant T. b. brucei after in vitro propagation as bloodstream forms for
up to 272 days (Kaminisky and Zweygarth 1989a). In addition, in vitro transformation of
the T. b. brucei multidrug-resistant bloodstream forms into procyclic, epimastigote and
metacyclic forms did not alter their drug-resistant profile. Ndoutamia et al. (1993)
demonstrated that quinapyramine-resistant clones of T. congolense remained resistant to
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quinapyramine during six months passage in mice in the absence of drug pressure. These
findings do not comply with earlier findings which demonstrated that the passaging o
uncloned populations in the absence of quinapyramine resulted in significant reductions
in resistance to quinapyramine in T. equiperdum (Hawking, 1958) and T. congolense
(Hawking, 1963). However, since Peregrine eta!. (1991) have demonstrated
heterogeneity in resistance to isometamidium amongst sub-clones of a cloned population
of T. congolense, it is unclear whether the reduction in resistance observed by Hawking
was due to a real reduction in sensitivity of individual trypanosomes or whether it
occurred as a result of selection of a more sensitive subpopulation. Therefore, stability or
instability depends on the mechanisms of resistance and the method by which resistance
has been selected.

1.2.6 Detection of drug resistance
Drug resistance in African trypanosomes is the most common reason for the
failure of treatment with trypanocides. Such failures in the field have led to the
requirement for assays to quantify the resistance. Many assays for determining drug
resistance in vitro have been described (Borowy eta!., 1985a, b; Kaminsky and
Zweygarth, 1989b; Ross and Taylor, 1990). However, these systems are not yet field
applicable; limited numbers of field isolates can be characterised, and all of the systems
take months to produce definitive data. There is therefore a requirement for assays that
will rapidly quantify the drug resistance phenotype of large numbers of trypanosome
isolates. The development of direct assays for drug resistance, that can rapidly
characterise the drug-resistance phenotype of large numbers of trypanosome isolates, will
most likely depend upon a detailed understanding of the molecular bases of drug
resistance.

1.2.7 The future
In addition to improving the present methods of detecting drug resistance, it is
clearly evident from the preceding sections that there is an urgent need to develop new
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compounds, chemically unrelated to those now in use, due to increasing problems of
acquired and cross resistance. Drug resistance will continue to remain a major problem
in the control of trypanosomiasis unless the mechanisms of resistance are understood.
Such information will potentially offer a means of overcoming this problem in a
sustainable and economically viable manner with new therapeutics if sufficient funds are
available. In the meantime, trypanocides must be used in a rational manner so as to limit
the spread of resistance.
In the future, the identification of new anti-trypanosmal compounds will be
dependent upon research on biochemical pathways that are unique to trypanosomes. In
T. b. brucei, for instance, the trypanocidal action of two chemically unrelated compounds
has recently been shown to be mediated by interference with biochemical pathways
involved in purine metabolism (Byers eta!., 1992; Carter and Fairlamb, 1993). Since an
inability to synthesize purines de flOVO is common to trypanosomes (Hassan and Coombs,
1988), research on development of purine analogues may be a promising area in the
future for developing trypanocides. The unique carbohydrate metabolism and energy
production pathways in African trypanosomes (Opperdoes, 1987) also provide several
novel targets for chemotherapeutic intervention (Sogin eta!., 1986; Mlsset and
Opperdoes, 1987).
Efforts to ellucidate the metabolic pathways of polyamine synthesis have been
most productive in the last decade, resulting in the identification of targets for new antitrypanosomal compounds such as DL-a-diflouromethyl ornithine (DFMO), which is now
in extensive clinical trials to treat human sleeping sickness (Pepin eta!., 1991). The
United States Food and Drug Administration has, in November 1990, registered the drug
for gambiense sleeping sickness, and thus for the first time in 40 years a new and
effective drug is available for the treatment of African trypanosomiasis. Despite the
success of DFMO, its use is limited in humans and impractical for animals because of its
complicated mode of application involving high doses given several times daily
intravenously, or orally for at least two weeks (Kuzoe, 1991).
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1.3

The genome of Trypanosonia brucei

1.3.1 Chromosome number
Trypanosomes lack histone HI and so their chromosomes do not condense into
cytologically recognisable structures at metaphase during the cell division cycle
(Vickerman and Preston, 1970). Therefore, cytological staining techniques cannot be
used in determining the chromosome number. However, the application of pulsed field
gel electrophoresis (PFGE) (Schwartz and Cantor, 1984) initially to T. bruce!, and
subsequently to other trypanosomes, has contributed greatly to the present information on
trypanosome karyotypes. Early investigations reveaecl that tnere are 1large ó1eiences
between species in their molecular karyotypes (van der Ploeg eta!., 1984a).
Furthermore, trypanosome clones from the same serodeme can differ in their karyotypes
(Bernards eta!., 1986). By PFGE, the trypanosome DNA can be classified into three
general classes of chromosomes (van der Ploeg eta!., 1984b; Majiwa eta!., 1986b); the
genome of T. b. brucei, for example, is organised into 100 minichromosomes ranging in
size from 50 to 100 kbp, intermediate size chromosomes between 150 to 800 kbp, and the
large chromosomes that are greater than 900 kbp in size. Recently, van der Ploeg et a!.
(1990) showed a total of 18 individual large chromosomes up to 5.7 mbp in size by
separating the chromosomes using a range of PFGE conditions. Furthermore, by
determining the chromosomal location of different genetic markers, it was demonstrated
that 14 of these chromosomes could be organised into seven pairs of homologous
chromosomes (van der Ploeg et al., 1990). In most instances the putative chromosome
homologues differed in size by about 20%. In some cases, however, non-homologous
chromosomes co-migrated as a single band, and some DNA remained at, or close, to the
well of the pulse field gels. As yet there is no evidence that the non-migrating DNA
represents very large chromosomes; van der Ploeg eta!. (1990) suggest that this DNA
represents different DNA molecules, among which are the kinetoplast DNA network (van
der Ploeg eta!., 1984a), as well as chromosome-sized DNA molecules which are non
specifically trapped.
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1.3.2 Ploidy
The size of the genome of one stock of T. brucei has been estimated to be 7.4 X
io7 base pairs per diploid genome (Borst eta!., 1982). Evidence based on isoenzyme
studies (Tait, 1980, 1983), analysis of restriction fragment length polymorphisms
(RFLPs) (Gibson eta!., 1985), DNA content with kinetic complexity (Borst eta!., 1982),
and measurements of DNA content by cytophotometry (Entilis eta!., 1987), indicates
that bloodstream forms of trypanosomes are diploid. Extension of flow cytometry to
other life-cycle stages of trypanosomes showed that each stage has an identical DNA
content and, by analogy to blood -stream forms of T. b. brucei, are thus also diploid
(Shapiro, 1984; Sternberg eta!., 1988a). The direct evidence for the existence of
diploidy, and a system of gene exchange, has been convincingly obtained following the
deliberate transmission of two different T. brucei subspecies through the tsetse fly vector
(Jenni eta!., 1986). The hybrid progeny of this cross fell into two categories: (1)
subtetraploid heterokaryons, which may have arisen from a simple fusion event and
which have an unstable DNA content (Jenni eta!, 1986; Pandavoine eta!., 1986; Wells

eta!., 1987), and (2) diploid hybrids showing Mendelian inheritance of some characters,
implying the involvement of meiosis at a stage as yet undetermined during cyclical
development in the tsetse fly (Le Page eta!., 1988; Sternberg et a!., 1988b; Tait eta!.,
1988).
Studies on the inheritance of karyotypes following genetic exchange has revealed
that minichromosomes of hybrids are principally composed of a mixture of the parental
ones. In addition, there are minichromosomes of non parental sizes and some parental
chromosomes that are absent (Wells eta!., 1987). These observations were made in
hybrids with elevated DNA contents compared to the parental strains, and are now
believed to be the product of an irregular mating event (Wells eta!., 1987). Analysis of
intermediate chromosomes has also revealed their non-Mendelian manner of inheritance
(Le Page eta!., 1988; Gibson, 1989), where some hybrids inherit all the intermediate
chromosomes from one parent, while others inherit variable numbers of intermediate
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chromosomes from both parents. These results suggest that the intermediate
chromosomes are not segregated as diploid homologues. They are therefore considered
as haploid chromosomes, inherited in a random manner (Tait eta!., 1993). Investigations
on the inheritance of the larger chromosomes (Gibson, 1989; Gibson and Garside, 1991;
Tait eta!., 1993) has convincingly shown their segregation and recombination to be as in
a normal diploid Mendelian genetic system. The results of such experiments have,
however, shown that genetic exchange is not obligatory, as only a limited number of flies
harbouring mature infections produce hybrid trypanosomes (Tait and Turner, 1990), with
between 10 and 100% of clones being identical to one or other of the parents (Gibson et
a!., 1989; Sternberg eta!., 1989). To date, the available data also suggest that the genetic
exchange systems in T. bruce! can involve both cross and self-fertilization (Tait et a!.,
1993). There remain however a number of unanswered questions regarding genetic
exchange in T. brucel. Firstly, since there is no evidence for the occurrence of haploid
gametes at any stage of the trypanosome life-cycle (Sternberg eta!., 1988b; Tait eta!.,
1988), the stage at which mating occurs has yet to be determined. Secondly, it is not
known whether meiosis results in haploid gametes which then fuse, or whether meiosis
occurs after fusion of the diploid parental cells.

1.3.3 DNA rearrangements in African trypanosomes
1.3.3a

Antigenic variation
Antigenic variation, in the manner and extent that it occurs in African

trypanosomes, is unique to these organisms and appears to be the primary mechanism for
evasion of the host's immune response (Cross, 1990). Antigenic variation is manifested
through frequent gene rearrangements within the trypanosome genome, enabling the
trypanosomes to evade the immune system of their hosts by the sequential expression of
variant surface glycoproteins (VSGs) (Vickerman, 1969, 1978). The VSG forms a
homogenous dense surface coat, accounting for about 10% of the total protein in
bloodstream forms ofT. bruce! (Cross, 1975); usually only one VSG is expressed at any
one time, covering the entire outer trypanosome membrane.

28

The classically described course of a trypanosome infection is that of a relapsing
parasitaemia in which successive waves of parasites contain trypanosomes with different
VSGs. Most of the parasites in each wave are destroyed by host antibodies against these
VSGs. A small number of trypanosomes survive, however, because individual parasites
from the population switch spontaneously from the expression of one VSG to another
(Miller and Turner, 1981). Since different VSG variants generally differ dramatically in
amino acid sequence (Bridgen, Cross and Bridgen, 1976; Vickerman, 1978; Johnson and
Cross, 1979), new antibodies must be raised against the VSG of the switched population
and its descendants, enabling the trypanosome population as a whole to stay one step
ahead of the host's immune response. Figure 2 presents a schematic summary of
antigenic variation. It has been demonstrated that a single trypanosome infection in an
experimental rabbit can result in the successive expression of over 100 different antigenic
types (Capbern eta!., 1972). Furthermore, DNA hybridisations have revealed that each
Irypanosome has a large repertoire, estimated at about 1,000, of silent, or basic-copy
VSG genes (van der Ploeg eta!., 1982a). Recent data show that this finite repertoire can
be further amplified by mosaic gene formation (Barbet and Kamper, 1993) and point
mutation (Baltz eta!., 1991), producing an almost limitless capacity to vary.
When a tsetse fly bites an infected animal, trypanosomes can be ingested with the
blood meal. In the midgut of the insect, T. congolense and 1'. brucei differentiate into
procyclic or procyclic-like forms and lose the VSG, but express another membrane
protein termed the procyclic acidic repetitive protein (PARP) (Clayton eta!, 1990) or
procyclin (Overath eta!., 1983; Roditi eta!., 1987, 1989). In the midgut, the
trypanosomes undergo several transformations before a final differentiation in the
salivary glands or the proboscis (depending on the life-cycle of the species) to metacyclic
forms. The metacyclic forms, which are infective for mammalian hosts, re-acquire a
VSG coat but exhibit a limited repertoire of metacyclic VSGs. On inoculation into the
mammalian host, the metacyclics switch to the expression of bloodstream VSGS, the first
of which is often the VSG originally ingested by the fly (Hajduk and Vickerman, 1981).
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Figure 2
(A) A schematic demonstration of the successive waves of parasitemia
during a Trypanosoma brucei rhodesiense infection of a human patient
(redrawn from Donelson, 1989).
(B) A schematic demonstration of a controlled T. b. rhodesiense infection in
an immunocompetent laboratory animal. A single trypanosome expressing
VSGA (clone A) is injected into the blood and gives rise to the first peak of
parasitaemia, in which all of the parasites are expressing VSGA. The host
immune system kills most of the parasites during the next few days, but one or
more trypanosomes switches to the expression of VSGB, vhich is not recognised
by the anti-V SGA antibodies. These trypanosomes begin the next wave of the
process again. From each peak of parasitaemia individual trypanosomes can be
cloned to investigate the VSG structure and the molecular mechanism of
antigenic variation. Since the switch to a new VSG occurs spontaneously and
individual trypanosomes can have different growth rates. the synchrony of the
parasitaemia peaks is lost later in the infection.
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1.3.3b Rearrangement of VSG genes
VSG genes are situated at one or two general chromosomal locations; either at an
internal DNA site or near a double-strand DNA break which has been identified as a
chromosomal end or telomere (Williams eta!., 1979, 1981; De Lange and Borst, 1982;
Young et a!., 1982). An expressed VSG gene is invariably localised in a telomeric
expression site (ES) (De Lange and Borst, 1982). Hybridisation studies suggest that there
may be as many as 20 different ESs (Cully eta!., 1985); expression sites occur on
chromosomes of both intermediate and large sizes. Only one antigen is generally
expressed at any time, although several telomeres can be used alternately for antigen gene
expression. Antigenic switching can occur by replacement of the VSG gene in the active
ES by another previously silent or basic copy VSG gene. The basic copy must be
duplicated and translocated to an ES before their transcription can occur. The duplicated
VSG gene was named an "expression linked copy" (ELC) by Hoeijmakers eta!. (1980).
This duplicative translocation is a gene conversion event (Bernards eta!., 1981; van der
Ploeg et a!., I 982b; Michels eta!., 1983; Pays eta!., 1983), a term used to describe the
non-reciprocal transfer of nucleotide sequences from one DNA region to another. The
ELC was found to be sensitive to DNase I, suggesting that it is the gene undergoing
transcription (Pays and Steinert, 1981). The telomere-linked basic copy VSG genes, on
the other hand, need not undergo gene conversion to be transcribed. They have the
potential to be expressed in silu, even though they sometimes do undergo duplication
prior to their transcription (Laurent eta!., 1983; Pays eta!., 1983; Buck eta!., 1984;
Young and Williams, 1984; Pays and Steinert, 1988). Attempts to understand the
differences involved between the two basic observations of VSG-gene location and VSGgene transcription have been the source of much of the interest in trypanosome antigenic
variation by molecular biologists. The possible rearrangements associated with the
expression of VSG genes are summarised in Figure 3a and 3b (Donelson, 1989). The one
factor that has stood the test of continued experimentation is that it is necessary, but not
sufficient, for a VSG to be linked to a telomere if it is to be transcribed. Furthermore,
several lines of evidence indicate that there are several different telomeres at which a
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Figure 3
(A) Summary of the activation of VSG genes that are located at interior
chromosomal sites (redrawn from Donelson, 1989).
The VSG genes, represented by A, B and C can only be transcribed after
undergoing a duplicative transposition to form an expression-linked copy (ELC)
gene in an expression site linked to a telomere (indicated by the black square).
The transposed segment usually includes the VSG coding region and I to 2 kb in
front of the gene. Often the VSG previously in that expression site, gene

Y, is

deleted from the genome during the formation of the new ELC. Sometimes,
however, the ELC goes to another telomere-linked expression site and gene Y
lingers as an unexpressed telomere-linked gene in the old expression site.

(B) Summary of the DNA rearrangements associated ' ith the expression of
VSG genes that are already located near telomeres. At the top of the
diagram, gene X is an unexpressed VSG near the telomere (open circle) of a
chromosome (dashed line). Gene Y is undergoing transcription from an
expression site near the telomere (black square) of another chromosome (solid
line). The left pathway shows the formation of an ELC of gene X at the
expression site on the solid chromosome with the concomitant deletion of gene
Y. The centre pathway illustrates the activation of gene X, and inactivation of
gene Y, by a reciprocal exchange of the telomeric regions, including genes X and
Y, between the dashed and solid chromosomes. The right pathway shos the
displacement of the telomere, plus gene Y, on the solid chromosome with a
duplicated copy of the telomere and flanking region of the dashed chromosome.
This telomere conversion event results in the activation of the duplicated gene X
on the solid chromosome.
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VSG gene can be transcribed (Longacre eta!., 1983; Pays eta!., 1983), although, the
factor(s) that activates one, and only one, of these telomere-linked VSG genes to the
exclusion of others remains unknown. The recent finding of relatively frequent DNA
rearrangement and recombinational events at ES inactivation, in a region encoding VSG
gene ES promoter(s) (Gottesdiener eta!, 1991, 1992), suggests their possible role in ES
control.
1.3.4 Transcription of VSG genes

In trypanosomes, several genes exist in tandem arrays whose primary transcripts
span several gene copies. This has been shown for the T. brucei tubulin (Imboden et a!.,
1987; Mulich and Boothroyd, 1988), actin (Ben AmaretaL, 1988) and calmodulin
(Tschudi and Ullu, 1988) genes. Genes with different specificities may belong to the
same polycistronic transcription unit (Ben Amar eta!., 1988).
VSG expression sites are also long multigene transcription units (Cully, Ip and
Cross, 1985; Kooter el a!., 1987; Murphy eta!., 1987; Alexandre eta!., 1988; Pays eta!.,
1989). The VSG gene is the last coding sequence of a large transcription unit, which also
includes other genes. The best studied of these is a family of genes called the expression
site associated genes (ESAGs) (Cully, Ip and Cross, 1985; CuIly eta!, 1986; Kooteret
a!., 1987). Transcription of these genes is simultaneously regulated with the downstream
VSG gene in the expression site. If the VSG gene is transcribed, then the corresponding
ESAG is also transcribed. If the VSG is not transcribed, then the neighbouring ESAG is
not transcribed. Salmon el a!. (1994) have recently demonstrated that ESAGS 6 and 7
most likely represent the transferrin receptor in T. brucei.
It is believed that expression of VSG genes is controlled at the level of
transcription since VSG-specific cDNA hybridises under high stringency only to RNA
from trypanosomes expressing that VSG and not to RNA from trypanosomes producing
other VSGs (Hoeijmakers et a!., 1980; Pays eta!., 1980). More recently, however, posttranscription control of expression has been reported; Pays eta!. (1990) have
demonstrated that the beginning of the AnTat 1.1 VSG gene expression site, about 45
kilobases upstream from the antigen gene, remains transcribed in procyclic forms. The
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permanent activity of the promoter can readily account for the systematic reappearance of
the VSG antigen type present in the ingested bloodstream form following cyclical
transmission through the tsetse fly. Investigations by Pays eta!. (1989) indicate that the
abortive transcription of the VSG gene expression site appears to be linked to RNA
processing abnormalities.

1.3.5 Discontinuous transcription
Other than elucidating the molecular mechanism of antigenic variation, studies on
expression of VSG genes shed light on other molecular aspects of gene regulation in
trypanosomes. Discontinuous transcription, which is a process by which a mature mRNA
is derived from two independent transcription units and events, is one such process.
Historically, the study of discontinuous transcription started with the analysis of the 5'
end of a VSG mRNA, and comparing that with the corresponding genomic ELC. This
produced the surprising result that the 5'-most 35 nucleotides of the mRNA were not
contiguous with the genomic copy of the VSG gene (Boothroyd and Cross, 1982). In
addition, it was found that VSG mRNAs from different telomeric expression sites also
possessed the identical 35 nucleotides at their 5' ends (Boothroyd and Cross, 1982).
Further investigations led to the finding that all trypanosome mRNAs have the same
sequence at their 5' ends, now known to be 39 nucleotides (Perry eta!., 1987). This
conserved 39 nucleotide sequence has been called the spliced leader or miniexon
sequence (Nelson eta!., 1982). About 200 copies of the miniexon sequence are present
in the T. b. brucei genome, of which the majority are clustered in 1.35 kbp tandem
repeats (Michels eta!., 1983; Nelson eta!., 1982; Dorfman and Donelson, 1984).
Demonstration that the primary transcript of the miniexon is 140 nucleotides with a
miniexon at its 5' end (Campbell eta!., 1984a Kooter and Borst, 1984; Milhausen eta!.,
1984), and that VSG genes may be transcribed from chromosomes that do not carry a
copy of the miniexon repeat (van der Ploeg eta!., 1984c; Guyaux eta!., 1985), proved
that the two exons are transcribed discontinuously. Kooter and Borst (1984) have shown
that different RNA polymerases are responsible for transcription of the miniexon and the
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VSG gene, since they differ in sensitivity to inhibition by a-amanitin. It appears that
during the maturation of trypanosome mRNAs the miniexon is transferred from the
miniexon-derived RNA precursor to pre-mRNAs transcribed elsewhere in the genome by
a trans-splicing mechanism (Guyaux eta!., 1985; Borst, 1986; Murphy eta!., 1986;
Sutton and Boothroyd, 1986; Ralph eta!., 1988).

1.4.1 Understanding drug resistance at the molecular level
The only currently available means for control of African trypanosomiasis are
vector control, drug treatment, and in the case of bovidae, the use of trypanotolerant
livestock. These three strategies have many shortcomings. For instance, there is yet no
obvious way of achieving sustainable control of trypanosomiasis by effectively
controlling the 31 species and sub-species of tsetse flies in their different habitats across
the tsetse-infested zone of Africa.
As far as drug treatment is concerned, the problem of drug resistance in certain
forms of animal trypanosomiasis is now so acute that it poses a grave threat to future
control of trypanosomiasis using the existing repertoire of drugs (Leach and Roberts,
1981). The level of drug resistance which becomes particularly important in the field is
resistance to the standard curative doses (Hawking, 1963).
The optimum solution for control of trypanosomiasis would be the development
of a cheap, simple vaccine with a wide range of protection against different species of
trypanosomes. However, as Stephen (1986) states, "The tantalizing prospect of
producing a vaccine which would protect animals against the establishment of
parasitaemic infections has cost a good sized fortune; expended thousands of personhours; killed untold numbers.of experimental animals; filled hundreds of pages of
scientific journals with articles that are seldom quoted; led dozens of scientists to jump
onto the vaccine band-wagon and just as smartly off again in a state of frustration".
There is truth in this statement, but when one considers the annual economic and human
loss due to trypanosomiasis his point of view appears extreme. Although the information
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presently available on the mechanisms of antigenic variation make it highly unlikely that
a vaccine against trypanosomes can be developed based on these molecules, the potential
for a vaccine based on invariant surface molecules, or pathogenic molecules secreted by
these parasites, still remains. Molecular studies on trypanosomes are also contributing to
our understanding of unique DNA structures and novel mechanisms of gene regulation,
but are yet to have an impact on the disease caused by these parasites.
Lastly, there is an urgent requirement for detailed information on the genetic basis
of resistance to trypanocidal drugs and on the mode of action of the drugs. Such
information would be invaluable as it would allow the development of rapid diagnostics
for drug resistance, thereby enabling the potential development of new, urgently required,
therapeutic strategies to complement and improve the presently used regimens. This is
exemplified in cancer research: advances have recently been made in understanding the
molecular mechanisms of drug resistance in cancer cells. These investigations have
contributed to improvements in the chemotherapeutic strategies for the treatment of
cancer (Endicott and Ling, 1989).

1.4.2 Mechanisms of resistance

Comparisons of drug resistance mechanisms in bacteria, insects, plants and man
reveal several common features, in that certain classes of proteins can be responsible for
conferring resistance to various drugs in a diverse number of organisms.
Drug resistance can arise as a consequence of various biochemical mechanisms:
(a) Reduced drug delivery, which is a consequence of factors independent of the target
cell. In mammals, blood circulation is a factor of crucial importance in the delivery of
the drug to the target cells. Also, the brain, for example is difficult to target in
chemotherapy due to the blood brain barrier (Jennings et a!., 1979).
(b) Decreased or defective transport of drugs into cells is a general mechanism of
resistance, the importance of which varies considerably, depending on both the
lipophilicity of the drug and the structure of the cell membrane (Goldenberg and
Begleiter, 1984).
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(c) Increased drug efflux by proteins which act as membrane-located, energy-dependent,
efflux pumps (Chopra, 1984, 1986).
(d) Drug metabolism due to enzymes which can act by either potentiating or reducing the
toxicity of the drugs (Arca eta!., 1988).
(e) Reduction in the active drug concentration achieved by drug sequestration. This
occurs by increased intracellular drug binding, thus preventing drug interaction with a
target site (Kelly eta!., 1988).
(f) Increased intracellular concentration of the target site(s) (Alt eta!., 1978).
(g) Structural alterations of the cellular target(s) in a manner which reduces the affinity of
the drug for the target site(s). This type of drug resistance is usually the result of point
mutations in the structural gene(s) encoding the target, and is usually associated with
drugs whose target is well defined (Simonsen and Levinson, 1983).
(h) By-passing of a metabolic block through the production of a novel protein. In this
instance the new protein, which has the same function as the target protein, no longer
interacts with the drug (Smith and Amyes, 1984).
(i) Increased rates of repair of damaged target site(s). This represents an important
mechanism of resistance to alkylating agents and particularly radiation (Walker, 1985).
DNA repair has been implicated in resistance to chemical carcinogens and a wide range
of anti-cancer drugs (Kessel, 1986).
It is now realised that resistance to a particular drug can be achieved by a
multitude of mechanisms. Recent work has shown that where drug resistance is due to
changes in either drug transportation or detoxification, protection against more than one
chemical is invariably observed. This can be manifested as cross-resistance to either
structurally related or structurally unrelated chemicals. The latter phenomenon has been
referred to as multidrug, or pleotropic, drug resistance (Hayes and Wolf, 1990).
The molecular changes which account for drug resistance include gene
amplification, gene deletion, point mutations, the loss of cis-acting regulatory elements,
the loss or dysfunction of trans-acting factors, transcriptional activation, hypo' or hyper'
methylation or production of heat shock proteins which have been implicated in
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protection against both physiological and chemical stress (Li eta!., 1982). All these
effects could occur within genes directly involved in combating the cytotoxic
compounds, or in genes involved in regulation or processing of genes combating the
cytotoxic compounds. In theory, the number of ways in which cells could become drug
resistant are almost limitless.

1.4.2a Multidrug-resistance
Since the early I 980s, considerable attention in cancer research has focused on
multidrug-resistance (MDR), where tumour cells selected for resistance to a sinJe agent,
such as vinblastine or actinomycin D, display high levels of resistance to a broad range of
structurally diverse drugs (Gerlach eta!., 1986). The basis of this multidrug resistance
appeared to be due to reduced cellular accumulation of drugs resulting from an energydependent increase in drug efflux (Dano, 1973; Inaba eta!., 1979). The MDR phenotype
could be reversed by a variety of pharmacological agents which promote drug
accumulation. These include calcium channel blockers such as verapamil and calciumcal modulin antagonists (Kessel, 1986).
In 1976, Juliano and Ling found that several MDR Chinese hamster ovary (CHO)
cell lines expressed an increased amount of a 170 kilodalton membrane glycoprotein,
termed the P-glycoprotein. They further showed that the level of resistance to colchicine
correlated to the level of expression of the P-glycoprotein and that there was an inverse
relationship between the accumulation of certain vinka alkaloids and expression of Pglycoprotein, suggesting that this membrane protein may be involved in drug transport.
The mammalian P-glycoprotein was found to be encoded by a multigene family
(Gottesman and Pastan, 1988; Endicott and Ling, 1989). On the basis of similarities
between sequences, the P-glycoprotein genes in mammals have been divided into two
major classes: mdrl and n;dr2. The mdrl class of genes have been further subdivided
into mdrla and rndrlb (Kane and Gottesman, 1989).
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Structure and function of the mdrl gene
The human mdrl gene, encodes a 1280 amino acid sequence consisting of two
homologous halves (Chen eta!., 1986). Each half of the protein includes a hydrophobic
region with six predicted transmembrane segments and a relatively hydrophillic region
which contains consensus sequences for a nucleotide-binding site. Each half of the
protein has a high degree of primary amino acid sequence and structural similarity with
bacterial transport proteins, particularly hemolysin B (Higgins eta!., 1986). The
hypothesised energy-dependent efilux pump function of P-glycoprotein received indirect
confirmation from biochemical studies in which P-glycoproteins puiifled from a human
leukemia cell line were shown to bind drugs and to hydrolyse ATP in vitro (Cornwell et
a!.,

1986, 1987; Hamada and Tsuruo, 1988).
Homology with bacterial transport proteins and the presence of potential channel-

forming membrane-spanning segments represents a structural motif which is a
characteristic feature of pore-forming proteins (Henderson and Maiden, 1987). The
presence of two highly conserved ATP-binding regions is consistent with a role for an
active efflux pump, responsible for the removal of drugs from multidrug-resistant cells.
However, more direct evidence has been obtained from investigations demonstrating that
transfection of mdrla and mdrlb cDNAs into drug-sensitive cells produces the MIDR
phenotype (Gros eta!., 1986; Croop eta!., 1987; Veda eta!., 1987; Pastan eta!., 1988).
Surprisingly, not all mdr genes have the ability to produce the MDR phenotype. Finally,
whilst the P-glycoprotein encoded by the mdrl class of genes can confer drug resistance,
the mdr2 class of genes encode a protein whose physiological function is presently
unknown. It is now evident that increases in either the expression of mdrl genes, or
changes that affect their function as efficient efflux pumps, are of central importance in
producing the MDR phenotype.
Amplification of specific genes has been implicated in a variety of adaptive
responses of cells to environmental stresses (Schimke, 1984). An early link was
established between the MDR phenotype and gene amplification as highly multidrugresistant cell lines revealed cytogenetic changes that are hall-marks of gene amplification
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(Stark, 1986). The term gene amplification is usually applied to changes in relative copy
number of a limited portion of the genome; specific amplification of genes encoding the
drug target is one means by which cells acquire resistance to the action of selective agents
(Schimke, 1984; Stark and WahI, 1984). Following the cloning of mdr genes,
examination of the DNA of highly resistant cells by Southern blotting revealed a marked
increase in the copy number of the mdr genes in many of these cell lines.
Other than gene amplification, Choi eta!. (1988) have shown that point mutations
in the human mdrl gene can also produce a P-glycoprotein that is more effective in its
efflux property.
Gene amplification and point mutations are not the only mechanisms which can
result in an MDR phenotype. Increased expression of P-glycoprotein mRNA has also
been observed in cell lines displaying an MDR phenotype, in the absence of amplification
of mdr genes (Shen eta!., 1986).
The expression of P-glycoproteins in normal human tissues has been recently
determined using monoclonal antibodies and DNA probes (Endicott and Ling, 1989).
These studies have shown that there is expression of P-glycoproteins in normal human
liver, kidney, pancreas, stomach, intestine, colon and spleen. Many of these organs play a
role in chemical detoxification, suggesting a possible normal role for P-glycoproteins in
transport and secretion. It is suggested that P-glycoproteins may transport different
compounds in different tissues, or, by analogy to its role in drug transport in MDR cells,
it may be a common route for the export of toxic compounds (Endicott and Ling, 1989).
Lastly, P-glycoproteins are widely distributed in nature. For instance, in addition
to mammals, other eukaryotes such as the malaria parasite P!asm odium falciparum
(Foote eta!., 1989; Wilson eta!., 1989), the yeast Saccharonzyces cerevisiae (McGarth
and Varshavsky, 1989) and the kinetoplastid protozoan flagellate Leishmania tareniolae
(Ouellette eta!., 1990) also possess mdrl-like genes.
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1.4.2b Drug resistance in Plasmodium and Leishmania
The appearance of chioroquine-resistant (CQR) Plasmodiumfalciparum has
thwarted the goal of global control of malaria. Chioroquine is a diprotic base and appears
to raise the pH of the parasite food vacuole and interfere with its function (Yayon, 1984).
It is suggested that the plasmodium parasite has a chloroquine-concentrating mechanism
that is absent from the mammalian acid vesicles. This mechanism accounts for the
relative inability of the parasite to buffer a base load in the presence of chioroquine, and
is thus responsible for the selective action of chloroquine against it (Krogstad, 1987).
Experiments have demonstrated that the CQR phenotype is associated with a
lower accumulation of chioroquine than that observed in sensitive parasites (Yayon eta!.,
1984). This has been attributed to the resistant parasite having an efflux mechanism by
which chioroquine is released at a rate 50-times that of susceptible parasites (Krogstad,
1987). The phenomenon of chloroquine efflux, and resistance, in P.fa!ciparum is energy
dependent and can be partially blocked by calcium channel antagonists (Martin et a!.,
1987), similar to the MDR phenotype characterised in mammalian cells (Fojo eta!.,
1985). These observations initiated the use of sequence conservation in the mdr gene
family to identify P.falciparum mdr homologues (Wilson eta!., 1989). Two genes were
identified and designated Pfmdrl and Pfmdr2. Foote eta!. (1989) demonstrated that the
malaria md.r copy number and transcripts are amplified in some chioroquine-resistant
parasites but not in any of the sensitive isolates examined. Furthermore, as for the
mammalian MDR phenotype, specific point mutations in the mdi gene were also
implicated in CQR (Foote eta!, 1990). However, genetic crosses between CQR and
chloroquine-susceptible strains indicated that there was no direct linkage between CQR
and the plasmodium P-glycoprotein gene homologues (Wellems eta!., 1990). This
suggests that if mutations in Pfmdr genes play a role in CQR, this is likely to be just a
component of a multigenic process (Foote et a!., 1990; Newbold, 1990).
In Leishmania spp, the H-circle amplicon was first observed in L. major lines
resistant to one folate analog methotrexate (MTX) (Coderre eta!., 1983). It was
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subsequently observed in lines selected with terbinafine and primaquine (Ellenberger and
Beverley, 1989), and in two natural isolates of L. tarenio!ae (Petrillo-Peixoto and
Beverley, 1988). The occurrence of H-circles in these diverse settings suggests that
amplification may confer simultaneous resistance to many drugs, as with the MDR
phenotype in mammalian cell lines (Schimke, 1984). Ouellette eta!. (1990) have shown
that the amplified H circle of MTX-resistantL. tarentolae contains a P-glycoprotein gene
(ltpgpA). Callahan and Beverley (1991) demonstrated, by transfection, that amplification
and over-expression of the lapgpA gene confers resistance to L. major against arsenite and
particular antimonial agents; drugs that are not typically transported by human Pglycoproteins (Endicott and Ling, 1989). In addition, L. iareniolae lines with the H
amplification were not resistant to a variety of compounds considered substrates of the
mammalian P-glycoprotein (Ouellette eta!., 1990). These experiments were unable to
demonstrate that ltpgpA conferred an MDR phenotype as in mammals. Callahan and
Beverley (1991) showed that !tpgpA proteins represent a functionally distinct group of Pglycoproteins that exhibit a substrate specificity similar to that of prokaryotic heavy
metal pumps. More recently, Henderson eta!. (1992) demonstrated that an MDR
phenotype as in humans, was conferred to L. donovani by amplification of a gene
homologous to the mammalian mdrl gene (ldmdrl). Henderson eta!. (1992) also
demonstrated that the !dmdrl locus was unrelated to H-region amplification, thus
showing that Leishmania species can acquire two dissimilar MDR phenotypes associated
with the amplification of genes highly homologous to the mammalian mdr gene.
Although the H-region was first described in MTX-resistant L. major, transfecting
with lpgpA did not confer resistance to antifolates, and the MTX resistance is not
reversed by calcium channel blockers verapamil (Callahan and Beverley, 1991). These
discrepancies have been explained with the recent discovery of a new gene called ltdth in
L. tarentolae (Papadopoulou et a!., 1992), that by transfection has been shown to confer
high levels of resistance to different antifolates tested. Such investigations suggest that a
large number of loci mediating a wide spectrum of reactions can be amplified under
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appropriate conditions, suggesting that no particular class of enzymes or loci are
especially prone to amplification (Beverly eta!., 1988).
Over-expression of genes as a consequence of gene amplification has been
reported in several MTX-resistant lines of Leishmania species, beginning with L. major
(Coderre eta!., 1983). Further studies showed a correlation between resistance to MTX
and elevated DHFR activity, which led to the isolation of the gene encoding the target of
MTX, the dihydrofolate reductase thymidylate synthase (DHFR-TS) gene product, a
novel bi-functional protein (Beverley eta!., 1987).
It is now known that there are at least three mechanisms by which resistance to
MTX occurs in Leishmania (Beverley eta!., 1988). The mechanisms identified are: (1)
amplification of the DHFR-TS gene, encoded on a segment of DNA termed the R region,
(2) decreased cellular MTX accumulation, and (3) amplification of a region of DNA
termed the H-region, which is completely distinct from the R-region. Ellenberger and
Beverley (1987, 1989) have shown that these three mechanisms can occur independently
or in combination in the same cell, indicating that the parasite has diverse mechanisms it
can marshal to survive chemotherapeutic attack. Amplified DNA such as the R region
occurs generally as extrachromosomal circular DNA, and can be readily detected due to a
high copy number and unusual mobility properties in conventional or pulsed-field
electrophoresis gels (Beverley, 1988). Multiple Leishmania spp. bearing amplified Rregions have been derived, and the location of the amplified segments of the
chromosomal DNA have been determined (Beverley eta!., 1984; Beverley, 1991). The
region amplified always includes the coding region for DHFR-TS, as well as substantial
flanking DNA ranging in size from 30-90 kbp.
Mutations in the DHFR-TS gene have been implicated in pyrimethamine
resistance in Plasmodiumfalciparum. Pyrimethamine, a substrate analogue, binds to, and

inhibits, the dihydrofolate reductase activity of the essential bifunctional enzyme DHFRTS (Ferone eta!., 1969; Garret eta!., 1984). It has been shown that a number ofF.
fa!ciparum DFIFR mutants exhibit the pyrimethamine resistance (Pyr) phenotype
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(Banyal eta!., 1986; ZoIg eta!., 1989). Inselburg et al. (1989) have also suggested that
chromosome-size changes that contribute to either gene duplication or gene regulatory
processes probably play an important role in the development of higher levels of PyrR.
The same workers have also noted that maintaining a PyrR culture of P.fa!czparum in the
absence of drug led to the selection or alternation of a parasite population with a
diminished level of resistance.
The outcome of studies on PyrR has had a great impact on control of P.
faciparum. For instance, it is now known that with control of pyrimethamine usage, the
selective drug pressure that maintains some highly resistant organisms can be eliminated,
thereby allowing the sensitivity to pyremethamine to be restored (Inselburg etaL, 1989).

1.4.2c Mechanisms of drug resistance in African trypanosomes.
To date, very little is known about the molecular mechanisms involved in drug
resistance of trypanosomes. Recently, however, Carter and Fairlamb (1993) have
reported that the in vitro trypanolytic effect of melarsen oxide, an arsenical used to treat
human African sleeping sickness (Apted, 1980), can be specifically abrogated by
adenine, adenosine and dipyridamole, all of which compete for uptake by an adenosine
transporter. Their investigations have also shown that melarsen-sensitive trypanosomes
have two high-affinity adenosine transport systems; a P1 type, which also transports
inosine, and a P2 type, which transports adenine and the melaminophenyl arsenicals.
These studies have shown that melarsen-resistant trypanosomes lack the P2 type
adenosine transporter, suggesting that resistance to these arsenicals is due to loss of
uptake.
By fluorescence analysis of the interaction of isometamidi.um with clones ofT.
congo!ense, Sutherland eta!. (1991) have observed an inverse relationship between the
intensity of trypanosome-associated fluorescence and the level of resistance to
isometamidium expressed by the clones. More recently, Zilberstein eta!. (1993) have
demonstrated that the alterations in fluorescence that occur when isometamidium
interacts with isometamidium-sensitive T. congolense are due to interaction of the drug
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with an intracellular component(s). This work has also demonstrated that isometamidium
is transported across the plasma membrane via a protein carrier. The role of these
processes in drug resistance, however, are yet to be determined.
The work presented in this thesis was the result of an attempt to identify genes
that may be involved in drug resistance in a multidrug-resistant T. b. brucei, CP
(Chemotryp Project) 547 (CP 547). This isolate has been characterised with regard to its
drug-resistance profiles both in vitro and in vivo (Zweygarth and ROttcher, 1988;
Kaminsky and Zwegarth, 1989b; Kaminsky eta!., 1989). It was isolated in 1985 from a
naturally infected cow in Jilib Somalia. It is a pleomorphic T. b. brucel (Zweygarth and
ROttcher, 1988) and has been shown to be resistant to diminazene, homidium,
isometamidium, quinapyramine, mel B and pentamidine, but fully sensitive to suramin.
The drug-sensitivity profile of the stock has been shown to remain relatively stable in
vitro conditions for at least 275 days (Kaminsky and Zweygarth, 1989 b). Table 7
(Zweygarth and ROttcher, 1988) shows the in vivo patterns of drug sensitivity ofT. b.
brucei stocks CP 462, a sensitive isolate, and CP 547, to currently used trypanocides. In
the present work the sensitive control population used was T. b. brucei ILTat 1.4. In
additional studies, the multidrug-resistant trait of CP 547 could not be reversed by
verapimil (Kaminsky eta!., 1991), a drug that reverses the mammalian ?vIDR trait. This
observation suggests that, as for Leishmania (Henderson eta!,. 1993) and possibly P.
fa!c:parum, trypanosomes may acquire MDR phenotypes that are dissimilar to the
mammalian MDR phenotype.
In view of the problem of drug resistance and the difficulties and expenses
involved in the development and introduction of new trypanocides, it is important to
improve on the presently available drugs, both in terms of modifying them and/or using
them in improved combinations. One of the strategies to combat resistance relies on
reversal of resistance, which has recently been experimentally demonstrated for
chroloquine resistance in human and rodent malaria (Krogstad, 1987). Such approaches
could also be extended to control of trypanosomiasis, but require an intense knowledge
both of the mode of action of the present drugs and the mechanisms by which

i.1
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Table 7:

Patterns of drug sensitivity in mice of Tb. brucei stocks CP 462 and
CP 547 to commercial trypanocides

Drug*

Dose
(mg/kg)

Results
(No. cured/No, treated mice)b
CP462

Diminazene aceturate

Homidium chloride
Isometamidium chloride
Quinapyramine sulphate
Suramin
Me1B
Pentamidineisethionate

6.3
16
50

7/8
8/8
-

CP547
0/8

80

-

0/8(5)

6.25
50
1
3
10
8
5
2.5
10
10
20
50

8/8
8/8
8/8
4/8
8/8
8/8
7/8
8/8
-

1/8
0/8
5/8
0/8
8/8
1/8
8/8
1/8
4/8
8/8

a Au drugs were injected ip
b Number in parenthesis indicates deaths due to toxicity
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tiypanosomes can overcome the toxic effects of trypanocides. The initial objective of
this study was to identify and characterise molecular differences between a multidrugresistant isolate (CP 547), and a reference drug-sensitive population, ILTat 1.4. The
aforementioned R- and H- region amplifications result in extrachromosomal circular
DNA elements which are readily detected. In light of the involvement of such elements
in drug resistance in leishmania spp., we were interested to determine whether similar
amplified sequences could be identified in a multiple-drug resistant T. b. brucei field
isolate, CP 547, and whether such elements could be used as DNA-based diagnostics for
drug resistance. Finally, we were interested to determine whether gene amplification is a
mechanism employed by drug-resistant tiypanosomes to overcome the toxic effects of
drug pressure as has been observed in Leishmania spp. (Segovia, 1994).
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CHAPTER 2

MATERIALS AND METHODS

2.1

Materials used:

Suppliers:
The following abbreviated forms are used for some suppliers:
Amersham:

Amersham International, Amersham, U.K.

BDH:

British Drug Houses, Poole, Dorset, U.K.

Bio-Rad:

Bio-Rad Laboratories, Richmond, California, U.S.A.

Boehringer:

Boehringer Mannheim, West Germany

BRL:

Bethesda Research Laboratories mc, Gaithersburg, MD, U.S.A.

Sigma:

Sigma Chemical Company, Poole, Dorset, U.K.

NEB:

New England Biolabs, Beverley, MA, U.S.A.

Promega:

Promega Corporation, 2800 Woods Hollow Road, Madison,
U.S.A.

S and S:

Schleicher and Schuell, Dassel, Germany

a)

Ordinary chemicals: All chemicals used were BDH or equivalent
analytical grade

b)

Enzymes: NEB, BRL, Amersham, Promega.

c)

Animals: Baib C mice and Sprague Dawley Rats were both
obtained from the animal breeding unit at ILRAD

d)

Miscellaneous
X-ray film: Fuji Photo Film Co. Ltd., Japan
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Polaroid film: Fabrique au Royaume-Uni par Polaroid (U.K.)
Ltd.
Nytran membrane: from Schleicher and Schuell
Radiochemicals: Amersham

2.1.1 Buffers:
Abbreviations for some buffers referred to in the text:
CGA:

Citrate glucose anticoagulant
100 mM trisodium citrate
40 mM glucose, (pH 7.7)

PSG:

Phosphate saline glucose
57 mMNa2HPO4
2.6 mM NaH2PO4(H20)2
42.8 mM NaC1
55.5 mM glucose

SSC:

Saline sodium citrate
150 mMNaC1
15 mM trisodium citrate
prepared as a 20 X stock.

ThE:

Tris borate EDTA
90 mM TRIS
90 mM boric acid
2.5 mM EDTA, (pH 8.0)
Prepared as a 10 X stock
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T.E:

TrisEDTA
10 mM Tris-HCI (pH 7.4)
0.1 mM EDTA, (pH 8.0)

TE:

Tris EDTA
10 mM Tris-HC1 (pH 7.4)
10 mM EDTA, (pH 8.0)

TNE:

Tris sodium EDTA
100 mMNaC1
5 mM EDTA
25 mM Tris-HC1 (pH 8.0)
Prepared as 20 X stock.

TAE:

Tris acetate EDTA
40 mM Tn s-I-ICE
20 mM HAc
2 mM EDTA (pH 8.0)
Prepared as a 50 X stock.

2.1.2 Markers:

DNA markers

lambda DNA cut with Hind ffl (NEB)
1

23,l3Obp

5

2,322bp

2

9,416bp

6

2,027bp

3

6,557bp

7

564bp

4

4,361bp

8

125bp
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DNA markers

4)

X 174 cut with Hae HI (NEB)

1

1,353bp

6a

281 bp

2

1,078bp

6b

271 bp

3

872bp

7

234bp

4

603bp

8

194bp

5

3lObp

9

118 bp

10

72 bp

RNA markers (Promega)
1

9,488 bp

5

1,898 bp

2

6,225 bp

6

872bp

3

3,911 bp

7

562bp

4

2,800 bp

8

363bp

ProMega-markers for PFGE
1)

S. porn be chromosomes: 3.5, 4.7 and 5.7 Mb

2)

S. cerevisiae chromosomes: 1900, 1640, 1120, 1100,
945, 915, 815, 785, 745, 680, 610, 555, 450, 375, 295, 225 kbp

3)

Lambda ladders: ranging from 50 kbp to 1000 kbp
increasing by 48.5 kbp in a 20 step ladder.

2.1.3 Media:
2 x YT (per litre)
16 g bactotyptone
10 g yeast extract
5gNaCl
NZCYM medium (per litre)
1OgNZ amine
5 g NaC1
1 g casamino acids
5 g Bacto-yeast extract
5 g MgSO4 7HO
0.5 mg ampicilfin
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L.B. Medium (per litre)
10 g Bacto-typtone
5 g Bacto-yeast extract
lOgNaCi
SOB Medium (pH 7.0) (per litre)
2% (w/v) Bacto-typtone
0.5% (w/v) Bacto-yeast extract
10 mM NaCI
2.5 mMKC1
10 mM MgCI,
10 mM MgSG4
Frozen storage buffer (FBS) pH 6.2 (per litre)
100 mM KCI
45 mM MnCl2
10 mM CaC12
3 mM HA CoC13
10 mM potassium acetate
10% glycerol
SM phage buffer (per litre)
5.8 NaCI
2gMgSO4
50 ml IM Tris-HCI pH 7.5
5 ml 2% gelatin

2.1.4 Drugs
Diminazene acetirate (Bexenil, Hoechst M3, FRG a.n.d isonietarnidium. chloride
(Samorin, May and Baker, UK) were purchased commercially. Concentration was
calculated on the basis of the active principle of 44% diminazene aceturate in Berenil.
The drugs were dissolved in triple distilled water on the day of use.
Ampicillin (Penbritin, Dawa Pharmaceuticals Ltd., Nairobi, Kenya) was stored dissolved
at 100 mg/ml and stored at -20°C. It was added to media and agar to a concentration of
100 .ig/ml when required.
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2.2

BacterIal strains and vectors

Escherichia coil EM 109 (recA 1 supE44 endA I hsdRl 7 gyrA96 re/Al thi F') (Yani sch-

Perron eta!., 1985). E coil Y1090 (supFhsdRaraLJl39 /acUl69rspL
t,pC22::TnlO(tef)pMC9) (Young and Davis, 1983).

Vectors
pUC19 (Promega, USA) is a 2.69 kbp vector which contains a polylinker with 20 unique
restriction sites and a lacZ promoter for blue/white colour selection (Yanisch-Perron et
a!., 1985).
pBluescript (KS) (Strategene, USA). This is a 2,964 bp phagemid derivative of pUC19
and possesses T3 and T7 promoters flanking a polylinker, which contains 21 unique
restriction sites and a iacZ promoter for blue/white colour selection (Yanisch-Perron et
a!., 1985).
lambda gtl 1 (/ac5 ,z1n5 c11857 S100; Young and Davis, 1983); (Promega, USA). This
bacteriophage vector possesses a unique EcoR I cloning site located in the lacZ promoter
allowing for blue/white colour selection (Young and Davis 1983).

All strains of bacteria with or without plasmids were stored at -70°C in 50 % glycerol,
50% culture medium.

2.3

Trypanosome management

2.3.1 Trypanosomes used
CP 547 is a pleomorphic T. b. brucei was isolated in 1985 from a naturally infected cow
in Jilib, Somalia. This stock causes relapsing parasitemia in mice and is resistant to
diminazene, isometamidium, quinapyramine, and melarsoprol (Kaminsky and
Zweygarth, 1989b).
ILTat 1.4 is a 7'. b. brucei monomorphic clone of a derivative of EATRO (East African
Trypanosomiasis Research Organisation) 795, which was isolated from a cow in

51

Uhembo, Kenya (Miller and Turner, 1981). The clone is highly virulent in mice and is
susceptible to diminazene, isometamidium, suramin and pentamidine (Kaminsky eta!.,
1989).
ILTat 1.1 is a pleomorphic clone that is also a derivative of EATRO (East African
Trypanosomiasis Research Organisation) 795 (Miller and Turner, 1981).
IL 3388 (Hirumi, 1980) is a T. b. bruce! clone a derived from EATRO 217, isolated from
Uganda in 1960.
1LB24 is a T. b. bruce! clone (Cunningham ci a!., 1962; Hlrumi, 1980). Reference
records available from ILRAD.
ILBIO is a T. b. bruce! clone isolated by Murray. K. form a cow in The Gambia in 1976.
Reference records available from ILRAD.
ILTat 221 was derived from a stock 427 isolated in Uganda from a sheep in 1960.
(Cunningham, eta!., 1962).
ILTar 2 was derived from stock 247 isolated in the Serengeti in Tanzania in 1973 (Geigy,
1973)
GUTat 3.1 is a sensitive T. b. bruce! clone (Black eta!., 1982) isolated from Uganda in
1966.
ANTat 1.8 is a T. b. bruce! clone (Magnus ci a!., 1981).

2.3.2 Routine propagation of trypanosomes
Stabilates were thawed on ice and expelled from capillary tubes with 0.5 ml of
PSG. The number of viable trypanosomes was estimated by counting motile organisms
in a haemocytometer. Irradiated mice (650 rad.) were infected with an intraperitoneal
injection of 106 trypanosomes from the capillary. The course of the infection was
followed by examination of tail blood using the wet blood film method. High
parasitaemia (greater than 5 x 108 trypanosomes per ml) was usually obtained after 4
days. Infected blood was collected from anaesthetised mice by cardiac puncture in a
solution of 3% sodium citrate glucose anticoagulant (CGA).
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When larger numbers of trypanosomes were required, infected mouse blood was
used to infect rats by intraperitoneal injection of blood diluted in 0.2-0.5 ml PBS,
containing 2 x io trypanosomes. The ensuing parasitaemia was monitored by
microscopic examination of tail blood using the wet blood film method. Rats were
anaesthetised and bled by cardiac puncture as for mice.

2.3.3 Enumeration of trypanosomes

Trypanosomes were counted in a Neubauer haemocytometer, as described by
Lumsden eta!. (1973). Only motile trypanosomes were counted and dividing stages
counted as one trypanosome.

2.3.4 Preparation of trypanosome stabilates
The method used for cryopreservation of trypanosomes is based on the work of
Cunningham eta!. (1963). Briefly, infected mouse or rat blood was collected into a 2 ml
syringe containing about 0.2 ml of CGA. The blood was then mixed with an equal
volume of 20% glycerol in PSG, and transferred into capillary tubes in aliquots of
approximately 50 .il. The capillaries were sealed at one end only with plasticine, and
then cooled, first on ice, and then in the vapour phase of a liquid nitrogen tank using a
slow cooling plug (Union Carbide) or an insulated bottle, both of which allowed cooling
at about one degree per minute. The frozen stabilates were stored in liquid nitrogen.

2.3.5 Trypanosome cloning
Trypanosomes were cloned by a modification of the dilution method of Walker
(1968). Infected blood was diluted in RPM! 1640 medium containing 10% foetal calf
serum. A dilution containing about 10 trypanosomes per ml was prepared. Small
droplets (about I gil) of this dilution were placed on coverslips which were then inverted
over the depression of a cavity microscope slide containing a drop of the dilution buffer.
These drops were examined with a phase contrast microscope. To the droplets containing
single living trypanosomes, additional medium containing 10% FCS was added and the
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diluted drop was drawn into a I ml syringe. The recovered mixture was then used to
infect irradiated mice (900 rads) by intravenous injection. The presence of only a single
trypanosome in each droplet was confirmed by independent observers. Blood was
collected from the infected mice after 3 days and transferred into additional irradiated
mice in which the parasitaemia was followed by examination of tail blood. Blood from
positive mice was then cyropreserved (section 2.3.4).

2.3.6 Characterisation of drug sensitivity
In order to characterise the drug sensitivities of the various populations, stabilates
of each clone were expanded in irradiated mice. Prior to the first peak of parasitaemia,
blood was collected into ethylene diaminetetra-acetate (EDTA) (final concentration 7.5%
w/v) and the parasitaemia estimated using a Neubauer haemocytometer. Groups of nonirradiated mice (6/group) were innoculated i.p with 1.0 x 66 bloodstream forms and
treated 6 h later with varying doses of isometamidium chloride (0.5-15 mg/kg body
weight) or dimina.zene aceturate (20-60 mg/kg body weight). Trypanocides were
administered i.p. in 0.2 ml of sterile water. Following treatment, mice were monitored
twice weekly for 60 days, for the presence of parasites, by examination of tail blood
using the wet blood film method. Using standard logic analyses, the sensitivities of each
clone to isometamidium chloride and diminazene aceturate were expressed as 50%
curative dose (CD 50 ) values, i.e., the dose of drug required to cure 50% of infected mice.
KendalPs rank correlation test (Sprent, 1989) was used to determine whether there was
any correlation between the isometamidium chloride and diminazene aceturate CD50
values of each clone.

2.3.7 Isolation of trypanosomes (Lanham and Godfrey, 1970; and Grab and
Mbwayo, 1982)
At peak parasitaemia, infected mice or rats were anaesthetised and the
parasitaemjc blood collected. To the parasitaemic blood, an equal volume of Percoll
solution (100 ml of Percoll Pharmacia containing 8.55 g sucrose, 2.0 g glucose and 0.34 g
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HEPES was added). The mixture was then centrifuged at 16,000 rpm, 4°C for 20 mm in
a Beckman J-20 rotor. The buf'fy coat of trypanosomes was collected and diluted 3X
with cold phoshate/glucose/saline buffer (PSG) and applied to a column of DEAE
cellulose (Whatman DE-52), previously equilibrated with PSG buffer pH 8.0 and poured
in a suitable plastic syringe barrel plugged with glass wool. The column was washed
with PSG to obtain the tiypanosomes separated from blood cells absorbed to the DEAF
cellulose. The trypanosomes were used for isolation of DNA and RNA.

2.4

Nucleic acid preparation:

2.4.1 Isolation of trypanosome DNA (Bun and Stafford, 1976).
Reagents:
T.E
TNE
Proteinase K: Stock prepared at 20 mg/mI in sterile water
RNase:

2 mg/mI RNase A (Serva) in water, incubated in boiling water (93°C in
Nairobi) for 15 minutes and stored at -20°C.

10% SDS:

10% w/v sodium dodecyl sulphate in sterile water stored at room
temperature.

Procedure:
Once trypanosomes were purified by DEAE cellulose chromatography (section
2.3.7), they were counted, washed once in PSG and resuspended at 0.3-10 x i09
trypanosome per ml in TNE in 30 ml Corex tubes. This suspension was brought to a final
concentration of 0.1% SDS by mixing quickly, but gently, by inversion of the tube. The
lysate was incubated at 37°C until completely clear (2-5 minutes) followed by addition of
0.05 volumes of RNase A (2 mg/mI) which was added and mixed by inverting and rolling
the tube gently. Proteinase K was added to a final concentration of 100 ig/ml and the
digestion allowed to continue for 4 h at 37°C. The lysate was extracted with an equal
volume of phenol equilibrated with TNE. The aqueous and phenolic phases were mixed
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gently by continuous inversion of the tube for about 3 minutes. The mixture was
centrifuged at 3,000 x g for 5 minutes, and the aqueous phase was removed with a plastic
pipette cut off to give a 2 mm aperture. The DNA solution was then precipitated in the
form of a loose fibrous clot with the addition of 2Y2 volumes of absolute ethanol (at room
temperature). The precipitate was recovered by pulling it out with sterile flat tipped
forceps and transferred twice into fresh 70% ethanol with agitation. It was then dried
under vacuum and resuspended in T.E at a final concentration of 200-500 pg/mi. DNA
concentrations were estimated by measuring the absorbance at 260 nm, assuming that
A260 of I represents 50 pg per ml of DNA. The typical yield was 1 mg of DNA per 1010
trypanosomes. The purified trypanosome DNA was stored at 4°C.

2.4.2 Isolation of trypanosome RNA (Chomczynski and Sacchi, 1987)
Reagents:
Solution D:
a)

4 M guanidinium thiocyanate
25 M sodium citrate pH 7.0
0.5% sarcosyl
100 mM 2-mercaptoethanol

b)

2 M sodium acetate pH 4.0
Phenol - water saturated
Choloroform-isoamyl alcohol (49:1)
Isopropanol, 75% ethanol and 0.5% SDS

Procedure
A trypanosome pellet of 2 x i0 9 cells was dissolved in I ml of solution Din a 30
ml corex tube. Subsequently, 0.1 ml of 2 M sodium acetate, I ml of phenol saturated
with water and 200 p1 of chioroform-isoamyl alcohol were added to this lysate. The
contents were mixed by vigorous vortexing for 10 seconds and cooled on ice for 15
minutes. Subsequently, the suspension was aliquoted into sterile Eppendorf tubes and
centrifuged in a microfuge at 10,000 x g for 20 minutes at 4°C. The aqueous phase,
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containing the RNA, was transferred into fresh sterile Eppndorf tubes and mixed with
one volume of isopropanol and placed at -20°C for 20 minutes to precipitate the RNA.
The RNA was pelleted by spinning in an Eppendorf centrifuge for 10 minutes at 4°C.
The resultant pellet was re-suspended in solution D and then re-precipitated with 1
volume of isopropanol at -20°C for 15 mm. The RNA was spun down as before and the
pellet was washed in 500 p1 of 70% ethanol, vacuum dried and dissolved in 100 p1 of
sterile water. The total RNA was quantified by determination of absorbance at 260 nm
(A260 X 42 X dilution gave the concentration of RNA in pg/mi). RNA aliquots were
stored at -80°C.

2.4.3 Affinity purification of trypanosome poly(A)RNA
Reagents:
1 X loading buffer:

20 mM Tris-HCI pH 7.6

(Prepared as IX and 2X stocks)

0.5 MNaCI
1 mM EDTA
0.1% SDS

01 igo(dT):

Collaborative Research Inc. U.K.

Sterile RNase free water

Procedure:
Poly(A) RNA selection by oligo(dT)-cellulose chromatography was done as
described by Edmonds eta!. (1971). The oligo(dT) cellulose (Collaborative Research
Inc., U.K.) with an average of 14-16 T residues and a binding capacity of 2.5 mg
poiy(A) RNA/gm of cellulose, was weighed to obtain 100 mg of resin per 1 mg total
RNA. The oligo(dT) cellulose was equilibrated with 1 X sterile loading buffer thrice by
mixing and discarding the fine particles that do not settle after 30 seconds. A final
resuspension was diluted in 2 ml of 1 X loading buffer and poured into a 1 ml syringe in
which the nozzle was plugged with sterile siliconised glass-wool. The column was
washed with 3 bed-volumes of 1 X loading buffer.
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The total RNA dissolved in water was heated to 70°C for 5 mm. To this an equal
amount of 2 X loading buffer was added and the mixture loaded on to the column. The
flow-through was collected and re-heated and re-applied to the column thrice. The flow
through which contains the non-polyadenylated RNA was kept on ice if required. The
column was then washed with 3 bed volumes of I X loading buffer. The poIy(A) RNA
was eluted with 100 il aliquots of sterile warmed water (50°C) until the final volume of
the eluent was 1 ml. To enrich the poly(A) further, the whole process could be repeated
on the eluted poly(A) enriched RNA. The final eluent of poly(A) RNA was then
precipitated on ice for 20 mm with an equal volume of isopropanol and 1110th volume of
3 M sodium acetate. This was centrifuged at 14,000 rpm or 30 mm at 4°C in an
Eppendorf minifuge. The supernatant was discarded and the mRNA pellet was vacuum
dried and dissolved in 50 p1 of sterile distilled water. The poly(A) RNA was then
aliquoted at a concentration of 1 pg/j.il and analysed by RNA agarose electrophoresis.
The aliquots of poly(A) RNA were stored at -70°C until used.

2.4.4 Isolation of plasmid DNA (Maniatis eta!., 1982)
Small scale (miniprep) plasm Id purification by alkaline lysis:
E coil JM109, transformed with plasmids, were grown overnight in 3 ml of 2xYT
medium containing 100 pg/mI of ampicillin in sterile tubes. 1.5 ml of this culture was
transferred into a sterile Eppendorf tube which was spun at 14,000 rpm for 10 seconds in
a microfuge. The medium was aspirated and the bacterial pellet was then resuspended in
100 p1 of ice-cold solution 1(50 mM glucose, 25 mM Tris-HC1, pH 8.0, 10 mM EDTA,
pH 8.0). To this suspension 200 il of solution 11 (0.2 M NaOH, 1% SDS) was added
followed by mixing of the contents by inverting the tubes and then placing on ice for 5
mm. Finally, solution 111(60 ml of 5 M potassium acetate, 11.5 ml of glacial acetic acid
and 28.5 ml of water, giving a resulting solution of 3 M with respect to potassium and 5
M with respect to acetate) was mixed with the bacterial lysate, vortexed and the mixture
centrifuged at 14,000 rpm for 5 mm at 4°C in a microfuge. The supematant was
transferred to a fresh tube and extracted subsequently with an equal volume of buffered
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phenol/chloroform. In this procedure, the SDS lyses the cells and the high pH denatures
the DNA by disrupting the hydrogen bonding between nucleotide base pairs. The buffer
of solution HI rapidly adjusts the pH to the range where the DNA re-anneals. Bacterial
chromosomal DNA, on the other hand, is circular and much bulkier. With its strands
completely separated, it does not re-anneal at an appreciable rate. Thus, while the
plasmid DNA re-anneals, the chromosomal DNA precipitates out of solution.
The plasmid DNA in the aqueous layer was then precipitated by adding 2.5
volumes of absolute ethanol at room temperature, mixed by vortexing and allowed to
stand at room temperature for 2 mm. The double stranded DNA was then pelleted by
centrifugation of the tube at 12,000 x g for 5 mm at 4°C. The supernatant was removed
and the tube placed in an inverted position on a paper towel to allow all the fluid to drain
off. The pellet was rinsed with 1 ml of 70% ethanol at 4°C and the pellet of nucleic acid
allowed to dry in the air for 10 mm. The DNA was dissolved in 50 j.tl of T.E (jH 8.0)
containing DNase-free pancreatic RNase (20 jig/mi; Sigma), vortexed briefly and stored
at -20°C until use.

2.4.5 Large scale preparation and purification of plasmid DNA
Apart from the difference in the volume of cell culture, the maxi-preparation of
plasmid DNA was similar to the method of alkali lysis employed in making DNA
minipreparations as described in the above section. The bacterial cells were harvested
from a 500 ml culture by centrifugation ar 4000 rpm for 15 mm at 4°C in a Sorvall G53
rotor. The pellets were first suspended in 100 ml of ice-cold STE buffer (100 mM NaC1,
10 mM Tris-HCI, pH 8.0 and 1mM EDTA, pH 8.0), after a thorough drain of the
centrifuge bottle. The bacterial cells were collected by recentrifugation and the washed
pellet resuspended in 10 ml of solution I. A I ml volume of freshly prepared solution of
lysozyme (10 mg/mi in 10 mM Tris-HCI pH 8.0), was followed by the addition of freshly
made solution II. The content of the centrifuge bottle was thoroughly mixed by gently
inverting the bottle several times. The bottle was stored at room temperature (23°C) for
10-15 mm before 15 ml ice-cold solution ifi was added. This was stored for 10 mm on
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ice after mixing. A flocculent white precipitate, consisting of chromosomal DNA, high
molecular weight RNA, and potassium/SDS/protein/membrane complexes, forms during
this storage. The bacterial lysate was centrifuged at 4000 rpm for 15 mm at 4°C in a
Sorvall 053 rotor. The supernatant was filtered through 4 layers of cheese-cloth into a
250 ml centrifuge bottle and transferred to a Corex tube. A 0.6 volume of isopropanol
was then added, mixed well and the tube stored for 10 mm at room temperature. Because
salt may precipitate out if centrifugation is carried out at 4°C, the nucleic acids were
recovered by centrifugation at 5000 rpm for 15 mm at room temperature in a Sorvall G53
rotor. The pellet was rinsed with 70% ethanol at room temperature, the ethanol drained
off and the DNA allowed to dry by placing the tube in an inverted position on a pad of
paper towels at room temperature. The DNA was dissolved in 1 ml of TE, pH 8.0.
The plasmid DNA was purified by equilibrium centrifugation in CsCl-ethidium
bromide continuous gradients as described in Sambrook et a!. (1989). The DNA solution
was made up to 9 ml with TE, pH 8.0, and for every millilitre of DNA solution, ig of
solid CsC1 was added. The solution was mixed gently until the salt dissolved. An aliquot
of 0.8 ml of a solution of ethidium bromide (10 mg/mI in water) was added for every 10
ml of the DNAJCsC1 solution. The ethidium bromide solution, which floats on the
surface, was mixed with the denser DNAJCsCI solution. This solution gives a final
density of 1.55 g/ml with a refractive index of 1.3860 and an ethidium bromide
concentration of approximately 740 ug/mI. Using a disposable syringe fitted with a
large-gauge needle, the clear red solution was transferred to a Beckman Quick-seal tube.
The tube was sealed with a Beckman sealer and inserted into a Beckman vertical VTi 65
or VTi 80 rotor. The density gradient was centrifuged at 45,000 - 55,000 rpm for 16-22
hr at 20°C. Two bands of DNA, located in the centre of the gradient, were visible in
ordinary light and most clearly under UV illumination. The upper band, which usually
contains less material, consisted of linear bacterial (chromosomal) DNA and nicked
circular plasmid DNA. The lower band consisted of closed circular plasmid DNA. The
deep-red pellet on the bottom of the tube predominantly consisted of ethidium
bromidefRNA complexes.
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The closed circular plasmid DNA was collected by the following procedure: the
tube was clamped on a stand close to a UV illuminator, which was used to visualise the
bands of DNA. For reasons of safety and in order to minimise damage to the DNA from
UV irradiation, the UV lamp remained off for most of the operation. A 21-gauge
hypodermic needle was inserted into the top of the tube to allow in air. Then an 18-gauge
hypodermic needle was attached to a I ml plastic syringe and, as the UV lamp was turned
on, the needle was inserted (bevelled side up) into the tube horizontally, so that the
bevelled side of the needle was positioned just below the band of closed circular plasmid
DNA and parallel to it. The plunger of the syringe was then immediately, but, carefully,
withdrawn in order to collect the banded DNA into the syringe, taking care not to include
the upper band. The collected DNA was then transferred into a Sterilin tube and the
ethidium bromide was removed from the purified DNA by extraction with either one of
two organic solvents, as described below.
To the solution of DNA in a glass or plastic tube, an equal volume of either 1butanol, saturated with water, or isoamyl alcohol was added. The two phases were mixed
by gentle vortexing and the mixture centrifuged at 800 x g for 3 mm at room temperature.
Using a Pasteur pipette, the lower aqueous phase was transferred to a clean tube and the
extraction repeated four to six times, until all the pink colour disappeared from both the
aqueous and the organic phase. The CsCl was then removed from the DNA solution by
dialysis for 24-48 hr against several changes of TE (pH 8.0). The dialysis tubing
(Spectropor) had been treated by boiling for 10 mm in a large volume of 2% (wlv)
sodium bicarbonate and I mM EDTA (pH 8.0). The tubing was then rinsed thoroughly in
distilled water, then boiled for 10 mm in 1 mM EDTA (pH 8.0). The tubing was allowed
to cool down and then stored at 4°C submerged in the 1 mM EDTA solution. The
dialysed DNA solution was carefully removed from the dialysis bag and precipitated with
2.5 volumes of ethanol, followed by centrifugation at 10,000xg for 15 mm at 4°C. The
precipitated DNA was then dissolved in 500 .tl to 1 ml of TE (pH 8.0) and the OD2
of the final solution measured in a Beckman DU-50 series spectrophotometer. The
concentration was calculated using the formula: OD 260 x dilution factor x 50 pg/mi
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(Maniatis et al., 1982). The purified, recombinant plasmid DNA was then stored at 20°C until used for physical mapping, Southern analysis and sequencing.

2.4.6 Alkaline lysis of CP 547 trypanosome DNA
In an attempt to enrich for circular extrachromosomal DNA from T. b. brucei
total CP 547 DNA, the alkaline lysis purification procedure for bacterial plasmids was
used. Briefly, 5 x 10 trypanosomes were treated exactly as the 1.5 ml bacterial culture
(section 2.4.4) to enrich for circular T. b. brucei DNA.

2.5

Nucleic acid manipulations

2.5.1 Restriction enzyme digestions
For all the restriction enzymes used, information for buffer conditions and
temperatures of incubation were obtained from the NEB catalogue (1989-1992). The
buffers used can now be obtained as 10 X stocks from NEB.
An excess of enzyme was always used. For digestion of trypanosome DNA, the
product of the number of units of enzyme and the number of hours of incubation was
always sufficient for at least ten-fold over-digestion. The percentage of glycerol in the
total reaction volume was always kept below 5%.

2.5.2 Agarose gel electrophoresis and blotting
2.5.2a DNA electrophoresis
Gels containing between 0.7% and 1.5% (w/v) agarose (Ultra-Pure, BRL) in 0.5
X TAE buffer were used for Southern blots and for restriction enzyme analysis of
genomic, plasmid and phage DNA as described in Maniatis eta!. (1982). Electrophoresis
was also used for the preparative separation of extrachromosomal DNA and restriction
enzyme fragments. The gels were prepared by boiling agarose in TAE until completely
dissolved, cooling to 55°C, and pouring into the gel former with an appropriate comb.
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The gel former with the set gel was then placed in the electrophoresis tank containing
sufficient TAE running buffer to cover the gel.
Sample buffer (10 X TAE, 50% glycerol, containing 1% bromophenol blue and
1% xylene cyanol FF) was added to samples before electrophoresis to give a I x TAE
final concentration. For preparative electrophoresis, several sample wells were
connected together by placing adhesive tape over the sample comb teeth. The voltage
was generally set at 5-10 V/cm of gel. After electrophoresis was completed, the DNA
was stained with ethidium-bromide so that the DNA fragments in the gel could be
visualised on a UV transilluminator. The gels were then photographed with a Polaroid
camera.

2.5.2b Pulsed Field Gel Electrophoresis (PFGE)
The technique of pulsed field gel electrophoresis was developed by Schwartz and
Cantor (1984) for the resolution of chromosome-sized DNA molecules from yeast. The
method exploits the dependence of the relaxation time of extended DNA molecules on
their length. Briefly, the DNA molecules are extended within an agarose gel matrix by
application of an inhomogeneous electric field, and then subjected to an approximately
orthogonot field. The extended molecules will be unable to move through the gel matrix
under the influence of the second field until their extended conformation has relaxed.
Smaller molecules, relaxing more rapidly, will move sooner. Continuous alternation of
the two fields will result in a greater net mobility of the smaller molecules. The
apparatus used in this work was the Pulsaphor system (Pharmacia LKB Biotechnology).
The HEX electrode array was used. With this electrode, two different fields, North/South
and East/West fields can be applied. The HEX electrode gives a homogeneous field
resulting in straight migration of the DNA in lanes when the pulsed field technique is
used.
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2.5.2c Preparation of DNA for PFGE
To avoid shearing of large DNA molecules during extraction, cells were lysed in
situ in agarose plugs (Schwartz and Cantor, 1984). Briefly, the pelleted trypanosomes
were suspended in phosphate saline glucosebuffer,pH 8, to a concentratin 014 X IO9
trypanosomes per ml. The parasite suspension was then mixed with an equal volume of
1.5% low melting point agarose (Ultra Pure LMP, electrophoresis grade; BRL),
previously maintained at 50°C, to give a final concentration of 2 X

trypanosomes/mI.

The mixture was then poured between glass plates separated by 1 mm plastic spacers.
These plates were previously blocked on 3 sides by clamping in the spacers. On pouring
in the mixture, the plates were placed on ice to allow rapid setting of the agarose. The
agarose blocks were then immersed into a lysing mixture of 10 mM Tris (pH 7.5), 0.2 M
EDTA (pH 8.0), 1% SDS, 1 mg/ml proteinase K and incubated in this for 36 h at 50°C.
The proteinase K-treated agarose blocks were washed in several changes of 10 mM
EDTA and stored in this buffer at 4°C.

2.5.2d gamma-irradiation of DNA in agarose plugs
PFGE of DNA in agarose plugs exposed to different levels of gamma-irradiation
as described by van der Bliek el a! (1988) was used to show the presence of large circular
DNAs within the CP 547 isolate. Briefly, the agarose embedded DNA was cut in 2cm X
1mm sizes and immersed in 200 iI of buffer (10 mM EDTA, 10 mM Tris-HC1, pH 7.5)
in a standard 1.5 ml propylene microcentrifuge tube. Six such samples were all placed at
ambient temperature at a distance of 16 cm from a single point Caesium source
(Conservatone Lisa IA) emitting 3 Gray/mm in the irradiation chamber (The source was
calibrated with Alanine dosemeters, NPL U.K). Individual sample tubes were withdrawn
at 3.3, 10, 20, 33, 50 and 60 mm, exposing the samples to a radiation dose of 10, 30, 60,
100, 150 and 180 Gray respectively. The samples remained at room temperature for at
least 30 mm prior to electrophoresis.
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Electrophoresis
The conditions of voltages, switch frequencies and run-times used for each pulsed
field gel (PFG) are specified in the figure legends. All the DNA samples were resolved
in 1.5% agarose gels run in 1 X TBE circulating buffer. At the completion of the run, the
gels were placed for 2-3 h in I ig/ml ethidium-bromide and destained overnight in 0.1
jig/mi ethidium-bromide. Southern blotting was carried out essentially as for regular
agarose gels (section 2.5.2e).

2.5.2e Southern blots (Southern, 1975)
After photography, DNA in gels was denatured with gentle agitation in 0.5 M
NaOH, 1.5 M NaCl for 45 minutes, and neutralised in 1 M Tris-HCI (1H 7.4), 3 M NaC1
for one hour at room temperature. Volumes of the soaking solutions were enough to
allow complete submersion of the gel.
The gels were then placed upside down on a sheet of Whatman 3 MM paper
resting on a 1.5 cm thick sponge in a shallow tray filled with 20 X SSC. A sheet of
nytran (Schleicher and Schueli), cut to the size of the gel, was first soaked in water and
then placed on top of the gel. This was followed by 20 similarly cut sheets of Whatman 3
MM paper and an approximately 4 cm stack of paper towels. The stack was lightly
weighed and blotting was allowed to proceed for 15-24 h. The nytran was then removed
and baked under vacuum at 80°C for 2 h, or, if nitrocellulose filters were used, the
nucleic acids on the filter were cross-linked and fixed on the membrane by a 2 mm
exposure to ultraviolet light. These Southern blots were stored at 4°C until required.

2.5.2f RNA electrophoresis
Electrophoresis of RNA was carried out in a manner similar to that described for
DNA (Section 2.5.2a), except that 10 mM phosphate (Na 21-IPO4INaH2PO4), pH 6.8 was
used as running buffer (Pellé and Murphy, 1993). Briefly, the RNA samples (2-20 jg)
were glyoxylated (Thomas, 1983), mixed with 6 X RNA sterile gel loading buffer (60
mM sodium phosphate, pH 6.8, 30% (w/v) glycerol, 0.25% (w/v) bromophenol blue,
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0.25% (w/v) xylene cyanol FF, 1.2% (w/v) SDS) and volumes adjusted to a final
concentration of 1 X of the RNA loading buffer). These samples were then denatured by
heating to 65°C for 5 minutes in a water bath. The RNA was loaded and the
electrophoresis performed in 0.01 M sodium phosphate buffer (pH 7.0), which is
constantly recirculated by the use of a peristaltic pump.

2.5.2g Northern blotting
The agarose gels with RNA were transferred immediately after electrophoresis to
nytran filters; no further treatment of the gel was necessary. The gel was placed in
contact with the nytran filter and blotted essentially as described for Southern blotting.
The blots were dried at room temperature and the RNA was fixed onto the filter by crosslinking with ultraviolet irradiation (254 nm).

2.5.3 Recovery of DNA from agarose gels
2.5.3a Geneclean(BIO 101, Inc., La Jolla, CA)
This procedure is adapted from the glass-milk extraction of DNA method of
Vogeistein and Gillespie (1979). This procedure involves isolation of DNA from agarose
gels run in TAE running buffer. The slice of agarose gel containing the required DNA is
removed and weighed. At least 2.5 volumes of saturated Nal solution was then added to
the slice and the mixture was then placed in a 50°C water-bath until the gel was
completely dissolved. For every jig of DNA, 5 j.xl of'glass-milk' suspension was added
and the suspension mixed well and kept on ice to allow the DNA to bind on to the 'glassmilk' particles. Subsequently the 'glass-milk' was spun down for 5 sec in a microfuge and
the Nal aspirated off. The 'glass-milk' with bound DNA was washed four times with
rNew..Wash solution by re-dissolving gently and spinning. The DNA was then eluted off
the 'glass-milk' with a small volume of sterile water at 55°C for 5 mm.
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2.5.3b DNA extraction by centrifugation
The section of the agarose gel containing the DNA fragment of interest was cut
out and cut into very small pieces. These pieces were put into a 500 il Eppendorf tube
which had a hole at its base made with an 18 gauge hypodermic needle. The hole was
plugged with siliconised glass wool which acted as a sieve. The tube was placed into a
1.5 ml Eppendorf tube. These were then spun at 8,000 rpm for 10 minutes in an
Eppendorf centrifuge. The glass wool blocks the agarose, but the buffer containing DNA
is collected in the lower Eppendorf tube. This DNA solution is then extracted once with
phenol followed by a phenol/chloroform extraction. Finally the DNA is purified by
ethanol precipitation.

2.5.4 Gel purification of the 6.6 kbp extrachromosomal element
i)

Geneclean®(section 2.5.3a)

ii)

Electrophoresis onto DEAE - cellulose membranes (Sambrook eta!., 1989)

Geneclean® (sect ion 2.5.3a) outlined above, and electrophoresis onto DEAE-cellulose
membrane (section 2.5.4a) gave the highest yields for the 6.6 kbp extrachromosomal
element DNA and was therefore routinely used for its purification.

2.5.4a Electrophoresis onto DEAE-cellulose membrane (Dret2en et a!., 1981)
Reagents:
DEAE-cellulose membrane (Schleicher and Schuell NA-45)
Low-salt wash buffer
50 mM Tris-HCI (pH 8.0)
0.15 M NaCI
10 mM EDTA (pH 8.0)
High-salt elution buffer
50 mM Tris-HCI
1 MNaC1
10 mM EDTA (pH 8.0)
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The membrane was soaked for 5 mm in 10 mM EDTA, pH 8.0. The EDTA was
replaced with 0.5N NaOH for a further 5 mm. The membrane was then washed six times
in sterile water and stored in sterile water at 4°C until used.
Electrophoresis of the uncut total DNA was performed with size markers. The gel
strip that corresponded to the migration of a 5 kb to 7 kb linear marker was excised. This
gel strip was placed perpendicular to its initial position in the gel former. This strip was
held in place by surrounding it with melted agarose which forms a supportive mould on
solidification. The DEAE-cellulose membrane was positioned in an incision made at the
end of the gel slice away from the 6.6 kb size marker (lambda DNA digested with Hind
III). The DNA was then transferred electrophoretically from the gel slice onto the
DEAE-cellulose membrane. The distance of the migrated 6.6 kbp element DNA was
monitored by the parallel mobility of the 6.6 kbp size marker. When all of the DNA had
left the gel slice and was trapped on the DEAE membrane, the membrane was rinsed in
the low salt wash to rinse off the agarose. The DNA was eluted from the membrane by
submerging the membrane in the elution buffer for 30 minutes at 65°C. The eluate was
extracted once with buffered phenol alone, followed by one extraction with
phenol/chloroform before it was precipitated with two volumes of ethanol and 0.2
volumes of 10 M ammonium acetate at 4°C. The DNA was recovered by centrifugation
at 14,000 rpm in an Eppendorf microfuge for 20 mm at room temperature.

2.5.5 Labelling of DNA
2.5.5a Radiolabelling
1) Radiolabelling with [a- 32P]dCTP of small quantities (less than 100 ng) of DNA was
carried out using a Random Priming kit (Amersham, U.K.) according to the suppliers
instructions. Likewise for labelling of DNA available in larger quantities, (more than 100
ng), a Nick Translation kit (Boehringer Mannheim) was used and the suppliers
instructions were followed. Since very small quantities of the 6.6 kbp extrachromosomal
DNA could be recovered from agarose gels, it was always labelled by random priming.
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Radioactive [c&-32 P]dCTP was obtained from Amersham Inc. (10 mCi/mi, 3000
Ci/mmol).
Labelled DNA was separated from unincorporated nucleoside triphosphates by
centrifugation through columns of Sephadex G-50 in 1 ml syringes (Maniatis

et a!.,

1982). To measure the incorporated radioactivity, a sample of the eluted DNA was
counted in Aquasol in a liquid scintillation counter (Beckman).

2) Kinasing 5'-ends of oligonucleotides (Sambrook

eta!.,

1989)

The 5' hydroxyl termini of oligonucleotides were labelled using the catalytic
activity of T4 polynucleotide kinase (Promega, USA). The enzyme catalyses the transfer
of the g-phosphate of ATP to the 5'-hydroxyl termini of oligonucleotides. The kinasing
reaction was carried out exactly as outlined in Sambrook eta!. (1989). Radioactive [g32P]dATP was supplied by Amersham (>5000 Ci/mmol).
Labelled oligonucleotides were used directly from the labelling reaction with no further
manipulation.

2.5.5b Hybridisation conditions
For both Southern and Northern blots, identical conditions were used which are a
modification of the procedure described by Wahi eta!. (1979). The same conditions
were used for both the prehybridisation and hybridisation steps.
Stock solutions
Final concentration
2OXSSC
10%SDS
10% NaPPi-HC1 (pH 7.4)
50 X Denhardts solution

4X
0.1%
0.1%
5x

50 X Denhardts solution
1% w/v of polyvinylpyrrolidone (molecular weight - 350,000)
1% w/v of Ficoll 400
1% w/v of BSA fraction V
These components were dissolved in water and stored at -20°C.

69

2.5.Sc Hybridisation procedure
The filters were placed in a heat-sealable plastic bag into which the prehybridisation solution was added, and incubated in a shaking water bath for 2 h or more
at 65°C. The Denhardt's solution was used to minimise non-specific binding of the probe
to the membrane because single stranded DNA, unlike RNA, has high affinity for nylon
membranes.
Radiolabelled probe DNA was denatured by incubation in a boiling water bath for
3-5 minutes and added to the hybridisation solution. The probe concentration was
between 5 X i05 and 106 cpm per ml of hybridisation solution.
After hybridisation, the filters were removed from the bags, and washed in 0.1 X
SSC, 0.1% SDS, unless otherwise indicated. After rinsing for 2-3 minutes at room
temperature, the filters were washed twice for 45 minutes at 65°C with one change of
washing solution. Filters were then blotted with 3 MM paper, air dried and exposed to Xray film at -80°C for 12-72 h with intensifying screens (Du Pont lightening plus).
Radioactive particles entering autoradiographic film cause ejection of electrons from
silver halide crystals. These electrons attract positively charged silver ions, generating
precipitates of silver atoms, hence formation of the autoradiographic image. There is a
five-fold enhancement in the intensity of the image when an intensifying screen is placed
on the X-ray film, as radioactive particles that pass through the film hit the screen, which
is coated with oxides of heavy metals and cause it to emit protons that are captured by the
silver halide crystals in the emulsion.

2.5.6 Preparation of plasmid vector for cloning
Plasmid DNA (0.5-1.0 jig) was digested with the required enzyme in a reaction
volume of 50 j.il. A tenth of this reaction was electrophoresed in a 1% agarose gel to
ascertain that digestion was complete. The linearised plasmid was then extracted with
phenol/chloroform and precipitated with 2 volumes of ethanol. The digested plasmid was
then de-phosphorylated by removal of the 5' phosphate group from both ends thus
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preventing inter- and intra- molecular ligation of the plasmid. The dephosphorylation
reaction was carried out as described by Maniatis

eta!.

(1982). Briefly, the digested

DNA was dissolved in water and the reaction was carried out in a total reaction volume
of 50 tl. The phosphatase reaction was set up as follows:
10 X calf intestinal phosphate buffer (CIP)

5 p1

(0.5 M Tris.Cl (pH 9.0), 10 mM MgCl 2, 1mM ZnCl2, 10mM spermidine)
Linearised plasmid in water

43 p1

Calf intestinal alkaline phosphatase (ClAP)

2 j.tl

(1 unit4il Boehringer Mannheim, Germany)
The reaction was incubated at 37°C for 30 mm and subsequently stopped by heat
inactivation at 70°C for 15 minutes followed by phenol/chloroform extraction. The
aqueous phase containing the dephosphorylated DNA was precipitated with ethanol and
the DNA dissolved in sterile water at a concentration of approximately 100 ng/pl.

2.5.7 Ligations
Ligations were generally carried out in 50 mM Tris-HC1 (pH 7.4), 10 mM MgC12
and 10 mM DTT, and 25 pg/mi BSA. This buffer was prepared and stored as a 10 X
stock. AlP (Sigma) was stored as a 10 mM stock and added to a concentration of 1 mM
in ligation reactions. 2 iI of T4 DNA ligase (Amersham, 2.5 U/j.il) was used for each
ligation. All sticky end ligations were incubated at 14°C overnight. For blunt end
ligations, the final concentration of ATP was decreased to 0.05 mM, and the ligations
were incubated at room temperature at 4°C overnight.

2.5.8 Preparation of competent bacterial cells, and transformation.
This was performed essentially as described by Hanahan (1988)
Reagents:
FSB: 10 mM potassium acetate (pH 7.4), 45 mM MnCl 2.4H20, 100 mM KC1, 3mM
hexamine cobalt chloride and 10% (w/v) glycerol.
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DMSO: Aliquots from a newly opened bottle of DMSO (Merck, Analytical grade) were
stored in full, tightly capped, 400 p1 tubes at -20°C. Aliquots were used only
once.
Procedure:
A 500 ml conical flask containing 50 ml of SOB medium was innoculated with
0.5 ml of an overnight culture of JM1O9. The culture was incubated with agitation at
37°C until the O.D. 600 reached 0.4 to 0.5 (approximately 4 hr). Forty five ml of this
culture was cooled on ice for 15 mm and then centrifuged at 2,500g in a Heraeus Christ
minifuge II for 10 mm at 4°C. The pelleted cells were resuspended in 15 ml of ice cold
FSB and left on ice for 15 mm. The centrifugation was repeated and the cells were
resuspended in 4 ml of FSB. After 10 mm on ice, 140 p1 of DMSO was added and the
cell suspension was gently swirled and replaced on ice for another 5 mm. A second
aliquot of 140 p1 of DMSO was added and the tube placed on ice for another 5 mm. The
cell suspension was then transferred to pre-cooled Eppendorf tubes in aliquots of 220 p1
each and instantly frozen in liquid nitrogen. The aliquots were stored at -80°C until used.
During transformations, the competent cells were left to thaw on ice. 100 p1 of
the competent cells were transferred into a 5 ml pre-chilled polystyrene tube. Between
0.1 and 50 ng of DNA from the ligation was added to the cells and the mixture gently
swirled and left on ice for 30 mm. The mixture was then heat pulsed at 42°C for 90
seconds after which it was replaced on ice. After addition of 800 p1 of SOC medium, the
transformed cells were incubated at 37°C for one hour. Meanwhile, NZYM plates
containing 50 pg/mI ampicillin were prepared for colour selection by spreading 120 p1 of
100 mM isopropyl 13-thiogalactopyronoside (IPTG; Gold Biotechnology, Manchester,
MO, USA) and 60 pl of 2% chromogenic 13-gal actosidase substrate, X-gal (5-bromo-4
chloro-3 inolodyl-13-D-gal actopyranoside; Boehringer Mannheim Biochemicals), the
latter being dissolved in dimethylformamide. Following the incubation of the heatpulsed cells, about 200 p1 of the transformation sample was spread on the plates which
were then allowed to dry prior to incubation at 37°C overnight.
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2.5.9 Hybridisation screening for putative recombinants
Transformant colonies and recombinant plaques were grown to 1-2 mm in
diameter and processed according to the method described by Grunstein and Hogness
(1975). Dry nitrocellulose filters (Schleicher and Schuell, Germany) were placed onto
the agar surface and marked for alignment by stabbing with a 23 gauge hyperdermic
needle dipped in Indian ink. The filters were peeled away as soon as they were
completely wetted and placed, colonies or plaques upwards, on 5 ml puddles of
denaturing solution (0.5 M NaOH and 1.5 M NaCl) for 5 minutes. The filters were then
gently blotted on a dry Whatmann 3 MM paper and transferred on to a 5 ml puddle of
neutralizing solution (1 M Tris-HC1 pH 7.4 and 3 M NaCl) for 10 minutes. The filters
were then given a quick rinse in 2 X SSC and allowed to air dry. The dry filters were
stacked between Whatmann 3 MM paper and baked under vacuum at 80°C to enable the
DNA to fix on the filters. Plates with colonies were replaced at 37°C to enable the regrowth of the lifted colonies. Subsequently, the plates were sealed with parafilm and
stored at 4°C. Triplicate sets of each filter could be generated from each plate with
recombinant colonies or plaques, allowing the simultaneous hybridisation of the filters
with different probes. The filters were hybridised (Section 2.5.5) using the appropriate
radiolabelled probe. The positive colonies were selected after autoradiography by
aligning the X-ray films with the plates. The positive clones were grown in liquid culture
and processed to isolate the plasmid DNA (Section 2.4.4)

2.6

Library construction

2.6.1 Construction of a genomic library
a)

Sonication
A genomic library was generated from total genomic DNA of T. b. brucei CP 547

by a modification of the procedure of Huynh eta!. (1988). Briefly, 40 pg. of the
trypanosome DNA was brought up to 2 ml with 0.2 M NaC1 in a 10 ml sterilin tube. The
material was sonicated for 2 seconds with a setting 5 on a with a Branson Sonifer®cell

73

disruptor (model B 30) equipped with wattmeter (model A 410) (Branson sonic power
co. Danburg, CT). A special microtip was used delivering 300 watts at I sec pulses (2 X)
at 4°C. The sonicated DNA was ethanol precipitated and the precipitate was washed in
70% ethanol, spun down and the DNA pellet vacuum dried. The sonicated DNA was
resuspended in 180 1il of water, of which 8 1il was tested on an agarose gel to examine the
level of shearing.

b)

Fill-in reaction
Since the DNA had been sonicated, its 3' or 5' overhanging ends were repaired

with Ti DNA polymerase in a reaction generating blunt ends. To the 172 t1 of sonicated
DNA, 20 j.il of 10 X T4 DNA polymerase buffer (500 mlvi Tris-HC1 (J)H 8.0), 50 mM
MgCl 2, 50 mM DTT, 500 jig/mI BSA) and 4 j.il dNTP (5 mM) was added. The reaction
was initiated with 4 jil T4 DNA polymerase (NEB, 3 U/jil) for 60 minutes at 14°C. The
reaction was stopped by phenol/chloroform extraction. The DNA was ethanol
precipitated followed by a wash in 70% ethanol, spun, and vacuum dried.

c)

Methylation of EcoR I sites and linker ligation
In order to make the blunt ended DNA suitable for ligation to a cloning vector, it

was methyl ated by EcoR I Methylase, ligated to EcoR I linkers and digested with EcoR I
to create cohesive ends. The methylation step was necessary to protect EcoR I sites in the
genomic DNA. The sonicated DNA was resuspended in 158 jil water and to this 20 jil of
10 X methylase buffer (100 mM NaCl, 100 mM Tris-HC1 pH 7.5, 1 mM EDTA, 100 i1
of 10 mg BSA/ml) was added. The methyl group was obtained from the addition of 20 .tl
of 10 X S-adenosylmethionine SAM (NEB). To the mixture, 2 jil of EcoR I methylase
400 U/mi (NEB) was added and the ingredients were mixed gently by pipetting up and
down. The reaction was carried out by 2 hr incubation at 37°C. The reaction was
stopped by phenol/chloroform extraction. The methyl ated DNA was then ethanol
precipitated and subsequently washed in 70% ethanol. The DNA was pelleted by
spinning and then vacuum dried. To ligate the EcoR I linkers, the DNA was resuspended
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in 86 j.ilofdistilledwater,towhich 10 jilofl0Xligasebufferand2 j.tlofEcoRllinkers
2 jig/jil (NEB) were added. The reaction was initiated by 2 jil of T4 DNA ligase
(Amersham 2.5 U/jil) and incubated at 12°C overnight.

d)

Removal of excess linkers
After the overnight incubation, the ligation reaction mixture was centrif'uged

briefly and placed in a 65°C waterbath for 10 mm to inactivate the ligase. To digest the
ligated and excess linkers, the tube was then placed on ice for 5 mm before addition of 85
jil of sterile distilled water and 10 jil 10 X EcoR I buffer. The reaction was initiated with
the addition of 5 jil (20 U/j.tl) of EcoR I and incubated at 37°C overnight.

e)

Potassium acetate gradient
The DNA was separated from the excess linkers by size fractionation. This was

done in a (5-20% w/v) potassium acetate (KAc) density gradient spun in an
ultracentrifuge using the Beckman SW 27 rotor. Twenty percent KAc, 2 mM EDTA, 1
pg/mi ethidium-bromide was prepared and filtered through a 0.45 jim (or 0.22 jim) filter.
A volume of 2.6 ml of 20 % KAc solution was added to the back chamber of a small
gradient maker. Air bubbles were removed from the tubing connecting the two chambers
by allowing the solution to flow into the front chamber followed by tilting to allow
bubbles to float upwards. The passage between the chambers was closed and 2.5 ml of
the 5% solution added to the front chamber. The apparatus was then placed on a stirring
plate, with the magnetic bar stirring as fast as possible. The stopcock connecting the two
chambers was first opened followed by the front stopcock, allowing the flow of the
solutions to form a gradient. A 5 ml poiyallomer SW55 tube (Beckman) was filled from
the bottom with the KAc gradient. The gradient was overlaid with the entire DNA
sample. A balancing tube was prepared, and the gradient spun for 3 hr at 70,000 X g at
20°C. The fractions were collected from the gradient by piercing the tube with a
vacutainer needle. All but the top 2 cm of the gradient were collected as 300 p1 fractions
and the size of each fraction tested on an agarose gel. The fractions with fragments
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between 2 and 6 kb were pooled and ethanol precipitated with two volumes of absolute
ethanol at -20°C. The DNA was spun at 12,000 X g for 30 mm, the ethanol decanted, and
the DNA pellet washed with 70% ethanol and vacuum dried. The DNA was then
resuspended in 80 it1 of sterile distilled water.

f)

Cloning of genomic DNA into bacteriophage lambda gtll
The target DNA was cloned into bacteriophage lambda gtll. The EcoR I

cohesive ends of the target DNA were inserted into the EcoR I site of the lambda gtl 1
located within the iacZ gene, downstream from the B-galactosidase initiation codon. On
the day before the experiment, an overnight culture of E. coil Y1090 was started by
inoculating a single colony into 50 ml of LB medium supplemented with 0.5 ml of 20%
maltose and 0.5 ml of I M MgSO4. This was shaken overnight at 37°C and the cells were
pelleted by centrifugation and then resuspended in 25 ml of 10 mM MgSO 4 and stored at
4°C.
Four standard ligations were set up using 3 jil, 5 p1, 7 p1 and 10 p1 of the target
DNA in a total volume of 20 p1. In all the ligations a constant concentration of 0.5 pg of
commercial Protoclone lambda gtl I and 0.5 pl of T4 DNA ligase (Amersham, 2.5 U/pl)
were used. The ligations were incubated for 3 hr at 14°C. Subsequently, the ligated
DNA was packaged using the Packagene in vitro packaging system (Promega). This was
mixed gently by tapping the bottom of the tubes several times and the mixture incubated
for 2 hr at room temperature. To this, 480 p1 of SM phage storage buffer was added,
followed by 15 p1 of chloroform. This was mixed gently by inversion and the
chloroform allowed to settle to the bottom of the tube.

g)

Titration of recombinant lambda gtll library

Dilutions of 1/1,000 and 1/10,000 of the packaging extracts were made in SM phage
buffer. The diluted phage (100 p1) was used to infect 100 p1 of freshly prepared E coli
Y1090 cells and the phage was allowed to absorb for 30 mm at 37°C. Y1090 contains (a)
a plasmid, over-expressing a lac I repressor which prevents lacZ-directed gene
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expression. The repressor is inactivated by the addition of IPTG to the medium; (b) a
deficiency in the ion protease which increases the stability of recombinant fusion
proteins; (c) supF to suppress the (S 100) phage mutation causing defective lysis.
Molten (45°C) LB top agar (3 ml), into which 40 tl of 1 M IPTG and 40 j.il of 40
pg/mI of the chromogenic indicator 5-bromo-4-chloro-3-indolyl B-D-galactosidase (Xgal) had been added, was placed into the tubes containing the bacteria. The tubes were
mixed gently and poured immediately onto LB plates. The top agar was allowed to
harden and the plates were incubated inverted at 37°C overnight. The size of the library
was determined by counting the number of plaque forming units per millilitre of the
original packaging extract.

2.6.2 Construction of a cDNA library
Messenger RNA (Section 2.4.3) was copied into single stranded cDNA using a kit
purchased from BRL (Bethesda, Maryland, USA) following the manufacturers
instructions. The reaction conditions were designed to convert 2-20 pg poly(A) RNA
into double stranded (ds) cDNA. To a sterile microcentrifuge tube on ice, the following
components from the kit and the mRNA were added for the first strand synthesis: 5 X
first strand buffer (10 j.tl), 10 mM dNTP mix (2.5 p1), oligo (dT) primer (3 1.il, final
concentration 50 tgIml) and 20 p1 of diethylpyrocarbonate (DEPC)-treated triple
distilled water and poly(A) RNA (10 pg). The final composition of the first strand
reaction was 50 mM Tris-HCI (pH 8.3), 75 mM KC1, 3 mM MgCl 2, 10 mM dithiothreitol,
500 pM each dATP, dGTP, dCTP and TTP, 50 pg/ml oligo(dT) and 100 pg/mi poly(A)
RNA. To the mixture was added I pCi of ct-32P] dCTP tracer, before initiating the
reaction by addition of 2.5 pl of cloned Moloney Murine Leukemia Virus (M-MLV)
reverse transcriptase (final concentration 10,000 U of enzyme/ml). The reaction was
incubated at 37°C for one hour and then transferred to ice. This was then processed for
the second strand cDNA synthesis reaction by adding the following reagents: DEIPCtreated water (289.5 .tl), 10 mM stock dNTP mix (6 Ml), 10 X second strand synthesis
buffer (40 p1), [a- 32P] dCTP (1.25 p1), E coil DNA polymerase 1(10 Ml) and E. co/i
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RNase-H (1.75 p1). The composition of this mixture was 25 mM Tris-HCI (pH 8.3), 100
mM KCI, 5 mM MgCl 2, 250 pM each dATP, dCTP, dGTP and TJTP, 5mM dithiothreitol,
250 U/mI DNA polymerase I, and 8.5 U/mI RNase-H. The tube was vortexed gently and
incubated at 16°C for 2 h, after which the reaction mixture was moved to ice and the
reaction stopped by addition of 25 p1 of 250 mM EDTA (pH 7.5).
The cDNA in the reaction mixture was extracted with an equal volume of
phenol/chloroform and ethanol precipitated. The pellet was redissolved in 200 1.il of
sterile T.E buffer, adjusted to 700 mM ammonium acetate and reprecipitated with
ethanol. The pellet was washed with 70% ethanol, dissolved in 20 p1 of sterile T.E
buffer, before using 2 jil for gel analysis. The volume of the double stranded (ds) cDNA
was adjusted to carry out the methylation reaction, the linker ligation, the removal of
excess linkers and the cloning of the cDNA in bacteriophage lambda gtl 1, essentially as
for the genomic library (Section 2.6.1). A cDNA Library of 6 x

recombinant was

obtained with over 95% recombinants per plate. The screening of the recombinants was
done essentially as previously described (section 2.5.9).

2.7.1 Polymerase Chain Reaction (PCR)

No single protocol of PCR is appropriate to all situations. Consequently, each
new PCR application generally required optimisation. The standard conditions used to
amplify most target sequences in a total volume of 100 p1 is outlined by Innis et a!.
(1990):
Template DNA (1-5 ng)
20 pmoles of each primer
20 mM Tris-HCI (pH 8.3) 20°C
1.5 mMMgCl2
50 mM KCI
0.05% Tween 20
0.05% Nonidet
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50 .iM each dNTP
2 units of Taq (Thermus aqualicus) DNA polymerase (Promega). The mix was
overlaid with 75 .il of mineral oil. The tubes were placed in a Perkin Elmer
programmable thermal cycler which was set using the following temperature profile for
35 to 40 cycles:
Denaturation at 94°C, for I mm
Primer annealing at 55°C for 30 s
Primer extension at 72°C for 1.5 mm
Cycling concluded with a final extension at 72°C for 5 minutes. Reactions were stopped
by chilling to 4°C. The primers used in this work are listed:
ILO: 2236
Miniexon (universal): TAG GCG GCG CIA GAA CAG ITT CTG TAC TAT AlT
ILO: 2235
Oligo d(T)
TAG GCG CGC ITT ITT UT UT UI UI 1TF
ILO 1148
N/a III

repeat (F)

GAA ACC CAA ICA CCC C
ILO: 1149
N/a III repeat (R)

CCC CAC TAA CCC AAA G

In this work PCR amplification technology was also exploited to amplify
unknown sequences using random hexanuci eoti des.

2.7.2 Amplification of membrane-bound DNA using random hexanucleotides in
PCR

Total undigested DNA (2 ig) from CP 547 was electrophoresed in a 1% agarose
gel and transferred to a nylon filter (I-Iybond-N, Amersham mt., U.K.). The 6.6 kbp
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element could not be visualised by ethidium-bromide staining, but could be localised on
the membrane by hybridisation with 32P-labelled total trypanosome DNA. It was
estimated that there was a maximum of I ng of the 6 kbp element bound to the filter. The
area on the filter encompassing the area to which the 6.6 kbp element was bound
(approximately 0.2 cm 2) was excised and washed twice in 20 ml of distilled water for 15
mm. The washed filter was then boiled in 50 j.iI of sterile water containing 10 tg of
random hexanucleotide primers (Sigma, U.K.) for 5 mm then placed on ice (10 ig of
primer was found to give optimum results in the reaction). The PCR was then carried out
in a 100 p1 reaction volume containing 100 pM dNTP, 3 mM MgCl 2, 10 mM Tris-HC1
(pH 8.3), 0.05% NP 40, 0.5% Tween 20, 50 mM KC1 and 2.5 units of Taq DNA
polymerase (Perkin-Elmer Cetus, Norwalk, CT). The PCR profile was 95°C for 45
seconds, 30°C for 1.5 mm and 72°C for 3 mm, for a total of 40 cycles. DNA from the
gel-purified element in solution was also amplified by PCR using the same conditions.
The amplified DNA from either source was subsequently purified from the primers and
from unincorporated nucleotides on a Sephadex G-50 spin column. The PCR products
were then 32P-labelled by random priming or nick translation.

2.7.3 Polymerase chain reaction amplification of unknown sequences using
arbitrary primers

Welsh and McClelland (1990) and Williams eta!. (1990) have described a
method for the analysis of DNA polymorphisms by using arbitrary primers in the PCR.
More recently, Waitumbi and Murphy (1993) have used arbitrarily primed PCR (APPCR) to show intra- and inter-species differences in trypanosomes.
AP-PCR conditions were similar to standard PCR conditions except that the
reaction contained 10 mM Tris-HC1 (pH 8.3), 50 mM KC1, 3 mM MgC1 2, 0.05% NP4O,
0.05% Tween 20, 200 pM of dNTPs, 0.6 mM primer and 2.5 units of Taq DNA
polymerase (Promega) and were performed on a Perkin Elmer thermal cycler. The
cycling conditions were 94°C for 1 minute, 40°C for 1.5 minutes and 72°C for 2 minutes,
for 40 cycles.
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2.7.4

ILRAD oligonucleotide numbers

The arbitrary primers used in this work are listed:
508 CGGCCCCTGT

1058 GCACGAGGCG

509 TGGTCAGTGA

1059 GQCCCGTCCG

522 TAAGCATCAACACCACGTGG 1060 CTGAGCCCCC
523 CGAGCCGCGG

1061 CGGQQCGGCT

524 CGCGCCCGCT

1062 CTCCGTCGCG

525 CGGACGTCGC

1069 GCCACGAGQC

526 GCCGTCCGAG

J070

GGAGQCTGCG

527 GCGCGCAGCG

Z070

GGAGGCTGGG

539 CGQCGGAGCT

1071 GCAGGACCGG

540 GAGGGGQCGT

1080 GCGCACGGCG

541 GCGQCTGCCA

1100 GCTTGTTCTGGATGQCCTC

542 GGGTGCGCGG

1110 CCTCGGTGAG

543

1112 TCCGGCCGCT

GTGTCCGGCG

548 CACCGAGTCCGTGTCACC

1113 GTGACCCGGG

868 CAGCCTCGGC

1114 GGACCGCACG

869 CAGGACGGAG

1114 GGACCGCACG

872 CCCGCCATCT

1115 GGCTGACGCG

873 CATGTGCAGG

1122 GCTGGCTCGC

874 GAGGTGGCGC

1123 AGACACCGCC

875 GTCCGTGAGC

1124 TGCGCCAGGC

876 GGGACGTCTC

1125 CGGGAGAGCG

878 GTCGCGGAGC

1126 GTTGGCTCGC

906 CCTTCATTCATCCTAC

1126 GTTGGCTCGC

914 CAGGGGGCCA

1127 CCGCGCCGQT

922 GQCCCTATCA

1128 CGGAGGCTTC

944 GQCCGCCACATTGG

1129 TGTGGTGcX3C
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967 TCTACCACCGATACAGATGG

1131 AACGAGGGCC

1047 CCCACGGGGG

1187 GTGGCGQQCG

1048 GGGGCCTTGG

1188 CGCAGCCGTG

1050 CTGCTGQCAC

1189 CCGGTTCTCC

1051 CCCCGCCTGT

1190 GQGQGQCTGC
1191 CGCAGCCTGC
1242 CGCATGGGTFGTCAGTGG

2.8

DNA sequencing

2.8.1 Deletions of target DNA for double-stranded DNA sequencing
To generate unidirectional deletions of predictable sizes in the insert, a
commercial Exo IIlJMung Bean deletion kit (Stratagene) was used. Following the
manufacturers instructions, this system allowed deletions in the insert, but not in the
pBluescript plasmid vector DNA. The principle involves double digestion to completion
of the recombinant plasmid with a unique (not in the insert) 3' overhang restriction site,
and a unique 5' site between the insert and the 3' site chosen. The polylinker has the
unique 3' restriction site on the outside edge of the polylinker, and 5' sites internally.
Thus, with the progression of the Exonuclease III, nested deletions of the insert can be
constructed. Subsequent treatment with Mung Bean nuclease digests the single stranded
DNA to create blunt ends that can be ligated to circularise the plasmid for use in double
stranded sequencing. For each time point, 5 .tg of double digested DNA was treated in
12.5 j.il of 2 X Exo buffer (100 mM Tris-HCI, pH 8; 10 mM MgC1 2, 20 .g/ml tRNA), 2.5
p1100 mM 2-mercaptoethanol and I p1 Exonuclease III (100 U/pl of DNA). A total
volume of 25 p1 was made up with sterile water. At 30°C, approximately, 230 bp were
deleted per mm. The reaction of each time point was stopped by heat inactivation at
68°C for 15 mm and then placed on ice. Subsequently, each time point tube was
incubated with 15 U of Mung Bean nuclease for 30 mm at 30°C. This reaction was
stopped with 4 p1 of 20% SDS, 10 p1 1 M Tris-HC1 (pH 9.5) and 20 p1 8 M lithium
chloride. The DNA was extracted with 250 p1 phenol/chloroform, ethanol precipitated
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followed by a wash in 70% ethanol, spun, and vacuum dried. The blunt end Exo/Mung
DNA was then ligated and the plasmid amplified for use in double stranded sequencing.

2.8.2 Sequencing reaction protocols
A modification of the dideoxy or chain termination sequencing method developed
by Sanger and Coulson (1977) was used. The method utilises DNA polymerase to
synthesize a complementary copy of the single stranded DNA template. The enzyme
catalyses chain elongation at the 3' end of the primer DNA which is annealed to the
template DNA. The deoxynucleotide added to the growing primer chain is directed by
base-pair complementation to the template DNA. Chain growth involves the formation
of a phosphodiester bridge between the 3'-hydroxyl group at the growing end of the
primer and the 5' phosphate group of the incoming deoxynucleotide, resulting in an
overall chain growth in the 5' to 3' direction.
This method capitalises on the enzymes ability to use 2', 3'-dideoxynucleotide
tn phosphates (ddNTPs) as substrates. When a ddNTP is incorporated at the 3' end of the
growing primer chain, the chain is terminated as it lacks the required 3'-hydroxyl group
for chain elongation. By using four different ddNTPs in four separate enzymatic
reactions, populations of oligonucleotides are generated that terminate at positions
occupied by every A, C, G or T in the template strand. These populations of
oligonucleotides are then resolved by electrophoresis and visualised on X-ray film due to
incorporation of radionucleotides during chain elongation.
In this work, sequencing of double stranded DNA strands was carried out. A
commercial kit (Sequenase, United States Biochemical, USA) was used.
For the sequencing of double stranded plasmid DNA, between 3 and 5 jig of
plasmid DNA in a volume of 16 j.tl of water was denatured by 2 1.il of 2 MNaOH and 2 jil
of 0.1 M EDTA (pH 8.0). The mixture was incubated for 5 minutes at 65°C. The
denatured plasmid was neutralised with 2 iil of 3 M sodium acetate (pH 5.2), and the
DNA precipitated with 60 .il of ice-cold ethanol. After washing the pelleted DNA in
70% ethanol, it was re-dissolved in 7 tI of distilled water before the addition of the
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sequencing buffer and primer Annealing of the primer to the denatured target DNA was
carried out in a total volume ot 10 jil by adding I jil Universal primer (100-200 ng) and 2
jtI 5 X reaction buffer (200 mM Tris-HCI, pH 7.5), 100 mM MgCl 2, 250 mM NaCI). The
mixture was mixed well and warmed to 70°C for 2 minutes and left to cool to room
temperature over a period of 20- 0 minutes and then placed on ice.
The labelling reaction was then carried out by adding to the annealed templateprimer 1 jil of 100 mM DTT, 2 jil of diluted (1:5) labelling mix, 0.5 jil of [a- 35 S] dATP
and 2 jil of diluted (1:7) Sequenase'. This mixture was incubated for

2-5

mm at room

temperature.
In the termination reaction, 2.5 jil of ddNTP termination mix (80 pM of each
dNTP A., C, G, T) was placed in the respective tubes labelled A, C, G and T. To each of
these tubes 3.5 p1 of the labelling incubation mix was added and the tubes were incubated
at 37°C for 5 mm. The reaction was stopped with 4 p1 of a stop solution. Prior to loading
on the gels, the samples were heated to 75°C for 2 minutes.
Sequencing gels were prepared as a 6% polyacrylamide mix made from a 40%
stock solution (2 g bisacrylamide, 38 g of acrylamide in 100 ml of distilled water). To 10
ml of 10 X TBE (108 g Tris, 55 g boric acid, 9.3 g EDTA) and 15 ml of 40% acrylamide,
42 g of urea was dissolved and made up to a total volume of 100 ml. This was warmed to
dissolve the urea and then cooled to 4°C. Polymerisation was initiated by addition of 600
p1 of 10% ammonium persuiphate and 100 p1 of TEMED (Ultra-pure, BDH, U.K.). The
gels were cast in a BRL model 50 sequencing gel apparatus using 0.2 mM spacers and
shark tooth sample combs. Both plates were siliconised by wiping with 5% dimethyl
dichlorosilane in carbon tetrachioride followed by ethanol. The sequencing reactions
were heated at 75°C for 2 mm before loading 3 p1 of the samples into the sample wells.
The gels were run with a Pharmacia model ECPS 3000/150 power supply.
Electrophoresis was carried out at a constant power of 70 watts in 1 x TBE running
buffer.
The short runs generally took 1 '/2-2 hr and the long runs 5 hr. On completion, the
gel plates were carefully separated and the plate holding the gel was gently immersed into
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fix solution (19% acetic acid, 10% methanol) for 15 miflUtes to wash out the urea. The
gels were transferred onto Whatman 3 MM filter paper by pressing in onto the gel and
gently rolling the gel off the plate. It was then wrapped Itt saran wrap and dried at 80°C
under vacuum. Exposure for autoradiography was done with direct contact between the
dried gel and the emulsion-coated side of an X-ray film, which was left overnight in a
cassette at room temperature. The sequencing gels were read using a sonic digitiser
(Science Accessories Corp., Stratford, Conn., USA) interfaced to a microcomputer. The
sequencing data were analysed using a Dnasis/Prosis program (Hitachi Software
Engineering, Brisbane, CA, USA) on an IBM PS/2 Model 80 computer with a 386
microprocessor.
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CHAPTER 3

RESULTS

3.1.1 Search for amplified genomic sequences in a muttidrug-resistant T. b.

brucei

isolate (CP 547).
Current data indicate that gene amplification is an important mechanism
employed by parasites to survive drug selection (Beverley, 1991). However, the
possibility of gene amplification being employed for the evasion of drug pressure by
drug-resistant African trypanosomes has not been carefully examined. In drug-resistant
Leishmania spp. amplified DNA often constitutes as much as 5%-1O% of total parasite
DNA (Coderre eta!., 1983) and the amplified DNA is readily detected as abundant DNA
fragments in undigested and restriction enzyme digested total genomic DNA (Coderre et
a!., 1983; Beverley et a!., 1988). Attempts were therefore made to look for the presence
of amplified sequences that may correlate with drug resistance within a multidrugresistant T. b. brucei isolate (CP 547).
In an experiment designed to detect amplified DNA sequences, total genomic
DNA was purified from bloodstream forms of the drug-resistant CP 547 isolate and a
drug-sensitive ILTat 1.4 clone. 2 jig of undigested and overnight restriction enzyme
digested genomic DNA from both the drug-resistant and the drug-sensitive populations
was electrophoresed in two identical 1.2% agarose gels, and stained with ethidiumbromide (Figure 4a). From these ethidium-bromide stained gels, no differences were
apparent between the resolved DNA from the drug-resistant and the drug-sensitive
populations. Southern blots of the two identical gels were generated and one blot was
hybridised with 32P-labelled total DNA from the drug-resistant CP 547, while the second
blot was hybridised with 32P-labelled total DNA from the drug-sensitive ILTat 1.4 clone.
The two blots had almost identical hybridisation profiles for the restriction enzyme
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digested DNAs, despite the use of the two different DNA probes (Figure 4b). The
hybridisations disclosed some of the well characterised repetitive DNA sequences within
7'. b. brucei, namely TRS-1 (ingi)(Kimmel eta!, 1987; Murphy eta!., 1987), the 177 bp
Mu repeat (Sloof et a!., 1983), the linearised minicircies (Borst and Hoeij makers, 1979)
and the well characterised miniexon repeat unit (Cornelissen eta!., 1986; Walder eta!.,
1986) (Figure 4b). In addition to these well characterised repetitive sequences,
hybridisation was also evident to other, as yet uncharacterised, repetitive sequences.
However, hybridisation to a band migrating as a 6.6 kbp DNA fragment was observed in
the lane of undigested DNA from the drug-resistant CP 547 isolate, but not the drugsensitive clone (Figure 4b, lane 1). In addition, there was a weaker hybridisation signal
with a band migrating as a 13 kbp fragment in the undigested DNA samples of CP 547
(Figure 4b), possibly a dimer or a higher hybridising form of the 6.6 kbp fragment.
Taking into consideration that the 6.6 kbp element was not visible on the ethidiumbromide stained gels, and it is possible to visualise 10 ng of DNA, it was estimated that
there are less than 70 copies of the 6.6 kbp element per genome of the CP 547 isolate.
With agarose gel electrophoresis, the kinetoplast DNA networks are trapped
within the gel slot and do not migrate into the gel. The undigested chromosomal DNA
enters the gel but does not migrate past the 20 to 40 kbp region. The migration of the 6.6
kbp fragment in the undigested DNA samples thus indicates that this element is neither of
chromosomal nor kinetoplast origin, but is of extrachromosomal origin. That the
revelation of this extrachromosomal element was not just an artefact was verified by reexpanding the population of CP 547 from the original stabilate and then comparing DNA
purified from it with DNA purified from two characterised drug sensitive T. b. brucei
clones, ILTat 1.1 and 221 (Kaminsky and Zweygarth I 989a) in addition to two 7'. b.
bruce! populations ILTar 2, and IL BlO whose drug-sensitivities are unknown.

3.1.2 Initial characterisation of the 6.6 kbp DNA

Since the extrachromosomal 6.6 kbp element represents the first identification of
an extrachromosomal element in African trypanosomes, further characterisation of it was
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warranted. In addition, some extrachromosomal nucleic acid elements are known to be
important carriers of genetic information (Esser eta!., 1986; Wickner eta!, 1986). They
can originate from several different sources, some common examples being organellar
genomes, amplified genomic DNA sequences, viral genomes and plasmids.
Hybridisation of total genomic DNA from the drug-sensitive trypanosomes to the 6.6 kbp
element in CP 547 (Figure 4b) indicates that sequences similar to those on the element
are also present within the genomes of the drug-sensitive clone, although not as
extrachromosomal DNA. Thus, the presence of the element in only the drug-resistant
isolate suggested a form of amplification which may be responsible for the drug
resistance phenotype, analogous to gene amplification in drug-resistant Leishmania spp.
(Beverley eta!., 1988). In drug resistant Leishmania spp., extrachromosomal elements
such as H and R circles are known to be directly associated with drug resistance (Section
1.4.2). The characterisation of such elements and amplified sequences in parasitic
organisms is of particular importance, as knowledge about them may shed light on
particular biological nuances of the parasite which may be exploited in devising new
control measures. For instance, the outcome of similar studies on the amplified
sequences of the DHFR-TS gene in pyrimethamine-resistant P.falciparum, has had an
important impact on the control of malaria. it is now known that with the control of
pyrimethamine usage the selective drug pressure that maintains some highly resistant
organisms can be removed and the sensitivity to pyrimethamine restored (Inselburg eta!.,
1989).
The characterisation of the 6.6 kbp element was further warranted because of its
small size and potential exploitation as a vector for experimental transformation of T.
brucei or other African trypanosome species. Such a vector could be of significant value
in molecular biology studies of trypanosomes.

3.1.2a Purification of the 6.6 kbp element

Since the 6.6 kbp element is not visible in ethidiurn-bromide stained gels, its copy
number was expected to be low. Therefore, initial purifications involved running
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Figure 4
Comparison of the drug-resistant T. b. bruce! CP 547 isolate and drugsensitive clones ILTat 1.4 and GUTat 3.1. In the figure are tracks of drugsensitive ILTat 1.4 (lane 1) and GUTat 3.1 (lane 2) and the multidrug-resistant
isolate CF 547 (lane 3).
(A) 2 .ig of total DNA from each population was grouped together as (U)
undigested, (A) Alu I digested, (S) Sau3A I digested and (1) Taq I digested total
genomic DNA resolved on a 1.2% agarose gel; and then stained with ethidiuinbromide.
(B) A Southern blot of the panel A was hybridised with 32P-labelled total DNA
from the drug-resistant CF 547 parental population. The filter was washed at
high stringency (0.1 X SSC, 65°C) and exposed to X-ray film overnight at -80°C
with intensifying screens. The size of the DNA size markers are given in kbp.
The arrow head on the left of panel B indicates the 6.6 kbp extrachromosomal
element detected in the undigested CF 547 DNA. The arrovs on the right of
panel B indicate the well characterised repetitive DNA sequences within T. b.
brucei; namely (T) TRS-1 (ingi) (Kimmel et a!., 1987; Murphy eta!., 1987), (A)
the 177 bp Alu-satellite repeat (Sloofet a!., 1983), (M) linearised minicircies
(Borst and Hoeij makers, 1979) and (X) miniexon repeat unit (Cornelissen et a!.,
1986; Walderetal., 1986)
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approximately 300 jig of undigested total DNA from CP 547 on large sized, 20.5 cm x 24
cm, preparative 1% agarose gels. The agarose gel slice corresponding to the 6.6 kbp
region was then excised and the DNA extracted either by the geneclean®method or
electroelution. Major losses were incurred during the purification of the relatively small
quantity of DNA contained in the large agarose slices. During geneclean®the agarose gel
slice of an approximate weight of 15 gm was dissolved in about 45 ml of saturated
sodium iodide solution. Although a ten-fold excess of glass milk (50 jil) was added to
the 50 ml sodium iodide and DNA mixture, the chances for the glass milk beads to
interact and then bind to the DNA were greatly reduced in the very dilute DNA solution.
Similarly, with eletroelution, the 6.6 kbp DNA was greatly diluted which made its
precipitation not only inefficient but also resulted in co-precipitation of large amounts of
contaminating components from the agarose. Generally, 500 jig of total genomic DNA
was required to isolate a sufficient quantity of the 6.6 kbp element to perform one
labelling experiment by random priming.
The ability to label the 6.6 kbp element with random primers and the Klenow
fragment of K coli DNA polymerase I verified that the 6.6 kbp element was DNA.
Attempts to radiolabel the 6.6 kbp element by the nick translation method resulted in
poor 32p incorporation, most likely because there was insufficient DNA and/or because
gel components inhibited the reaction.
From the specific activity of the radiolabelled probe generated from the gel
isolated 6.6 kbp element, it was estimated that from the 500 jig of genomic DNA
approximately 20 ng of DNA from the 6.6 kbp region could be isolated. Using this value
and assuming a 50% loss during the purification, it was estimated that the copy number
of the 6.6 kbp element was approximately one per genome.

3.1.2b Initial efforts at cloning sequences from the 6.6 kbp element

The gel-purified 6.6 kbp DNA was used as a radiolabelled probe on the same
Southern blot shown in Figure 4b after removal of the original probe. In such blots,
curiously, the 6.6 kbp probe hybridised back to the 6.6 kbp element very faintly or not at
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all, whereas it hybridised strongly to restriction fragments from both the drug-resistant
and the drug-sensitive populations (Figure 5a). Hybridisations of additional Southern
blots like those of Figure 5a, generated from different preparations of the element,
indicated that the hybridisation profiles of the restriction fragments could be organised
into classes representing the relative frequency of hybridisation to a particular restriction
fragment. The first class represents restriction fragments that hybridised most frequently
with the different preparations of the 6.6 kbp probes (given in Table 8). However, among
this class some fragments were not always apparent in the different Southern blots. The
second class represented restriction fragments that hybridised infrequently with the
different 6.6 kbp probes. The third class represented fragments that were unique to the
different probes. The different Southern blots contained hybridising restriction
fragments from the three classes in varying combinations. Figure Sc shows a
representative example of an identical set of Southern blots of total CP 547 DNA
digested with some commonly used restriction enzymes, each probed with a different
isolation of the gel-purified 6.6 kbp DNA.
At this stage of the analysis, the variability with respect to infrequent
hybridisations to some restriction fragments was attributed to incomplete transfer of
DNA during blotting and the presence of varying amounts of contaminating sheared
genomic DNA which co-purified with the different preparations of the 6.6 kbp region.
The latter explanation was, however, incomplete considering that the different 6.6 kbp
probes did not hybridise strongly to any of the well characterised T b. brucei repetitive
sequences which are the most likely sequences expected among contaminating DNAs.
This indicated that the 6.6 kbp region is relatively pure and free of contaminating
genomic DNA. Therefore, it was possible that the inconsistencies in the hybridisations
were due to variations within the 6.6 kbp region itself or due to variations within
sequences hybridising to the 6.6 kbp region. Evidence to support this contention is
presented later in section 3.5.lc.
In the Southern blots of different restriction enzyme digests it was not clearly
evident which (if any) enzymes cut the 6.6 kbp element, and what its resulting profile
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Figure 5
Genomic Southern blot analysis of trypanosome DNA by hybridisation with
the purified 6.6 kbp DNA.
(A) The Southern blot from Figure 4B was stripped of its previous probe and rehybridised with 32P-labelled gel purified 6.6 kbp DNA from CP 547 in order to
identify putative genomic copies of the 6.6 kbp element.
(B) A Southern blot of CP 547 DNA digested with six base pair cutting
restriction enzymes was also hybridised with 32P-labelled gel purified 6.6 kbp
DNA. Lanes (1) and (9) contain undigested total genomic DNA while lanes 2 to
8 contain genomic DNA digested with (2) Sph 1, (3) Psi I, (4) Sal I, (5) Sma I,
(6) Kpn I, (7) Sac I, (8) EcoR I.

(C) Two sets of Southern blots were hybridised with different preparations of the
6.6 kbp element (numbered I to 4). Probes I and 2 were hybridised
consecutively to one Southern blot which was stripped between probing.
Similarly probes 3 and 4 were hybridised to a second Southern blot. The
position of the size marker fragments is indicated by the lines on the left of each
blot. Differences in hybridisation signals between probes are shown by the
brackets and asterisk on the right of each pair of lanes.
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was. This was partly because hybridisation of the 6.6 kbp probe to the various genomic
copies masked the digestion profile for the 6.6 kbp element. Furthermore, because of the
differences between the hybridisation profiles of the drug-resistant isolate in comparison
to the drug-sensitive clone, it was difficult to distinguish the restriction fragments
originating from possible digestion of the 6.6 kbp element (Figure 5a and 5b). This
problem was compounded by the fact that hybridisation to the element itself was weak or
nonexistent. Nevertheless, the hybridisation profiles with the gel-purified 6.6 kbp probe
were obviously selective since there was lack of hybridisation to known repetitive
sequences. At this point it was unclear why there was weak or lack of hybridisation to
the 6.6 kbp element with probes generated from the region encompassing the 6.6 kbp
element. The possible reasons for some of these problems became apparent later, but at
this stage attempts to clone fragments from the element were initiated.
As there was only sufficient purified 6.6 kbp DNA for either cloning or restriction
analysis, it was decided that it would be preferable to attempt to directly clone the
element or sequences from it. Since it had been difficult to determine the restriction
enzymes that might cut the 6.6 kbp element, the approach involved taking aliquots of the
gel-purified 6.6 kbp DNA and digesting each aliquot with restriction enzymes that cut
within the polylinker sequence of theE. coil plasmid vector pBluescript. Efforts to clone
the digested 6.6 kbp DNA into pBluescript digested with the same restriction enzymes
yielded only very few recombinants. DNA was purified from these recombinants and
subsequently tested as 32P-labelled probes on Southern blots containing undigested CP
547. None of the clones hybridised to the 6.6 kbp element, and the restriction enzyme
digestion profiles were too ambiguous to establish whether the cloned sequences were
derived from the 6.6 kbp element or were due to contaminating genomic sequences.
The apparent failure to clone sequences from the purified 6.6 kbp element was
attributed to several possible reasons: (1) The presence of contaminating components
from the agarose which may have been sufficient to inhibit the restriction enzymes used;
(2) The 6.6 kbp region may not be double stranded DNA and therefore cannot be cut by
restriction enzymes; (3) The 6.6 kbp region may lack restriction enzyme sites either
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through cont fflng simple sequence repeats or modified bases; (4) Since very small
quantities of B kbp DNA could be isolated from the gel, accurate quantitation was not
possible. Therefore, the optimum quantities required for efficient cloning experiments
could not be aIiieved.
Since these problems were difficult to overcome, an alternative approach was
adopted which Involved attempting to clone genomic copies of sequences contained on
the 6.6 kbp element. The rationale behind this approach was that if a genomic copy could
be cloned, then it would be easier to determine which enzymes cut the 6.6 kbp element
and thus allow the cloning of a full length copy. This approach involved cloning of DNA
purified from the regions corresponding to restriction enzyme fragments which
hybridised to the gel-purified 6.6 kbp (Figure 5a and 5b). Additional restriction
fragments to which the gel-purified 6.6 kbp DNA hybridised were identified by using
some commonly used six base cutting restriction enzymes (Figure Sb). Table 8 lists the
restriction fragments that were selected as putative genomic copies of the 6.6 kbp
element.
The 15 restriction fragments marked with an asterisk were selected using the
following criteria:
(1)

Some of the restriction fragments of choice were those that were identified in the

drug-resistant isolate only. The rationale behind this was that since these fragments were
absent in the drug-sensitive population, they most likely represent digested fragments
from the 6.6 kbp element or genomic copies unique to the drug-resistant isolate.
(2)

Restriction fragments were chosen if they consistently hybridised to the probes

generated from the 6.6 kbp DNA purified from different CP 547 stock expansions. The
rationale behind this selection approach was to try and eliminate fortuitous hybridisation
signals due to different levels of contaminating genomic sequences in the various probes
generated. It was likely that the degree of contamination with genomic DNA would
differ in the separate 6.6 kbp preparations, whereas consistent quantities of the element
were expected. Therefore, the probes generated from seperate preparations were
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Table 8: Putative genomic copies of the 6.6 kbp element
Restriction enzyme

Fragment sizes (kbp)

1.80

A/u I

1.65
1.40
1.20*
0.84
0.60
6.60*

Sau3AI

5.90
1.90
1.75*
0.90
0.54
Taq I

5.90
3.50
1.40*
0.60*

BstUI

5.80
3.05*
2.55
1.10*
0.72

EcoR I

13.50

*

10.80
9.20*
1.58*
16.50

BamH I

10.50
9.00
1.90*

Sph I

7.80*
*
1.20
0.70

Key: * DNA fragments most likely representing genomic copies of the 6.6 kbp element which were selected
for further analysis.
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expected to give consistent hybridisations to sequences specific to the element. It was
hoped that such a selection would reduce the possibility of studying ai-tefacts.
(3)

Preference was given to restriction fragments hybridising with a greater intensity

in the lane with DNA from the drug-resistant isolate in comparison to the corresponding
fragment from the drug-sensitive population. The rationale behind this was that the
greater intensity may be due to additional copies arising from sequences derived from the
6.6 kbp element, in addition to the genomic copies.
(4)

Hybridising restriction fragments that corresponded to faint bands on the

ethidium-bromide stained gels were given preference. Strong bands on the ethidiumbromide stained gels were avoided as these most likely contained repetitive sequences.
(5)

Restriction fragments localised at a close proximity to known repetitive sequences

were avoided so as to eliminate the possibility of cross-contamination by these repeats
during the gel purification of the selected region.
To purify DNA corresponding to these 15 restriction fractions, aliquots of 8 ig of
CP 547 genomic DNA were each digested with the respective restriction enzyme of
choice and then resolved by agarose gel electrophoresis. The selected fractions were
excised and the DNA extracted by the geneclean®method. The purified DNA from each
of these 15 regions was then radiolabelled and used as a hybridisation probe on test
Southern blots generated from CP 547 DNA. Each test blot had at least a lane of
undigested genomic DNA, a lane of DNA digested with the restriction enzymes used to
purify the fragment and representatives of genomic DNA digested with some of the
restriction enzymes used to purify the different fragments. Figure 6 shows a
representative example of results of some of these hybridisations. Of the 15 restriction
fractions used as probes, none hybridised back to the 6.6 kbp element. Some of these
probes hybridised to repetitive sequences within the genome as depicted by the A/u I 0.6
kbp fraction (Figure 6, blot A, probe A 0.6) which hybridised to the well characterised
177 bp Mu-satellite repeat, and Sph I 7.8 (Figure 6, blot C, probe Sph I 7.8) which
hybridised to uncharacterised repetitive sequences. The hybridisation profiles revealed
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Figure 6
Southern blot analyses of DNA from the CP 547 parental stock using size
selected total genomic DNA fragments as hybridisation probes.
DNA from CF 547 parental stock (2 j.g) digested with different
restriction enzymes was resolved in 1% agarose gels and Southern blotted. In set
A the lanes represent, (1) undigested DNA, (2) A/u I, (3) Sau3A I; in set B, (1)
undigested DNA, (2) A/u I, (3) EcoR I, (4) Sau3A I; in set C, (I) undigested
DNA, (2) Sph I, (3) EcoR I; in set D, (I) undigested DNA, (2) EcoR I, (3)
Sau3A I. The different 32 P-labelled DNA probes and their relative sizes in kbp
are indicated at the bottom of each blot. The probes were generated by resolving
total CF 547 DNA that was digested with the enzymes, (A) A/u I, (S) Sau3A I,
(B) BsIU I, (E) EcoR I, (Sp) Sph I, and the region corresponding to the required
fragment size, gel-purified.
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that despite the critical selection of the restriction fragments, the putative genomic copies
did not hybridise to the 6.6 kbp element.
In order to increase the chances of obtaining sequences specific to the 6.6 kbp
element, an alternative approach was then tried. In this approach, the purified DNA from
the region corresponding to the restriction fragment of choice was first checked for crosshybridisation to any of the other purified restriction fragments. Figure 7 shows one
representative example whereby a 32P-labelled probe generated from the DNA region
corresponding to the Taq I 1.4 kbp region (Figure 7a) was shown to cross-hybridise to
some of the other selected fractions, one of which was the EcoR 11.58 kbp region (Figure
7b, lane 7). On verifying this cross-hybridisation, clones were then generated from the
DNA purified from the Taq 11.4 kbp region and subsequently screened with 32P-labelled
DNA isolated from the region corresponding to the EcoR 11.58 kbp region. Cloning
from one restriction enzyme digested size-class and screening with the cross-hybridising
one was expected to reduce the chances of selecting false positives because, presence of
the same genomic contaminants in different restriction fragment size-classes was
unexpected. Subsequently, to cross-check specificity to the 6.6 kbp element, DNA was
prepared from the isolated clones, and used as 32P-labelled hybridisation probes. Even
by this procedure, none of the clones hybridised to the 6.6 kbp element; one clone from
the Taq 11.4 kbp region hybridised to the miniexon sequence. Seven regions shown to
cross-hybridise to other putative genomic copies were used in generating clones, but none
of the clones hybridised to the 6.6 kbp element. This approach required large quantities of
genomic DNA for the preparation of restriction fragments and for generating the many
test Southern blots of undigested and restricted CP 547 DNA. Therefore, to ease the
requirement for large quantities of genomic DNA, simple Southern blots containing lanes
with only undigested DNA were generated for the initial testing of specificity of
hybridisation to the 6.6 kbp element. Although such strips economised on the quantities
of genomic DNA, no further information regarding the restriction enzyme profiles was
obtained for the tested clones. The lack of this information at the time did not seem
essential, but in retrospect such information could have been very useful. Although there
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Figure 7
Cross-hybridisation analysis of the different size-selected genomic DNA
fragments.
(A) This is a representative Southern blot probed with 32 P-labelled 6.6 kbp DNA
whereby the lanes contain genomic DNA from (1) CP 547 population, (2) ILTat
1.4, (3) ILTat 1.1, (4) GUTat 3.1 digested with (A) Alu 1, (B) Bst U I, (H) Hinp I,
(S) Sau3A I, and (T) Taq I. The arrow on the right indicates the Taq 11.4 kbp
fragment hybridising sequence selected as a putative genomic copy of the 6.6
kbp element. However when this blot was stripped and reprobed with one
labelled clone generated from the region corresponding to the Taq I 1.4 kbp
fragment, hybridisation to the miniexon sequence was apparent.

(B) In this Southern blot the different size-selected genomic DNA fragments
were resolved on a 1% agarose gel, blotted and hybridised ith the 32P-labelled
Taq I fragment of 1.4 kbp. The different lanes are (1) DNA size marker, (2)
Sau3A I 5.9 kbp, (3) BamH 11.35 kbp, (4) Sph I 0.70 kbp, (5) Sau3A 11.90 kbp,
(6) Sau3A 11.75 kbp, (7) EcoR 11.58 kbp, (8) BsIU 11.1 kbp, (9) Blank, (10)
Gel-purified 6.6 kbp DNA.
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were other putative genomic copies which were not tested, this approach was not pursued
because, in addition to being expensive, cloning of DNA from the different regions
followed by screening and eventual testing of the clones proved to be very time
consuming and did not appear to yield the desired results.
The problems encountered with the above-mentioned different approaches to
clone sequences contained on the 6.6 kbp element highlighted that the very low
recoverable amounts of gel-purified 6.6 kbp DNA and contaminating genomic DNA
were the two major obstacles towards the characterisation of the element. Some of the
fragments and clones generated from these efforts hybridised to repetitive sequences
from the tiypanosome genome, some of which corresponded to well characterised
repeats. Therefore, to rule out the possibility that the 6.6 kbp e'ement conta:ins some ol
the well characterised repetitive sequences, Southern blots with lanes of both undigested
total CP 547 DNA and lanes of DNA cut with some commonly used restriction enzymes
(Figure 8) were hybridised with six well characterised repetitive sequence probes;
namely TRS-1 (ingi), minicircles, the miniexon repeat, the 177 bp Alu-satellite repeat
and a telomere repeat sequence. However, even at low stringency washes (4 x SSC at
65°C), none of these repetitive probes hybridised to the 6.6 kbp element, thus ruling out
their presence on the 6.6 kbp element.

3.2.1 Instability of the copy number of the 6.6 kbp element
Large amounts of genomic DNA from CP 547 stock were constantly required for
gel purification of sufficient quantities of the 6.6 kbp element, for labelling purposes, for
the purification of the various selected restriction fragments (Section 3.1.2 b), and for the
preparation of Southern blots required to test the various clones and restriction fragments.
To meet this continuous demand the CP 547 stock was continuously passaged and then
expanded in rodents over the first 6 months of this investigation. However, as DNA was
prepared from the consecutive passaged isolations, problems were emerging in detecting
the 6.6 kbp extrachromosomal element. This was initially attributed to faulty transfer and
binding of the DNA to the nylon filters, as the batch of nylon had changed. To overcome
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Figure 8
Southern blot analyses of CP 547 DNA using some of the well characterised
T. b. brucei repetitive sequences as probes. Identical 1.4% agarose gels with
lanes each containing 2 .tg of total CP 547 DNA which was (1) undigested, and
digested with (2) Alu I, (3) Sau3A I, (4) EcoR I and (5) Taq I were generated.
Southern blots of these gels were hybridised with 32P-labelled (A) total genornic
DNA, and five other well characterised repetitive DNA sequences which are (B)
TRS-1 (ingi), and the 177 bp Alu repeat, (C) the miniexon repeat sequence, (D) a
telomere repeat sequence and (E) minicircles.
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this problem, nitrocellulose was used as the solid support and more caution was exercised
in ensuring efficient transfer of all DNA from the gel to the filters. In addition, for
clearer visualisation of the 6.6 kbp element on autoradiographs, it became apparent that it
was essential to avoid mechanical shearing of the genomic DNA during its preparation.
Nevertheless, although care was taken, some proportion of shearing was inevitable
resulting in masking of the already weak signal corresponding to the 6.6 kbp element.
The problem of shearing was however overcome by lysing the cells in silu through
embedding of purified trypanosomes in 0.5% low melting point agarose and processing
them as for PFGE (Section 2.5.2). The agarose blocks containIng the embedded CP 547
trypanosomes were cut into strips sized 0.5 cm by 2.5 cm so that when required the strips
could be aligned to fit the length of the preparaüve gel slot. Thetce
blocks was then resolved by electrophoresis in conventional agarose gels. Using this
approach, not only was the 6.6 kbp element visualised more clearly but the problem of
contaminating genomic sequences appeared to be reduced (Figure 9a). However, despite
these precautions, the hybridisation signal corresponding to the 6.6 kbp element from the
consecutive trypanosome isolations was still extremely faint and eventually un-detectable
on Southern blots. The reduction and eventual loss of signal corresponding to the 6.6 kbp
element indicated that the copy number of the 6.6 kbp element was unstable. Continuous
passaging of the CP 547 stock for 6 months in mice, in the absence of selective drug
pressure, resulted in the selection of a sub-population lacking the element. Subsequently,
the CP 547 stock that had been passaged has been referred to as the 'passaged CP 547
stock'.
Similar reductions in the copy number of extrachromosomal elements have been
observed in some drug-resistant Leishmania spp., whereby the instability is known to be
directly associated to the removal of selective drug pressure (Beverley eta!., 1987).
Since the CP 547 stock had been passaged for almost 6 months in the absence of drug
pressure, as for Leishmania spp., the reduction and loss of the 6.6 kbp element could be
associated with a change in the drug resistance profile of this population. Therefore,
experiments were carried out to determine the sensitivity of the 'passaged CP 547 stock'
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Figure 9
Southern blot analysis of CP 547 genomic DNA prepared in agarose blocks
and in liquid.
(A) This blot shows the difference in the amount of shearing and masking of the
6.6 kbp element when DNA was prepared from CP 547 trypanosomes embedded
in agarose blocks (E), as opposed to liquid preparation (2 .tg) of DNA (L). The
embedded DNA was prepared as outlined in section 2.5.2c, whereas liquid DNA
was prepared as outlined in section 2.4.1. The DNA was resolved on a 1%
agarose gel, Southern blotted and hybridised with 32 P-labelled CP 547 total
genomic DNA.

(B) & (C) A comparative analysis between 'unselected' and diminazene
selected CP 547 clones.
Total undigested DNA from four clones generated from a CP 547 stock passaged
in mice over 6 months without any drug pressure (B), and four clones generated
from the relapse population that emerged from treating the parental CP 547 stock
with 60 mg/kg b.w. of diminazene aceturate (C) was resolved on a 100 agarose
gel, Southern blotted and probed with 32 P-labelled total CP 547 genomic DNA.

A
L

ry
.1

6.6kbp-

Si

E

m

B
234

66kbp-!

S

C
1 234

-6.6kbp

to diminazene aceturate and isometamidium chloride. These experiments disclosed that
the drug sensitivity of the 'passaged CP 547' population had altered. The 'passaged CP
547' stock had become less resistant to the two trypanocides in comparison to the parental
CP 547 population (Table 9). For instance, 60 mg per kg body weight (b.w.) of
diminazene aceturate, the maximum tolerated dose in mice, now cured infections of the
'passaged CP 547 population', whereas the original isolate relapsed at this drug dosage.
These findings, however, contradicted earlier studies by Kaminsky and Zweygarth
(1989a), who showed no alteration in the drug-sensitivity profiles of CP 547 populations
to diminazene aceturate and isometamidium chloride after in vitro propagation for up to
275 days in the absence of drug pressure.
Thus, as for Leishmania spp., the CP 547 population passaged without drug
pressure expressed lower levels of resistance and also displayed a reduction and eventual
loss of the 6.6 kbp element,, suggesting a correlation or partial involvement of the element
in resistance However, the original population of CP 547 was not cloned, it is possible
that continuous passaging of the stock resulted in selection for a more sensitive
population in the mixed population, similar to selection for pyrimethamine-sensitive
populations in P. falciparum (Inselburg eta!., 1989).

3.2.2 Drug sensitivity of clones derived from the CP 547 stock
In order to determine the variation in sensitivity to diminazene aceturate of
trypanosomes within the 'passaged CP 547' stock, four clones were generated from the
population as described by Barry and Gathuo (1984). Since no drug pressure was applied
during their production, these clones were designated as the 'unselected' clones. The
sensitivity to diminazene aceturate of these four 'unselected' clones did not vary
significantly from each other. It also appeared to be similar to the 'passaged CP 547'
stock from which they were derived (Table 9). In comparison to the parental, unpassaged, population of CP 547, the four 'unselected' clones were significantly less
resistant to diminazene aceturate (Table 9). However, although the 'unselected' clones
were more sensitive to diminazene aceturate than the parental unpassaged CP 547
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population, in comparison to the reference drug-sensitive population ILTat 1.4, the
'unselected' clones expressed significant levels of resistance to diminazene aceturate.
To evaluate the effect of selection with diminazene aceturate, four additional
clones were generated from the parental population of CP 547. To generate these clones,
six mice were each infected intraperitoneally with iC)3 CP 547 trypanosomes. After 24 h,
the maximum tolerated dose of diminazene aceturate (60 mg/kg b.w.) was administered
intraperitoneally. After a further six days a relapse population was detected in the tail
blood smears. On purification of the relapsed parasites, four clones were generated and
designated as the 'drug-selected clones'. These four selected clones were all characterised
for their sensitivity to diminazene aceturate in mice and were found to be resistant to 60
mg/kg b.w. of diminazene aceturate. Since this was the maximum tolerated dose in mice,
an absolute measure of the level of resistance displayed by these clones could not be
established. However, from the evaluation of the clones' sensitivity to diminazene, it was
evident that the application of diminazene aceturate selected for a population expressing
a higher level of drug resistance whereas, in the absence of drug pressure, the population
reverted to a lower level of resistance.

3.2.3 Southern blot analysis of the CP 547 clones.
Presence of the 6.6 kbp element in the diminazene-selected and 'unselected' CP
547 clones was determined in Southern blots of undigested DNA from each population.
Hybridisations with 32P-Iabelled CP 547 DNA showed that, of the four 'unselected'
clones, only one (clone 3) had detectable amounts of the 6.6 kbp element (Figure 9b). In
contrast, all four clones generated under diminazene pressure possessed detectable
amounts of the 6.6 kbp element (Figure 9c). These experiments confirmed that in the
absence of diminazene pressure, there was both loss of the 6.6 kbp element and a
significant decrease in the level of resistance to diminazene. In contrast, if diminazene
pressure was applied, the element reappeared and the maximum levels of resistance
measurable in mice did not decrease. Although it was not possible to establish the
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absolute levels of diminazene resistance that the populations expressed, the results
suggest a correlation between presence of the element and expression of high levels of
resistance. Having said this, a direct correlation between both observations is
complicated by the presence of the 6.6 kbp element in 'unselected' clone 3. In addition,
'unselected' clone 2 expressed a higher level of diminazene resistance than 'unselected'
clone 3 (Table 9). The results obtained from the Southern blots could thus be interpreted
as: (I) the presence of the element in the multi-drug resistant isolate is fortuitous and not
directly associated with diminazene resistance, (2) the element is associated with
diminazene resistance but other unknown factors are also involved in expression of
resistance, (3) the element is generated as a consequence of the drug but is not directly
involved in the expression of drug resistance or (4) the higher hybridising forms of the
element, and to some degree the 6.6 kbp element, are involved in diminazene resistance.
The unstable resistance characteristics of the 'passaged CP 547' population to
diminazene aceturate, and the associated instability of the 6.6 kbp element, emphasised
the requirement for generating uniform parasite material for informative analyses. Thus,
generation of the diminazene selected clones containing the 6.6 kbp element helped
overcome such problems. Henceforth, for all subsequent investigations, the dimina.zene
selected "clone 2" was used as it displayed the strongest hybridisation signal for the
element. Furthermore, in order to ensure maintenance of both a high level of
diminazene-resistance and the associated 6.6 kbp element, "clone 2" parasites were
passaged and expanded in mice treated with 55 mg/kg b.w. of diminazene aceturate.
Whenever CP 547 trypanosomes were required, clone 2" was expanded in mice which
were each infected intraperitoneally with iO3 CP 547 trypanosomes. After 24 h, 55
mg/kg b.w. diminazene aceturate was administered intraperitoneally and the relapse
population harvested.

3.2.4 The 6.6 kbp element displays unusual mobilities
The drug-selected clone 2 was now expected to generate consistent and higher
quantities of the element. Curiously however, when the region corresponding to the 6.6
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kbp element was purified and labelled, it became evident that the material isolated from
some electrophoretic runs did not incorporate the radio-isotope at all, whereas others
labelled easily. This puzzling result was attributed to major losses still being incurred
during purification of the element from the large agarose gel slices. Consequently, in
order to improve the recovery, it was considered preferable to first localise the element
and then excise the exact region of the agarose strip corresponding to it. To accomplish
this, undigested CP 547 genomic DNA was first electrophoresed in a 0.8% w/v
preparative agarose gel. To reduce co-migrating contaminating genomic DNA, as
mentioned earlier, agarose blocks with parasites lysed in situ were used and the gels were
also resolved slowly at 60 volts for a period of 18 h. On completing the electrophoretic
run, a test agarose strip of about 3 cm was cut from one edge of the preparative gel and
analysed by Southern blotting, while the remaining gel was stored at 4°C to reduce
diffusion of the DNA. The test strip was probed with 32P-labelled total CP 547 genomic
DNA to localise the element. The hybridisation signal thus allowed accurate localisation
of the region within the gel corresponding to the element which was then excised and
purified by the geneclean®method. Alternatively, the DNA in the agarose strip was
concentrated onto a DEAE-45 cellulose membrane from which it was eluted. This
approach of purifying the element was an improvement because it reduced the amount of
contaminating genomic DNA that was co-purified with the element from the wider
agarose gel strips previously used. it also gave a cleaner preparation with less
contaminating agarose material, and ensured consistent recovery of the element. The
approach of first localising and then isolating the element also revealed that the element
displayed differential mobility in different gel systems. This resulted in differences in the
apparent size of the element with respect to linear DNA size markers in different
percentage agarose gels, a property of circular DNA molecules (Beverley, 1988). This
finding explained the lack of recovery of the element from some of the previous gel
isolations in which the 6.6 kbp region was localised on the basis of linear DNA size
markers.
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3.3.1 PCR-amplification of membrane-bound 6.6 kbp element.
In order to obtain sequences specific for the 6.6 kbp element, efforts were first
made to clone directly from the gel-purified 6.6 kbp element. Lack of success led to
attempts at cloning the putative genomic copies of the element. However, these two
approaches did not produce the desired results and were therefore abandoned. The major
obstacles appeared to be the co-purified genomic contaminants which interfered in the
identification and cloning of the required sequences. In addition, it was possible to purify
only very small quantities of the 6.6 kbp element; from 500 .ig of total genomic DNA,
less than 20 ng of the 6.6 kbp element was isolated. Consequently, in order to overcome
these two major problems, a PCR-based amplification method for sequences specific to
the 6.6 kbp element was developed. This method involved the use of the 6.6 kbp element
fixed on a nitrocellulose membrane as the target DNA in a PCR reaction. The
localisation was achieved by conventional Southern blot analysis whereby the
electrophoresed undigested CP 547 DNA was transferred onto a nitrocellulose
membrane. The precise position of the 6.6 kbp element on this membrane was then
determined by hybridisation with 32P-labelled total CP 547 genomic DNA. The region
encompassing the signal (approximately 0.5 cm x 0.1 cm) was excised and washed
thoroughly in sterile water to remove salt and traces of genomic DNA. This was
achieved by immersing the membrane in 50 ml of distilled water for 10 minutes and then
soaking for an additional 20 minutes in 10 ml of warm distilled water maintained at 37°C.
The washed and air dried membrane was then cut into pieces that were small enough for
complete submersion in 100 ).1l of the PCR buffer. As there was no sequence information
for the 6.6 kbp element, it was therefore not possible to generate specific primers
required to initiate the amplification. Consequently, random hexanucleotide primers
(Sigma) were used as non-specific primers. In order to achieve amplification of any
sequences it was necessary to first optimise the concentrations of the MgC1 2 and the
random hexanucleotide primers in the reaction mixture. On trying out varying
concentrations in trial reactions it was found that 3 mM MgC12 and 10 to 20 pg of the
random hexanucleotides in the PCR mixture resulted in amplification of membrane-
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bound DNA. The temperature profile applied for 50 cycles involved denaturing at 94°C
for 1.5 mm followed by primer annealing at 40°C for 1 mm, and primer extension at 72°C
for 3 mm. The cycling was concluded with a final extension at 72°C for 5 mm. The
resulting amplified sequences designated as the 'random-primed PCR product' consisted
of heterogeneously sized fragments in the range of 7 kbp to about 200 bp. The excess
primers and dNTPs were removed by centrifugation in a Sephadex G-50 column
followed by ethanol precipitation of the flow-through DNA. Aliquots of this DNA were
then used in standard random primer labelling reactions to generate a 32P-labelled
'random-primed PCR probe' for Southern blot analysis.

3.3.2 Specificity of the random-primed PCR probe

Southern blots of restriction enzyme digested CP 547 DNA hybridised with the
random-primed PCR probe displayed profiles almost identical to those obtained when
using a gel-purified 6.6 kbp DNA probe generated from the same CP 547 DNA (Figure
lOa, lob). Furthermore, as for the gel-purified 6.6 kbp probe, and the probes generated
from putative genomic copies (Section 3.l.2b), the random-primed PCR probe also did
not hybridise to the 6.6 kbp element (Figure lOa, lob), except on very long exposures
when only a faint signal was evident. The lack of hybridisation to the 6.6 kbp element by
the random-primed PCR probe was similarly perplexing since judging from the lack of
hybridisation of the random-primed PCR probe to any of the well characterised T. brucei
repetitive sequences (Figure l0a lane 3) there was negligible contamination of genomic
DNA. Thus it appeared that the random-primed PCR product originated from
amplification of sequences present only on the excised membrane. The specificity of this
method of PCR amplification was further tested by replacing the membrane-bound target
DNA with approximately 2 ng of gel-purified 6.6 kbp DNA in solution. The
amplification resulted in a product which, when used as a 32P-labelled probe, produced a
hybridisation profile similar to the one obtained by the random-primed PCR probe
generated from membrane-bound 6.6 kbp (Figure lOb, lanes 2 and 3). The ability to
generate random-primed PCR probes with identical specificity for the restriction
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Figure 10
Comparison between the random primed PCR probe, the gel purified 6.6
kbp DNA probe and total genomic CP 547 DNA control probe by Southern
blot analyses.
(A) Southern blots of A/u I digested CP 547 genomic DNA (2 pg) were
generated, cut into strips and probed with 32P-labelled (1) total CP 547 DNA, (2)
gel purified 6.6 kbp DNA and (3) random primed PCR probe. In lane 1, the well
characterised T. b. brucei Alu satellite repeat is evident at the bottom.
(B) Similarly, Southern blots of Sau3A I digested CP 547 genomic DNA (2 Mg)
were generated and hybridised with 32P-labelled (1) total CP 547 DNA, (2)
random primed PCR probe generated from membrane bound 6 6 kbp DNA, (3)
random primed PCR probe generated from the liquid, gel purified 6 6 kbp DNA
and (4) random primed PCR probe having gone through three more
amplifications of 40 cycles each. The well characterised T. b. brucei repetitive
sequences, the IRS-I and the miniexon are evident in lane I at 1 6 kbp 135 kbp
respectively.
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fragments hybridising to the gel-purified 6.6 kbp probe using two separate 6.6 kbp target
DNA sources, shows the high level of reproducibility and specificity of this approach.
Furthermore, large quantities of random-primed PCR probe could be consistently
generated by additional rounds of amplification resulting in little or no loss of specificity
(Figure lOb, lane 4).

3.3.3 Analysis with the random-primed PCR probe
3.3.3a Screening of a lambda gtl 1 T. b. brucei genomic library
The availability of unlimited quantities of the random-primed PCR probe
generated from the membrane-bound 6.6 kbp element now made it possible to screen a T.
b. brucei CP 547 genomic library. The random-primed PCR probe was considered as a
preferable alternative to the gel-purified 6.6 kbp probe for the following reasons:
(1) The random-primed PCR probe had a specificity for the same restriction fragments as
the DNA probe generated from the gel-purified 6.6 kbp region.
(2) The generation of a random-primed PCR probe was more economical because the
target DNA for the PCR amplification was obtained from only 2 pg of membrane-bound
CP 547 DNA. From the resulting 100 p1 PCR reaction, 10 radiolabelling experiments
could be carried out, whereas only one radiolabelling was achieved with the gel-purified
6.6 kbp DNA isolated from 500 pg of total genomic CP 547 DNA. Additional rounds of
amplification of the random-primed PCR product resulted in little or no loss of apparent
specificity, thus generating an almost limitless supply of probe. Hence, the problems of
having to isolate and work with low quantities of DNA were circumvented.
(3) Radiolabelling of the random-primed PCR product resulted in high specific activity
probes, whereas there were persistent problems associated with labelling the gel-purified
6.6 kbp element as outlined in section 3.1.2.
A lambda gUi library of total genomic DNA from T. b. bruce! CP 547 sheared to
an average size of 4.0 kb was generated. The frequency of recombinants was estimated
to be 70% on the basis of the number of blue and white plaques, and the total library
represented approximately three T. b. bruce! genomes. In order to screen the CP 547
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Figure 11
Southern blot hybrid isation profiles of randomly chosen genomic clones
selected with the random primed PCR probe.
(A) This figure contains different Southern blots, each with three lanes (each
blot is represented by the broken line on the top). Each blot is hybridised with
DNA purified from one of the 7 clones selected with the random primed PCR
probe. From left to right, the three lanes in each blot represents undigested, Alu I
digested, and Sau3A I digested CP 547 total DNA. Only clone 9 (pRPC9) gave a
weak signal of hybridisation to the 6.6 kbp element, as evident in the lane of
undigested DNA.
(B) Strips from three different Southern blots of Sau3A I digested CP 547 DNA
were hybridised with 32P-Iabelled (1) gel-purified 6.6 kbp DNA, (2) pRPC9, and
(3) random primed PCR probe. Similar symbols on the right of each blot
indicate fragments that hybridise to the three different probes.
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genomic library with the random-primed PCR probe, about 50,000 recombinants were
plated at a density of 5,000 per 150 cm2 plate. Twenty randomly chosen positive clones
were picked and the DNA prepared from each clone was used as a radiolabelled probe on
test Southern blots of undigested and restriction enzyme digested CP 547 DNA. The
DNA from all the selected clones hybridised to many restriction fragments (Figure ha).
However, only clone pRPC9 gave a weak signal of hybridisation to the 6.6 kbp element
(Figure ha set 2, lane 1). Since this clone hybridised to many restriction fragments, it
was difficult to ascertain which of the restriction fragment(s), if any, was derived from
the 6.6 kbp element. There were far too many differences between the hybridisation
profiles of the clones not hybridising to the element in comparison to clone pRPC9,
making identification of restriction fragments derived from the 6.6 kbp element difficult.
The hybridisation profile of the pRPC9 disclosed that there were some restriction
fragments that also hybridised to the gel-purified 6.6 kbp probe and the random-primed
PCR

probe. Figure 1 lb shows an example of such common hybridising sequences using

the three different probes. Since analysis of the Southern blots with the random-primed
PCR probe and clones selected with the random-primed PCR probe was complicated by
the presence of many hybridising restriction fragments (Figure 10 and Figure 1 la),
alternative approaches to isolate sequences which were unequivocally derived from the
6.6 kbp element were required.

3.3.3b Northern blot analysis

Since there was no obvious genomic difference between the drug resistant and
drug-sensitive isolates with the PCR probe and the clone pRPC9 which could account for
the different phenotypes, it was decided to look for differences at the level of expression.
Simpler profiles were expected in Northern blot analysis as hybridisation would be
limited only to the transcribed sequences. Hence, poIy(A) RNA was purified from the
bloodstream and procyclic forms of both the drug-resistant and the drug-sensitive
populations. 2 .ig of poly(A) RNA from each of these was size-fractionated on a 1.4%
agarose gel and transferred to a nylon membrane for Northern blot analysis.
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Figure 12
Northern blot analysis of transcripts prepared from different life cycle stages
of ILTat 1.1 and long slender bloodstream forms of the drug-resistant CP
547 population.
Approximately 3 .ig of poly(A) enriched RNA from the different life cycle
stages of T b. brucei was glyoxylated and separated alongside with size markers
(Promega RNA ladder) on 1.4% agarose gels as indicated in section 2.5.2g. The
gels were blotted onto a nylon filter, and probed with 32P-labelled probe.
(A) 3 hour exposure of hybridisations of the PCR probe to long slender (LS),
intermediate (I), short stumpy (SS) and procyclic (P) forms of the different life
cycle stages purified from ILTat 1.1 clone.
(B) Overnight exposure of hybridisations of the PCR probe to long slender (LS)
bloodstream forms from ILTat 1.1 and CP 547.
(C) Hybridisations of the pRPC 9 probe to long slender (LS) bloodstream forms
from ILTat 1.4 and CP 547.
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Hybridisation with the random-primed PCR probe revealed the presence of many
transcripts (Figure 12b, PCR probe). At medium post-hybridisation stringency washing
(50°C, 3 x SSC, 0.1% SDS for 45 mm), no differences were apparent between the drugresistant and the drug-sensitive populations (Figure 12b). Similarly, hybridisations to a
Northern blot of poly(A) RNA generated from four different life-cycle forms, the long
slender, intermediate and short stumpy bloodstream, forms and in vifro-generated
procyclic, cultured insect forms, of ILTat 1.1, disclosed that some of the transcripts
hybridising to the random-primed PCR probe are developmentally regulated (Figure
12a). However, whether this was also true for the CP 547 population could not be
established as the intermediate and short stumpy forms of this clone could not be
produced as uniform populations. Clone pRPC9 was also used as a hybridisation probe
because although it hybridised to the 6.6 kbp element weakly on Southern blots, the
possibility existed that it might hybridise strongly to transcripts specific for the 6.6 kbp
element. Hence, a Northern blot similar to the one in Figure 12b was probed with
radiolabelled DNA from clone pRPC9. However, no differences were apparent between
the drug-resistant CP 547 and the drug-sensitive ILTat 1.4 populations (Figure 12c).
Clone pRPC9 detected a transcript of 1.2 kb in both the populations. In addition to other
transcripts, the random-primed PCR probe also hybridised to a 1.2 kb transcript in both
the populations (Figure 12b). However, the transcriptional analysis did not reveal any
apparent differences between the drug-resistant and drug-sensitive populations using
either the random-primed PCR product or clone pRPC9 as hybridisation probes.

3.4.1 Collective analysis of results from the different Southern blots
Although the different approaches to identify sequences specific for the 6.6 kbp
element should have resulted in the identification of such sequences, definitive results
were not forthcoming. This prompted an overall re-evaluation of the results generated
from four of the different approaches and a direct comparison between them. These four
approaches had resulted in the generation of different Southern blot profiles produced by
hybridisation with: (1) the gel-purified 6.6 kbp element (Section 3.1.2b), (2) the putative
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genomic copies of the 6.6 kbp element (Section 3.1 .2b), (3) the PCR product generated
by random priming of the 6.6 kbp element (Section 3.3.1) and (4) DNA isolated from
clone pRPC9 (Section 3.3.3). From the different Southern blots, a search was made for
common restriction fragments that hybridised to the four different probes. DNA
corresponding to some of these restriction fragments was isolated from size-fractionated
DNA electrophoresed in preparative agarose gels and subsequently purified by the
geneclean® method. The purified DNAs were 32P-labelled and used as hybridisation
probes on test Southern blots of undigested and

Alu

I and Sau3A I digested CP 547

genomic DNA. Of the 15 probes tested, the DNA pthf'$ fto Sau3k I tt of
1.9 kbp, 5.9 kbp, 6.6 kbp and 13 kbp, and EcoR I fragments of 9.2 kbp and 10.9 kbp
regions hybridised weakly to the 6.6 kbp elemel'kt in cLc!ition to other restrcton
fragments (Figure 13). On careful scrutiny of these blots (Figure 13), it became evident
that when there was hybridisation to the 6.6 kbp element, then strong hybridisation was
also apparent to a larger element that was higher than the 23 kbp fragment of the lambda
Hind III

size marker. However, when there was no hybridisation to the 6.6 kbp element,

then there was either no hybridisation or a very faint hybridisation to the larger DNA size
class. Although not shown, in the ethidium-bromide stained gels of the Southern blots
from figure 13, this large element was visible as a faint band. Since it was difficult to
determine the exact size of this large element from conventional agarose gel
electrophoresis, it was referred to as the '> 40 kbp element'. Re-analysis of earlier
Southern blots probed with putative genomic copies of the 6.6 kbp element also
displayed that, although no hybridisation to the 6.6 kbp was evident, some of the putative
genomic copies hybridised faintly to the> 40 kbp element (Figure 6, fragment

Sph

I 7.8

and EcoR I 9.2). Examination of some of the earlier ethidium-bromide stained gels
revealed that the >40 kbp element was not evident in all the preparations of CP 547, even
though the gels were well resolved. Therefore, it appeared that the >40 kbp element, like
the 6.6 kbp element, also displayed a level of instability with respect to its copy number.
These observations suggested a possible linkage between the 6.6 kbp element and the>
40 kbp element, thus prompting its
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Figure 13
Southern blot analysis of DNA from the CP 547 population using as probe,
size-selected genomic gel-purified fragments shown to have cross-hybridised
with 1) the gel purified 6.6 kbp element, ii) the putative genomic copies of
the 6.6 kbp element, iii) the PCR-product generated by random priming of
the 6.6 kbp element and (iv) DNA isolated from clone pRPC9. This figure
shows six Southern blots (the blots labelled as S, represent short exposures
carried out overnight and those labelled as L represent longer exposures of four
nights at -80°C with intensif'ing screens). The lanes cou*aitz <V) undigc.cia)/oi)
CP 547 DNA, (l)Alu I and (2) Sau3A I digested total CP 547 DNA. ThePlabelled hybridisation probes are indicated at the bottom of the blots whereby,
S=Sau3A I and E=EcoR I. For example, S 13 represents DNA purified from the

13 kbp region of Sau3A I digested CP 547 DNA, resolved by gel electrophoresis.
The washing conditions were of high stringency (0.1 X SSC, 65°C). The arrow
heads indicate the 6.6 kbp element which is more evident in the longer
exposures. The arrow points to the> 40 kbp element evident in some of the
hybridisations.
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isolation. Purification of sufficient quantities was achieved from CP 547 clone 2 by
electrophoresis of two preparative gels, each with 300 .tg of total DNA. Following
resolution of the region corresponding to the >40 kbp element, the corresponding gel
slice was excised and the DNA extracted by the geneclean®method. Approximately 20
ng of this DNA was then labelled with 32P-dCTP and used as a probe on a test Southern
blot of undigested and restricted CP 547 DNA (Figure 14). At high post-hybridisation
stringency the> 40 kbp probe hybridised strongly not only to the 6.6 kbp element, but
also to a 13 kbp fragment, a region corresponding to 23 kbp, a region corresponding to
the> 40 kbp element and a region just below the well. The hybridising size classes larger
than the 6.6 kbp element may represent its multimeric forms (Figure 14) and have hence
forth been referred to as the 'higher hybridising forms'. In some cases the hybridisation
was more evident on longer exposures of the filters to X-ray films.

3.4.2 Analysis with the> 40 kbp element
In order to identify clones containing sequences specific for the 6.6 kbp element,
the remainder of the gel-purified > 40 kbp element was used as a 32P-labelled
hybridisation probe for screening the genomic and cDNA libraries generated from the CP
547 clone. For each library, about 50,000 recombinants were plated at a density of 5,000
plaques per 150 cm 2 plate. There were approximately 180 positive plaques per plate for
the genomic library. From this value, it was estimated that approximately 5% of the
genome is represented by this sequence. Screening the cDNA library displayed
approximately seven positive plaques per plate, indicating that this sequence is highly
transcribed. From each library, five positive clones were randomly chosen and DNA
purified from each was used as a radiolabelled probe on test Southern blots containing
undigested, Sau3A I and Aizi I digested CP 547 genomic DNA. All these clones gave
hybridisation to the 6.6 kbp element and the higher hybridising size classes. Most clones
hybridised strongly, while others weakly to the 6.6 kbp and the 13 kbp elements.
However, all the clones hybridised strongly to the other higher hybridising forms. In
addition, all the clones hybridised to fragments of various sizes generated by digestion

109

Figure 14
Identification of the 6.6 kbp element in Southern blots of CP 547 DNA using
32P-labelled > 40 kbp probe. DNA from CP 547 digested with (1) Sau3A I,
(2) Alu I and undigested DNA was resolved in a 1.2% agarose gel and blotted
onto a sheet of nitrocellulose filter paper. The blot on the right is one generated
with only undigested CP 547 DNA. The autoradiogram was obtained when the
blots were hybridised with the 32P-labelled >40 kbp probe. The arrows on the
right point to the higher hybridising elements.
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with the two restriction enzymes (Figure 15). Curiously, however, although complete
digestion of the genomic DNA was evident from the ethidium-bromide stained gels by
the presence of the Sau3A 11.6 kbp fragment representing the TRS-1 sequences (Murphy
eta!., 1987), and the 177 bp satellite repeat mA/u I digested DNA (Sloofetal,. 1983),
the sizes of the 13 kbp and the >40 kbp elements were not altered in lanes containing the
digested DNA. Similarly, the region corresponding to the 6.6 kbp element in the lanes
with the digested DNA was not altered in size although it appeared to be of weaker
intensity in the digested DNAs, especially Alu I digests of some blots (Figure 15 lanes 1).
Various charateristics such as simple sequence repeats, base modifications, single
stranded (ss)DNA, ssRNA or DNA/RNA hybrids,

could account for lack of digestion of

DNA with frequently cutting restriction enzymes such as the Sau3A I and A/u I. Since
the 6.6 kbp element and some of the higher hybridising elements were not digested
completely with the frequently cutting enzymes, they were expected to display some such
characteristic(s).
From the hybridisation profiles obtained with the gel-purified > 40 kbp probe
(Figure 14), it became evident that screening of the CP 547 libraries would result in
selection of clones which originate not only from the 6.6 kbp element and the>40 kbp
DNA, but also from other size classes represented by the higher hybridising forms.
Hence, in an attempt to isolate clones specific for only the >40 kbp or the 66 kbp
element, 10 additional clones were randomly selected (five from the genomic library and
five from the cDNA library), and DNA purified from them tested as hybridisation probes
on Southern blots of undigested and digested CP 547 DNA. All 10 clones also
hybridised to the 6.6 kbp element, other size classes of elements, and to some restriction
fragments generated by digestion of total genomic DNA with Sau3A I and A/u I.
However, two clones, cDNA clone CAl 5 and cDNA clone CA4 hybridised very strongly
to the 6.6 kbp and the higher hybridising elements (Figure 15, blot 4 and 15). Unlike the
other clones, these two clones did not hybridise to any restriction fragments, although
complete digestion of the genomic DNA was evident from the ethidium-bromide stained
gels. Failure to obtain clones specific only for the> 40 kbp and the 6.6 kbp element
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Figure 15
Southern blot analysis of clones isolated from CP 547 genomic and cDNA
libraries containing sequences specific for the 6.6 kbp element. identical
Southern blots were generated with CP 547 DNA whereby each lane contains 2
.tg of(U) undigested DNA, (1) Alu I and (2) Sau3A I digests. The blots were
hybridised with 32 P-labelled DNA purified from clones picked from CP 547
libraries; genomic clones pCA 1, 2 and 3 and cDNA pCA clones 4, 5, and 15.
Both pCA4 and 15 were used for sequence analysis.
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prompted the sub-cloning of the entire insert of 408 bp from CAI5 and 1.4 kbp from
CA4 in the EcoR I site of pBluescript SK (+) to enable further analyses. These clones,
subsequently referred to as pCAI 5 and pCA4 were selected due to their lack of
hybridisation to restriction fragments, suggesting that the cloned sequences were limited
to the 6.6 kbp element and the higher hybridising classes only, and not distributed
throughout the genome.

3.5.1 Verification of the characteristics of the 6.6 kbp element
Earlier experiments (Sections 3.1.2 and 3.2.4) suggested that the 6.6 kbp element
is a circular, double stranded DNA molecule. However, these experiments were not
conclusive. The availability of a probe specific for the extrachromosomal element now
made it possible to verify some of the previous observations regarding the 6.6 kbp
element.

3.5.la The 6.6 kbp element is DNA
To verify the chemical nature of the 6.6 kbp element, aliquots of CP 547 DNA
were incubated with RNase free DNase I, (which digests double and single stranded
DNAs), RNase A (that degrades RNAs into small oligoribonucleotides), RNace itTh1
(Stratagene) (which is a cocktail mixture of a RNase A and a non-specific RNase from
Aspergillus o!yzae that also degrades RNAs into small oligoribonucleotides) and RNase

H (which digests DNA-RNA hybrids). For DNase I digestion, 2 ig of total DNA was
incubated in S units at 37°C for 30 mm. 2 .tg of DNA was incubated in 5 units of RNase
A as for RNace 'It' at 37°C for 30 mm. Similarly, for the RNase H digestion, 2 ig of
DNA was incubated with 5 units at 37°C for 20 mm. The enzymatic reactions were
stopped by phenol-chloroform extraction followed by ethanol precipitation. The
products were subjected to agarose gel electrophoresis, Southern blotted and hybridised
with 32 P-labelled clone pCA4. The 6.6 kbp and the higher hybridising elements all
appeared to be sensitive to DNase I, indicating that all the elements are either double
stranded or single stranded DNA. On overnight exposures, all the hybridising size

ill

Figure 16
The chemical nature of the 6.6 kbp element.
A Southern blot with each lane containing 2 pg of total CP 547 DNA treated
with (1) RNase free DNase 1, which digests double and single stranded DNAs,
(2) RNase A that degrades RNA5 into small oligoribonucleotides, (3) RNace
ti t

TM (Stratagene) which is a cocktail mixture of a RNase A and a non-specific

RNase, (4) RNase H which digests DNA-RNA hybrids, and (U) undigested CP
547 total DNA. This blot was hybridised with 32 P-labelled pCA 15 at high
stringency (0.1 X SSC, 65°C), and exposure was carried out for 3 h at room
temperature with intensifying screens. The brackets indicate the sequences that
are sensitive to RNase H.
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classes appeared to be resistant to the two RNase As and RNase H, indicating that all are
DNA molecules. Curiously, however, shorter exposures ranging from 1-3 h revealed that
in the region just above the 23 kbp DNA size marker fragment, some of the hybridising
elements that are resistant to digestion with RNase A and RNace 'It

are digested with

RNase H (Figure 16). This suggests that these elements may be DNA-RNA hybrids. The
existence of such molecules was confirmed by repeating the experiments with a different
preparation of the CP 547 DNA. However, these molecules were not characterised
further.

3.5.lb The 6.6 kbp element has characteristics of circular DNA molecules

In the earlier experiments it was curious that some preparations of the gel-purified
6.6 kbp element could not be 32P-labelled (3.1.2b). At the time, this was attributed to
insufficient quantities of gel-purified 6.6 kbp DNA on account of its low copy number
and due to major losses incurred during its purification. Thereafter, it was realised that in
different percentage agarose gels the mobility of the 6.6 kbp element varied relative to
linear DNA size markers; for instance, in a 0.8% agarose gel, the 6.6 kbp element
migrated at 6.6 kb, in a 1.2% gel, it migrated at 8 kb, in a 1.4% gel, it migrated at 9 kb
and in a 1.7% gel it migrated at> than 23 kb (Figure 17). It was then realised that the
lack of labelling of some 6.6 kbp DNA preparations was due to the absence of the
element in the 6.6 kbp region excised from the agarose gel. Such gel migration
characteristics have previously been shown to be typical of circular DNA elements
(Beverley eta!., 1984). To verify the circular nature of the 6.6 kbp element, an attempt
was made to enrich for it by an alkaline lysis method used in the isolation of double
stranded circular plasmid DNA molecules from bacteria (Sambrook eta!., 1991).
Approximately 5 x 108 CP 547 trypanosomes were suspended in 500 .ii of solution I and
the protocol was followed as outlined in section 2.4.5. Southern blot containing
undigested CP 547 DNA was hybridised with one fifth of the alkaline lysis preparation.
At high stringency washes, strong hybridisation to the 6.6 kbp element, and the elements
of higher size classes (Figure not shown) were observed. It was estimated that from 5 x
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Figure 17
The mobility of the 6.6 kbp element varies relative to linear DNA size
markers in different percentage agarose gels.
Southern blots containing 2 .ig of undigested CP 547 DNA (U) resolved in
different percentage agarose gels were generated. Lambda DNA cut with Hind
III was used as a size marker (M). The Southern blots of these gels were
hybridised with a mixture of 32P-Iabelled digested lambda size marker and 32P.
labelled total genomic CP 547 DNA. High stringency (0.1 X SSC, 65°C)
washing conditions were used. The bracket on each panel is what has been
referred to as the 6.6 kbp element (even when it is not localised to the 6.6 kb
region).
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108 trypanosomes, approximately 200 ng of DNA specific for the 6.6 kbp element and
the higher hybridising elements could be purified. The extent of enrichment by the
alkaline lysis protocol was determined by concurrently size separating titrations of the
DNA enriched by alkaline lysis in comparison to titrations of total CP 547 DNA by
agarose electrophoresis. A Southern blot of this gel was probed with the 32P-Iabelled
clone pCA4 (Figure 18). This revealed that approximately 10 ng of DNA enriched by
alkaline lysis gave a signal intensity corresponding to the 6.6 kbp element achieved by
approximately 2 pg of total genomic DNA from CP 547 (Figure 18). Therefore, the
alkaline lysis protocol enriched for the 6.6 kbp and the higher hybridising elements by a
factor of 200 X. An attempt was made to digest 10 ng aliquots of the alkaline lysed
preparation with I unit of frequently cutting restriction enzymes like A/u I, Sau3A I and
Taq I. However, as for the 6.6 kbp and the higher hybridising elements in total CP 547

genomic DNA, the elements enriched by the alkaline lysis method also lacked sites for
these restriction enzymes. Since the alkaline lysis protocol enriches for double stranded
circular elements, the enrichment of the 6.6 kbp element and the higher hybridising
elements using this protocol establishes their circular, and double stranded, nature.
The circular nature is also indicated by the lack of hybridisation to an
oligonucleotide probe generated from a consensus telomeric sequence (5
CCCTGAACCCTGAA 3) (gift from Dr. Bishop). Even at medium stringency washes (5
X SSC, 0.1% SDS at 50°C for 40 mm) (Figure 19), this probe did not hybridise to the 6.6
kbp element and the> 40 kbp element, indicating that either these elements do not have
classical telomeric ends characteristic of chromosomes, or that they are circular in nature.
In order to further confirm the circular nature of the 6.6 kbp and the highersize
class elements, an attempt was made to determine their sensitivity to BAL 31 exonuclease
digestion. 10 pg of total CP 547 DNA was incubated at 30°C with 2 units of BAL 31 in a
volume of 1 ml of the enzyme specific buffer (one unit was previously determined to
delete 400 base pairs per minute). At time points 0.5, 1, 5, 10 and 15 mm, 200 p1 aliquots
were withdrawn from the reaction and added to 100 p1 of phenol, 10 mM EDTA to stop
the reaction. The DNA was phenol-chloroform extracted and isopropanol precipitated.
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Figure 18
The 6.6 kbp and the higher hybridising elements are enriched by an alkaline
lysis protocol for the isolation of circular DNA molecules.
This Southern blot shows the extent of enrichment of the 6.6 kbp element from
total genomic CP 547 DNA by the alkaline lysis protocol (Section 2.4.5) in
comparison to total genomic DNA prepared by conventional protocols (Section
2.4.1). Lanes 1-5 of the alkaline lysis DNA preparation represent 10 ng, 20 ng,
30 ng, 40 ng and 50 ng of DNA respectively. For the total CP 547 DNA lanes 15 represent 100 ng, 200 ng, 300 ng, 400 ng and 500 ng, respectively. To ensure

that complete transfer of the resolved DNA was achieved, a 0.7% agarose gel
was used and the transfer on to nylon membrane was carried out over 2 days.
The blot was then hyridised with 32 P-labelled clone pCA4 with washing
conditions of high stringency (0.1 X SSC, 65°C) and exposed overnight at -80°C
with intensifying screens.
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Figure 19
The 6.6 kbp and the> 40 kbp element do not hybridise to telomeric
sequences.
A Southern blot generated from a gel of (1) undigested DNA, (2) Alu I, (3)
Sau3A 1, (4) EcoRl and (5) Taq I digested CP 547 DNA. The blot was
hybridised with a 32 P-labelled consensus telomeric sequence. Even at medium
stringency washes (5 X SSC, 0.1% SDS at 50°C for 40 mm) this probe did not
hybridise to the 6.6 kbp and the> 40 kbp element; in lanes 2-5 the> 40 kbp
element is not visible. (C) represents a control blot of undigested CP 547 DNA.
This strip was cut from the same Southern blot as the one probed with the
telomere probe, but was hybridised with 32 P-labelled total CP 547 DNA. From
lane C, the position of the 6.6 kbp element and the> 40 kbp element (in
brackets) is evident.
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All the BAL 31-digested DNA aliquots and a control sample of undigested CP 547 DNA
were resolved by agarose gel electrophoresis and analysed by Southern blot hybridisation
with "P-labelled clone pCA4. The hybridisations revealed that the region corresponding
to the 6.6 kbp element was consistently masked by sequences generated from the
degradation of genomic DNA and possibly some of the higher hybridising elements
sensitive to the exonuclease activity of BAL 31. However, on short exposures it was
clearly evident that the 13 kbp and some regions corresponding to the 23 kbp of the
lambda DNA size marker were BAL 31 sensitive, indicating their linear nature (Figure
20a). Attempts to confirm these results using the DNA enriched by alkaline lysis were
unsuccessful, most likely due to the presence of impurities that inhibited the BAL 31
exonuclease. Although it was difficult to establish the sensitivity of the 6.6 kbp element
to BAL 31 exonuclease, it became apparent that the> 40 kbp element is resistant to BAL
31 digestion and is thus most likely a circular molecule (Figure 20a marked with an
asterisk). Efforts to visualise the 6.6 kbp region involved doubling the number of units of
BAL 31 in order to increase the rate of digestion and therefore clear the fragments

masking the 6.6 kbp region. This approach, however, did not accomplish the desired
results because of apparent nicking of the circular DNAs as evidenced by the apparent
lneacithg of the> 40 kbp moiecule (Figure 20b, marked with an asterisk). Although the
6.6 kbp element could not be clearly visualised, there are indications of it being resistant
to the exonuclease (Figure 20b, marked with an arrow). Size-fractionation of the BAL
31-digested total CP 547 DNA revealed far more higher hybridi sing extrachromosomal
elements than is evident by electrophoresis of undigested CP 547 DNA. From their
response to BAL 31 digestion it became evident that some of these elements are linear
while others are circular (Figure 20b).

3.5.lc Plasticity within the 6.6 kbp element
i)

Unstable copy number

The availability of a specific probe for the 6.6 kbp element enabled the
unequivocal demonstration of instability of its copy number. In Southern blots of
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Figure 20
The sensitivity of the 6.6 kbp and the higher size class-elements to BAL 31
exonuclease digestion.
(A) 10 pg aliquots of total CP 547 DNA were treated with 2 units of BAL 31
(one unit was previously determined to delete 400 base pairs per minute) and
samples removed at different time points. Lanes 1-5 represent time points 0.5, 1,
5, 10 and 15 mm and U is untreated, undigested DNA. The DNA was resolved

by agarose gel electrophoresis and analysed by Southern blot hybridisation with
32P-labeled clone pCA4. High stringency washes (0.1 X SSC, 65°C) revealed
that the region corresponding to the 6.6 kbp element (indicated by arrow) was
consistently masked by sequences generated from the degradation of genomic
DNA and possibly some of the higher hybridising elements sensitive to the
exonuclease activity of BAL 31. However, it was clearly apparent that the> 40
kbp element is resistant to BAL 31 digestion (marked with an asterisk).
(B) In a similar experiment designed to increase the rate of digestion, and
therefore clear the fragments masking the 6.6 kbp region, 4 units of BAL 31 were
used for time points 8, 10, 30, 40 and 45 mm (lanes 6-10 respectively). In
addition, this gel was electrophoresed longer so as to better resolve the region
around> 40 kbp. Hybridisation of this Southern blot with 32 P-labeled clone
pCA4 however showed apparent nicking of the circular DNAs. This is evident
by the possible linearising of the> 40 kbp molecule (asterisk) in lane 7 which
shows relative shift in mobility in lanes 8-10. The 6.6 kbp element was clearly
seen at the 8 mm time point, although at the 10 mm time-point the 6.6 kbp
element was degraded. In longer exposure of the blots, there are indications of
some copies of it being resistant to the exonuclease (at the position indicated by
arrow).
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undigested CP 547 DNA purified from different CP 547 populations it was possible to
illustrate that the copy number of the element is directly associated with the application
of diminazene aceturate drug pressure (Figure 21). The response to passaging
diminazene-selected clone 2 (figure 21, lane 3) in the absence of diminazene pressure is
evident by the reduction in the copy number of the 6.6 kbp element (Figure 21, lanes 4).
Hence, as previously mentioned in section 3.2.2, Figure 21 verifies the instability of the
copy number of the 6.6 kbp element in the absence of selective drug pressure. That the
DNA loading was uniform in all the lanes was confirmed by reprobing the Southern blot
with a 32P-labelled 13-tubulin gene probe isolated from T. b. brucei (Figure 21).

ii)

Size and sequence heterogeneity of the 6.6 kbp element
Southert blots generated from different isolations of CP 547 total genomic DNA

showed that the 6.6 kbp element va.rie not only in size and copy number, but also in
appearance (Figure 22a). In most pTeparations of the CP 547 DNA, the signal
ticw,to the 6.6 kb element appeared as a tight band, although in some
preparations it appeared as a smeared, fuzzy region. Furthermore, in some DNA
isolations from the CP 547 stock, the 6.6 kbp element appeared as a doublet, whereas
clones generated from this stock gave a single band corresponding to the element (Figure
22a). This variability in the 6.6 kbp element implies that there may be rapid
reorganisation occurring within the population(s) of the 6.6 kbp element, giving rise to a
heterogeneously sized species of the element. In addition, it could be possible that the CP
547 stock is a mixed population.
During the course of these investigations, evidence was obtained which suggested
that in addition to size heterogeneity, the 6.6 kbp element also displays a level of
sequence heterogeneity. The first indication was obtained from earlier results presented
in section 3.1 .2b whereby, although infrequently some gel-purified 6.6 kbp probes
hybridised to restriction fragments that were not recognised by other 6.6 kbp probes.
These results suggested that there may be some level of sequence heterogeneity within
the 6.6 kbp region, either due to the presence of different sheared, comigrating genomic
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Figure 21
The copy number of the 6.6 kbp element is directly influenced by the
application of diminazene aceturate drug pressure.
A Southern blot was generated containing DNA from different CP 547
populations resolved on a 1.2% agarose gel. Each set of 4 lanes is represented by
(1) the CP 547 stock passaged in mice, without any drug pressure over the
duration of 6 months, (2) the unselected CP 547 clone I generated from the
passaged CP 547 stock in lane 1, (3) the diminazene selected CP 547 clone 2
generated from the relapse population of the parental CP 547 stock after
treatment with diminazene aceturate (60 mg/kg b.w.) and (4) the diminazene
selected CP 547 clone 2, passaged in mice for 2 months without drug pressure.
The sets of lanes contain 2 .tg of(U) undigested DNA, (S) Sau3A I, (E) EcoR I
and (N) Ma III digested DNAs. The Southern blot was hybridised with
labelled pCA4 with washing conditions of high stringency (0.1 X SSC, 65°C).
Passaging clone 2 in the absence of diminazene pressure results in a reduction in
the copy number of the 6.6 kbp element (lanes 4). To verify that the DNA
loading was uniform in all the lanes, the same Southern blot vas re-probed with
a 32P-labeled 13-tubulin gene probe isolated from T. b. brucei. The arrow marked
with T indicate the hybridising tubulin sequences which show equal signal
intensities in the four lanes of the Sau3A I and EcoR I digested DNAs from the
different populations.
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contaminants, or heterogeneity within the 6.6 kbp element itself. Subsequently,
verification that not all 6.6 kbp species are homogeneous in sequence was established
from one CP 547 clone generated without selective drug pressure. Total DNA purified
from this clone was digested with selected frequently cutting restriction enzymes and
analysed by Southern blot analysis through hybridisation with 32P-labelled clone pCA4.
The 6.6 kbp element from this CP 547 population was completely digested by Sau3A I
and A/u I, but not EcoR I (Figure 22b, lane 2), suggesting that unlike most 6.6 kbp
elements, this population of the 6.6 kbp element possessed sites for Sau3A1 anàAluYt,ut
not for EcoR I. However, after digestion of the 6.6 kbp element no hybridisation to
restriction fragments smaller than 6.6 kbp element was evident. This observation could
be explained by the possibility that in the 6.6 kbp element the sequence specific for the
pCA4 was digested to such small sized fragments, that they were not evident because
they ran off the agarose gel. Due to lack of specific probes, sequences other than those
present on pCA4 can not be detected. This CP 547 clone appeared to have the ideal
species of the 6.6 kbp element, since the presence of the different restriction enzyme sites
could allow one to clone sequences directly from the element. Therefore, in an attempt to
isolate sufficient quantities of this 6.6 kbp species, the clone of CP 547 was expanded in
mice and DNA isolated from the parasites. Curiously, however, the 6.6 kbp element
from the expanded population reverted to being the typical form of 6.6 kbp element,
devoid of restriction enzyme sites that could have permitted its cloning into an E. coil
plasmid vector. These puzzling observations indicated that a high level of sequence
reorganisation may be occurring within the 6.6 kbp element or that selection of a subpopulation from a heterogeneous 6.6 kbp population is taking place. Further evidence to
support the presence of heterogeneous 6.6 kbp species was obtained from Southern blots
in which the total CP 547 DNA was digested with frequently cutting restriction enzymes.
Some of these blots disclosed that in some isolations of CP 547 DNA, digestion with Alu
I resulted in a decrease in signal intensity corresponding to the 6.6 kbp element in
comparison to the signal intensity corresponding to the 6.6 kbp element from the
undigested DNA (Figure 22c). However, in some isolations of total CP 547 DNA, no
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Figure 22
Size and sequence heterogeneity of the 6.6 kbp element in dilTerent
populations of the same T. b. brucei isolate.
(A) Southern blot containing 2 ,tg of undigested CP 547 DNA from different CP
547 populations were generated (tracks 1-6). The arrows depict what has been
referred to as the 6.6 kbp element and the position of the linear 6.6 kb size marker
is indicated on the left. Hybridisation of blots with 32P-labelled pCA4 with
washing conditions of high stringency (0.1 X SSC, 65°C) and overnight exposure
at -80°C with intensif'ing screens revealed differences in the appearance of the
element from different DNA preparations. In most preparations, the 6.6 kbp
element appeared as a tight band (1), in some, it appeared as a fuzzy, smeared
region (5 & 6), in some, the 6.6 kbp element appeared as a doublet (2 & 3),
whereas clones generated from this stock gave a single band corresponding to the
element (4). As previously illustrated, the percentage of the agarose affects the
mobility of the 6.6 kbp element. It should be noted that in panel A, the possible
influence of percentage of agarose has not been given any consideration.
(B) A Southern blot of CP 547 DNA containing (U) undigested, (1)Alu I, (2)
EcoR I and (3) Sau3A I digested DNA resolved by agarose gel electrophoresis.

The blot was hybridised with 32P-labelled pCA4 DNA. For this C? 547 clone,
the 6.6 kbp element was un-typical as it was completely digested by A/u 1(1) and
Sau3A 1(3). However, on expanding this clone in mice, in addition to EcoR 1, the
6.6 kbp element could not be digested by Alu I and Sau3A 1.
(C) The 6.6 kbp element from the diminazene selected clone 2 also displayed
some heterogeneity. The lanes in panel C are as in panel B, except DNA from the
diminazene selected clone was used. This and similar blots disclosed that in some
preparations of CP 547 DNA, digestion with Alu I resulted in a decrease in signal
intensity corresponding to the 6.6 kbp element (1) in comparison to the signal
intensity corresponding to the 6.6 kbp element from the undigested DNA (lane
U). However, in some isolations of total CP 547 DNA, no such decrease in signal
intensity was apparent in A/u I digested DNA (Figures 15 & 36b). That this is not
a result of unequal loading is evident from the equal signal intensities of the
higher hybridi sing elements.
The observations in panels A, B and C show that the 6.6 kbp element is composed
of heterogeneous populations whereby minor populations of the 6.6 kbp species,
displaying 'un-typical' characteristics, are sometimes selected for.
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such decrease in signal intensity was apparent in A/u I digested DNA. These observations
indicate that the 6.6 kbp element is composed of heterogeneous populations, and in some
total DNA isolations, minor populations of 6.6 kbp species contain site(s) for Alu I and
are digested by this enzyme. Since the major species lack an A/u I site and remains
undigested, the digestion of some of the elements results in a decrease in hybridisation
signal intensity. However, in other isolations, for unknown reasons, the species
containing sites for A/u I are selected against. If the estimation of copy numbers in
section 3.1 .2a is reasonably accurate, then the minor species containing the Alu I sites
must occur at less than one copy per genome in a mixed population of parasites once they
have been expanded for analysis.

3.5.2 Sequence analysis of clones hybridising to the 6.6 kbp element
In order to identify the precise sequences responsible for hybridisation to the 6.6
kbp and the higher hybridising elements, cDNA clones pCAI5 and pCA4 were
sequenced. To localise the sequences within these clones responsible for the
hybridisation to the 6.6 kbp element, restriction enzyme analysis of both these clones was
performed. Digestions of 2 ig aliquots of each clone were attempted with some
frequently cutting enzymes, and some restriction enzymes with sites present in the
pBluescript polylinker sequence. However, since neither of the inserts contained sites for
any of the tested restriction enzymes, the entire inserts of pCA 15 and pCA 4 were
sequenced by the di-deoxy method developed by Sanger eta!. (1977).
Nucleotide sequence analysis of pCA15 disclosed the presence of a short poly A
tail composed of 9 A's (Figure 23). In addition, it contained 2 complete and 2 partial
copies of a 108 bp tandem repeat sequence, whereby, each repeat unit is interspersed with
a 5 bp spacer sequence (Figure 23). A direct 5 bp repeat sequence flanks copy 1 and
partial copy 3. These 5 bp direct repeats are unique to pCAI5 as they are and not present
in other sequenced clones. Upstream of the poly A tail is a small microsatellite sequence
of seven CA dimeric repeats. From the sequence generated, NIa ifi is the only restriction
enzyme that cuts within the 108 bp repeat, thus explaining the lack of digestion of the
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Figure 23
Nucleotide sequence of pCA15.
Using a 32 P-labelled >40 kbp probe, this clone was isolated from a cDNA library
generated from CP 547. By the dideoxy sequencing method, this clone was
found to contain two complete copies of a 108 bp repeat (subsequently referred
to as the Nia III repeat) and two incomplete copies of the 108 bp repeats. The
complete and partial copies of the 108 bp repeat lying consecutive to each other
are defined within the vertical lines. Each copy is flanked by a 5 bp spacer
sequence (underlined in purple, and lying between the two vertical lines). In
most, but not all clones, the ends of the 108 bp repeat is followed by the TTAGT
sequence. However, the 5 bp ATATG sequence represented in red possibly
represents the duplicated ends of a transposed segment containing two complete
and one partial copy of the 108 bp repeat. Each 108 bp repeat contains
overlapping copies of smaller sub-repeats. These are represented by three copies
of a 9 bp repeat (shaded yellow), t'o copies of a 10 hp repeat (shaded blue) and
two copies of a 27 bp repeat (boxed). The nucleotide oer1apping the yellow and
the blue repeats is represented in green.
At the 3' end of the 108 bp repeats, a short poly-A tail composed of 9 A's
is present. Upstream to the poly-A tail is a small microsatellite sequence of
seven CA dimeric repeats. The restriction sites identified in this clone are (N)
N/a III. (A) ApaL I and (B) Bsp 1286.
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inserts with all the tested restriction enzymes. Immediately 5' to the microsatellite
sequences exists a site for ApaL I and Bsp1286 I restriction enzymes. As discussed later,
the 5 bp direct repeats flanking the two complete and one partial 108 bp repeats in pCA15
may represent a transposed segment. The 108 bp repeat unit contains no open reading
frames and is itself made up of several overlapping smaller repeat sequences. These are
represented by three copies of a 9 bp sub-repeat, 2 copies of a 10 bp sub-repeat and 2
copies of a 27 bp sub-repeat (Figure 23). In expectation of additional sequence
information, pCA4, the larger of the clones, was also sequenced. Nested deletions of this
clone were generated using an Exonuclease 1111 Mung bean-nuclease kit (Stratagene)
(Figure 24a,b). Sequencing ends of six consecutive size deletions suggested that the
entire pCA4 clone is made of 108 bp-derived repeats arranged in tandem. Various copies
of different N/a Ill repeats sequenced from independent clones are shown in Figure 24c.
Examination of these copies revealed that the repeat can be bigger than 108 bp due to
insertion of parts of the same repeat sequence within the basic repeat unit; the repeat
could be smaller than 108 bp due to deletion of some nucleotides. The 5 bp spacer
sequence was most frequently, but not always, represented by the sequence TTAGT, a
potion of 9 bp subrepeat. Sequence analysis of the ends of three additional genomic
clones that also hybridised to the 6.6 kbp element and the larger elements revealed only
the presence of 108 bp-derived repeats.
Database searches (Genbank database release 77) disclosed that the 108 bp
repeats show the highest homology (87.5% in a 40 bp overlap) with a subtelomeric
sequence in a subset of minichromosomes of T. b. brucei (Figure 25) (Weiden el a/.,
1991). The maximum homology of the 108 bp repeat was with a 29 bp subtelomeric
sequence repeated 6 X in the minichromosome.

3.5.3 The 6.6 kbp element contains the Nia ifi repeat.

The hybridisation of clones pCAI5 and pCA4 at high stringency to the 6.6 kbp
element and the higher hybridising elements indicates the presence of the 108 bp repeat,
or a part its sequence, on these elements. To test this possibility, attempts were made to
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Figure 24
(A) Nested deletions of cDNA clone pCA4 generated using an Exonuclease
III! Mung bean-nuclease kit (Stratagene).
Panel A is an ethidium-bromide stained gel showing the progressive nested
deletions of pCA4 in pBluescript (KS). Lanes 1-7 represent aliquots from the
digestion removed for each increasing time point (1 mm intervals). Kpn I was
used to generate the 3' overhang and Cia I to generate the 5' overhang between
the insert and the 3' overhang site (Section 2.8.1).
(B) Following digestion with Exonuclease 111/ Mung bean-nuclease, the plasmids
were re-circularised. The insert sizes from plasmids (lanes 1-13) digested for
different times points was examined by digestion with Pvu II (a restriction
enzyme with sites flanking the insert cloned in the EcoR I Site).

(C) Comparison of Nla III repeats sequenced from independent clones.
This figure shows alignment of copies of the Ma III repeats obtained from
sequencing independent clones Cl, C3, C4, CS, C6, C7, CS, C9, dO, CII and
C12. A, B and C represent the non overlapping copies from one clone. The
purple hatched line represents the positions of deletions in some copies of the
repeat, whereas the nucleotides in purple represent the inserted sequences. The
nucleotides shown in blue represent the differences from the consensus 108 bp
repeat sequence represented by CIA. The asterisks indicate the nucleotides that
are conserved in all the copies.
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Figure 25
Database searches (Genbank database release 77) disclosed that the 108 bp
repeats shows the highest homology (87.5% in a 40 bp overlap) with a
subtelomeric sequence in a subset of minichromosomes of T. b. brucel
(Veiden ci a!., 1991).
This schematic figure shows the combined information of the homology between
the 108 bp repeat and the region within the subset of minichromosomes described
by Weiden et a!, (1991). One end of the minichromosome (MC) is orientated
with the telomere sequence to the right. The purple hatched box represents the
subtelomeric 29 bp repeat, the open hatched box represents the telomeric repeat
sequence and the three open boxes represent the G+C-rich subtelomere repeats.
The sequence in purple in the MC sequence represents the 29 bp subtelomeric
repeat. In the Ma III repeat, the yellow represents the 9 bp, the blue the 10 bp
repeat and the boxed region the 27 bp repeat sequences. The regions of
homology between the MC and the Ma Ill repeat are indicated b) the ertical
lines between the two sequences.
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amplify sequences from gel-purified 6.6 kbp DNA in a polymerase chain reaction using
primers ILO 1148 and ILO 1149 designed from the ends of the 108 bp repeat.
Approximately 2 ng of gel-purified 6.6 kbp element in solution, and membrane-bound
6.6 kbp element derived from 2 jig of total DNA were used as target DNAs in the PCR.
10 ng of pCA4 insert was used as a positive target control DNA, and 10 ng of pBluescript
DNA was used as the negative target control DNA. The PCR was carried out in a total
volume of 100 p1 at an annealing temperature of 55°C for 40 cycles. On Southern blots,
the amplified PCR products of both the 6.6 kbp DNAs and the pCA4 insert appeared as a
faint uneven ladder which ran into a smear (Figure 26a, lanes 2, 3 and 4, respectively),
whereas no amplified product was generated from the pBluescript (Figure 26a, lane 1).
The amplified PCR products generated from the 6.6 kbp target DNA were size-seperated
from the un-incorporated primers by agarose gel electrophoresis. The PCR products
were then excised from the gel and purified by the geneclean® method and used as a
labelled probe on a test Southern blot of undigested CP 547 DNA. At high stringency
washes the products hybridised to the 6.6 kbp and higher hybridi sing elements, verifying
the presence of the 108 bp repeat sequence on them. Furthermore, since both the 6.6 kbp
element and pCA4 generated a PCR product which appeared as a ladder (Figure 26a),
these results suggest that the 6.6 kbp element also contains tandem repeats of sequences
similar to pCA4. It is evident from sequencing independent clones that not all copies of
the repeats are always 108 bp (Figure 24c). Insertions and deletions may vary the size of
the basic repeat. Therefore, an uneven ladder of the PCR products can be expected.
N/a III is the only restriction enzyme site identified from sequence analysis as
cutting within the 108 bp repeat. Now that a specific probe was available, experiments
were performed to verify whether this was also true for the 6.6 kbp element and the
higher hybridising elements. 2 jig aliquots of total genomic CP 547 DNA from
diminazene selected clone 2 were digested overnight with restriction enzymes such as
N/a III, A/u I, EcoR I and Sau3A I. The digested DNA was resolved by agarose gel
electrophoresis and the Southern blots generated were probed with 32P-labelled pCA4
(Figure 26b). Only N/a III (Figure 26b, lane 4) completely digested the 6.6 kbp element
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Figure 26
The 6.6 kbp element is composed of Nia III repeats.
(A) Primers ILO 1148 and ILO 1149 designed from the ends of the 108 bp repeat
were used in a PCR to amplify sequences from pBluescript DNA as the negative
control DNA (1), gel-purified membrane bound 6.6 kbp DNA (2), gel-purified
liquid 6.6 kbp DNA (3), and pCA4 as a positive control DNA (4). In lanes 1-3,
75% of the PCR product (from a total volume of 100 tl) was ethanol precipitated
and resuspended in 15 jtl; in lane 4, 11.11 of the PCR product was directly
resolved in a 1.5% agarose gel. The Southern blot was hybridised with
labelled pCA4 with washing conditions of high stringency (0.1 X SSC, 65°C).
Exposure to X-ray film carried out over 3 nights at -80°C with intensifying
screens revealed no product in the lane 1, but faint, uneven ladders in lanes 2-4.
(B) A Southern blot of genomic CP 547 DNA from the diminazene selected
clone 2, containing (U) undigested, (1) Alu I, (2) EcoR I, (3) Sau3A I and (4) Ma
III digested DNA was generated and probed with 32P-labeled pCA4. The
restriction enzyme Ma III is the only enzyme found to digest the 6.6 kbp element
and the higher hybridising elements to completion (4).
(C) A Southern blot generated from the diminazene-selected CP 547 clone 2
containing (U) undigested, (1) ApaL I and (2) Bsp 1286 I digested DNA. The
blot was hybridised with 32P-labeled pCA4. The washing conditions were at
high stringency (0.1 X SSC, 65°C) and exposure was carried out overnight at 80°C with intensifying screens. As for some digestions with Alu I, digestion
with ApaL I and a Bsp1286 I resulted in a decrease in signal intensity of the 6.6
kbp element in one preparation of CP 547, indicating heterogeneity in this
population of the 6.6 kbp elements.
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and the higher hybridising forms into DNA that migrated predominantly to the region
corresponding to 113 bp (Figure 26b). Henceforth, the 108 bp repeat sequence was
referred to as the 'N/a III repeat'. As mentioned earlier, in some CP 547 preparations
digestion with A/u I resulted in decrease in signal intensity corresponding to the 6.6 kbp
element, whereas in others such a decrease in signal intensity was not evident. This
experiment confirmed this and an earlier suspicion that the 6.6 kbp element lacked the
sites for commonly used restriction enzymes (Figure 26b, lanes 1, 2, 3). The absence of
these sites offered an explanation for the lack of success in attempts to directly clone
sequences from the gel-purified 6.6 kbp DNA digested with these restriction enzymes
(Section 3.1.lb).
Sequence analysis of pCA1 S displayed the presence of an ApaL [anc a &p?2&61
restriction enzyme site downstream from the Nia III repeat sequence (Figure 23). To test
whether the 6.6 kbp and the higher hybridising elements contain sites for these restriction
enzymes, 2 pg aliquots of total DNA from one preparation of CP 547 were digested
overnight with these enzymes. The digested DNA and undigested CP 547 DNA was
resolved by agarose gel electrophoresis and the Southern blots generated were probed
with 32P-labelled pCA4. As for some digestions with A/u I, a decrease in signal intensity
of the 6.6 kbp element was observed (Figure 26c, lanes 1, 2), suggesting that only some
species of the element contain sites for ApaL I and aBspl286 I.

3.6.1 Specificity of the Nia ifi repeat for the subgenus trypanozoon
To test for the presence of the N/a III repeat sequence among the different

subgenera of trypanosomes, Southern blots of undigested DNA from different
trypanosome species were probed with 32P-labelled pCA4. At high stringency,
hybridisation to large DNA only in the subgenus Trypanozoon was observed (Figure 27).
Even at low stringency (4 x SSC at 65°C), the N/a Ill repeat did not hybridise to DNA
from T. congole,zse or T. vivax. For the 10 populations tested belonging to the subgenus
Trypanozoon, strong hybridisation signals were apparent in the regions just below the slot
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Figure 27
Specificity of the Nia III repeat for the subgenus Trypanozoon.
2 tg of undigested DNAs purified from different trypanosome species were
resolved in a 1.2% agarose gel. Lanes 1-1 1 are represented by Trypanozoon
populations ILTat 1.1, IL 16E1, IL B24, IL 770, IL 3400, GUTat 3.1, IL 3397,
AnTat 1.8, ILTar 2, IL 3398 and ETAt 1.8. Lanes 12-14 are represented by
Nannomonas, IL 1180, IL 3000 and IL 2985. Lane 15 is represented by a
Duttonella, IL 1392. Lane 16 contains the multidrug-resistant CP 547,
representing the control DNA. A Southern blot of this gel was hybridised at high
stringency (0.1 x SSC at 65 °C) with a 32 P-labelled Nia III repeat. Signals to
sequences only in the subgenus Trypanozoon were revealed; even at low
stringency (4 x SSC at 65 °C), the Ma III repeat does not hybridise to DNA from
T. congolense or T. vivax. This figure also verifies the presence of the Nia III

repeat in extrachromosomal elements of three T. b. brucei populations other than
the CP 547 population. Hybridising elements in IL B24 (Ugandan isolate) and
IL 3388 (Ugandan isolate) migrating as 8.8 kbp and 13.5 kbp fragments are
indicated by arrows (lanes 3 & 4). In Anlat 1.8 (Uganda) (lane 8) elements of 7
kbp and 15 kbp are indicated by arrow heads. As for the 6.6 kbp element, these
extrachromosomal elements are not visible in ethidium-bromide stained gels.
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and at the main genomic band around the 23 kbp marker region (Figure 27). These
experiments showed the presence of the N/a III repeat sequence in populations belonging
to the subgenus Trypanozoon. In addition to the 6.6 kbp and the higher hybridising

extrachromosomal elements in the CP 547 clone, extrachromosomal elements were
identified in three additional T. b. bruce! populations. In IL B24 (Ugandan population)
and IL 3388 (Ugandan population) hybridisation to sequences migrating as 8.8 kbp and
13.5 kbp fragments (Figure 27 lanes 3 and 4) were identified. In Anlat 1.8 (Uganda)
(Figure 27 lane 8,) elements of 7 kbp and 15 kbp were identified. As for the 6.6 kbp
element, these extrachromosomat elements were not visib(e (t eth

-6rornde stained

gels. Furthermore, these elements also lacked sites for frequently used restriction
enzymes, suggesting the presence of a sequence arrangement similar to that of the 6.6
kbp element. However, since the drug-sensitivity profiles of these three trypanosome
populations was un-determined, further analysis of these extrachomosomal elements was
not pursued.

3.6.2 Organisation of the Nia Ill repeat sequence in the trypanosome genome

In order to determine the genomic organisation of the N/a ifi repeat, CP 547 DNA
and DNA form different trypanosome populations embedded in agarose plugs was
subjected to PFGE or orthogonal-field-alternation gel electrophoresis (OFAGE). The
pulse intervals indicated in the figure legends (Figures 28 and 29) were used to size
separate the chromosome-sized DNA molecules from the different populations. To
determine the genomic distribution of the N/a III repeats, the gels were Southern blotted
and hybridised with several different probes. The blots were first probed with a
labelled consensus telomeric sequence to identify all the chromosomes (Figures 28b and
29b). This blot was subsequently stripped and re-probed with the 32P-labelled N/a III
repeat (pCA4) (Figures 28c and 29c). The resolved chromosomes as apparent from the
ethidium-bromide stained gels (Figures 28a and 29a), ranged from 50 to greater than
1,500 kbp, when compared with size standards (oligomers of bacteriophage lambda DNA
or yeast chromosomes). Depending on the pulse time, there was also a region of
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Figure 28
Chromosomal location of the Nia III repeats using Orthogonal-fieldalternation gel electrophoresis (OFAGE).
(A) An ethidium-bromide stained OFAGE geL In this figure, chromosomesized DNA from seven different trypanosome populations was resolved by
OFAGE. The conditions for separation were 50 V for 4.5 h at 40 sec pulses
followed by 14 hat 300 V at 40 sec pulses. The 1.5% agarose gel contained
embedded DNA prepared from diminazene-selected CP 547 clone 2 (1), CP
2469, a drug resistant T. b. brucei field isolate (2), a T. b. brucei (IL 3509) (3),
and two clones generated from the CP 2469 stock (4 & 5); lanes 6 & 7 contain
DNA from a T. congolense clone IL 1180 and a quinapyramine-resistant clone
derived from the IL 1180 clone, respectively.

(B) Chromosome profiles identified by h3bridisation vith a 32P-labelled
consensus telomere sequence.
A Southern blot of the gel in (A) was hybridised with a 32 P-labelled consensus
telomeric sequence. The arrow heads in panel B are representative examples of
intermediate chromosomes that do not hybridise with the Nia III repeat (panel
C).

(C) Distribution of the Nla Ill repeats.
Following removal of the telomere probe the blot in (B) was hybridised with the
32P-labelled Ma III repeat at high stringency conditions.

(D) A longer exposure of lane I in panel C representing hybridisation of the Nia
III repeat was carried out. The arrows in panel C and panel D represent curious
molecules containing the Nia Ill repeat sequence that do not hybridise to the
telomere sequence and are not visible in the ethidium-bromide stained gel.

0

1-

01

0)

3

t: !
I

C.)

Se.

I

01

I •

C.)

'S.

C)
=

C,)

•

0)

-4

Figure 29
Chromosomal location of the N/a III repeats in CP 547 and subclones of
GUTat 3.1 using pulsed field gel-electrophoresis (PFGE).
(A) A ethidium-bromide stained PFG.
This is a figure of a 1.5% PFG containing DNA prepared from parental CP 547
stock and GUTat subclones 1, 2, 3 and 4 (cultured in vitro under different culture
conditions by Dr. Hirumi). The chromosome DNA was resolved by PFGE using
a pulse times of 250 sec for 30 h, followed by 180 sec for 20 h and 120 sec for
12 h.

(B) Chromosome profiles identified by hybridisation with 32P-labelled
consensus telomere sequence. A Southern blot (A) was hybridised with a
labelled consensus telomere sequence and washed at moderately high stringency
(1 X SSC, 65°C). The arrow heads are representative examples of intermediate
chromosomes that do not hybridise with the Ma III repeat.

(C) Distribution of the NIa HI repeats. Following removal of the telomere
probe, the blot (A) was re-hybridised with the 32 P-labelled Nia III repeat at high
stringency conditions. The arrows in panel C show the 'curious' molecules
containing Ma III repeat sequence that do not hybridise to the telomere sequence,
and are not visible in the ethidium-bromide stained gel.
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compression in which larger sized DNA migrated (marked as 'c' in Figure 29a). The 32Plabelled consensus telomeric probe hybridised to all the size separated chromosomes that
were visible on the ethidium-bromide stained gels (Figure 28b and 29b). The telomeric
probe also disclosed the marked heterogeneity in the overall molecular karyotypes of the
different populations of trypanosomes. Following the removal of the telomere probe, the
Southern blots were reprobed with the N/a HI repeat sequence (Figure 28c and 29c).
High post hybridisation stringency showed that the NIa Ill repetitive sequence is
dispersed in the genome of different populations of the subgenus Trypanozoon. Under
these stringency conditions, the N/a Ill repeat sequence was not detected in populations
of T. congolense or T. vivax, which belong to different subgenera. For members of the
Tiypanozoon subgenus, the majority of the N/a III repeat hybridising sequences were on
chromosomes larger than 1 Mb. Not all the intermediate chromosomes (120 to 1,000
kbp) contained N/a HI repeats (Figure 28b, arrows pointing to the intermediate
chromosomes which do not hybridise with the N/a III repeat). However, the
intermediate-sized chromosomes in most populations contained the N/a III repeat
sequence, but the ratio of the hybridisation signal to the ethidium-bromide fluorescence
showed substantial variation in the numbers the N/a III repeat units carried in a given
length of chromosome-sized DNA.
Superimposing the hybridisation results obtained with the telomeric and the Nia
III repeat probes (Figure 28b, 28c and 29b, 29c) to the profiles of the ethidium-bromide
stained gels (Figure 28a and 29a) showed that the N/a III repeat hybridises to some
chromosome-sized DNA molecules which are not chromosomal since they are not
detectable by staining with ethidium-bromide or by hybridisation with the telomeric
probe (Figure 28c, d and 29c, marked with arrows). These molecules have subsequently
been referred to as 'curious' DNA molecules. Since the curious molecules are present in
size classes in which the haploid chromosomes stain with ethidium-bromide, these
molecules apparently exist in copy numbers of less than one per genome. Alternatively,
these molecules are not seen in ethidium-bromide stained gel because they are
considerably smaller than their migration would suggest. In PFGE, altered migration of
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circular DNAs is a recognised characteristic (Beverley, 1988). These curious
chromosome-sized molecules differ even in the subclones derived from a cloned parental
population of GUTat 3.1 (Figure 29c). Although the subclones have similar karyotypes,
in two of the subclones, a new intensely hybridising DNA molecule is evident (Figure
29c, lane 2 & 4). Similarly, in the lane with CP 547 DNA, no hybridisation was evident
to the telomere probe in the region below the 50 kbp marker, whereas this region had
strong hybridisation to the N/a III repeat (Figure 29c, indicated by an arrow in lane
containing CP 547 DNA). This hybridising region in CP 547 DNA may represent the 6.6
kbp element and possibly some higher hybridising elements evident by conventional
agarose gel electrophoresis.
The PFGE gels disclosed that the diminazene-selected multidrug-resistant CP 547
clone 2 contains a non-chromosomal curious element, which does not hybridise to the
telomere probe also is not visualised in ethidium-bromide stained gels (Figure 30a, lane
2, indicated as SC). This curious molecule exhibits pulse time-dependent mobility and a
migration path slightly displaced from the consensus "track" of the linear DNAs (Figure
30a and 30b marked as SC). This intermediate sized molecule, at one set of pulse times,
is approximately 600 kbp (Figure 30a, lane 2), and at another set of pulse times, is 750
kbp (Figure 30b, lane 2). Such unusual mobility properties are known to be characteristic
of circular DNAs (Garvey and Santi, 1986; Hightower eta!., 1987; Beverley, 1988).
Hence, to examine whether this intermediate-sized molecule in CP 547 is circular, CP
547 DNA samples embedded in agarose plugs were subjected to different doses of
gamma irradiation (Figure 30c). Gamma irradiation introduces a spectrum of structural
lesions into DNA, including base modifications and strand breaks, with single-stranded
breaks occurring 10 to 20 times more frequently than double-stranded breaks
(Hutchinson, 1985). After an appropriate dose of gamma irradiation, linear molecules
yield a heterogeneous collection of fragments of various lengths because of the
introduction of random double-stranded breaks. In contrast, a circular molecule initially
gives rise to a discrete linear molecule whose length corresponds to that of the original
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Figure 30
PFGE analysis of DNA from unselected and diminazene-selected CP 547
show that the 'curious' DNA molecules have characteristics of circular DNA
molecules.
(A & B) Agarose embedded DNA from unselected CP 547 clone I and
diminazene selected clone 2 was resolved in a 1% agarose gel by PFGE using two
different sets of pulse times. The pulse times in panel A were 250 sec for 40 h,
180 sec for 20 h, 10 sec for 20 h and finally 5 sec for 10 h; the pulse times in
panel B were 250 sec for 40 h; 150 sec for 20 h; 60 sec for 20 h and finally 50 sec
for 10 h. Southern blots of these gels were hybridised with a 32P-labelled NIa 111
repeat probe. The washing conditions were of high stringency (0.1 X SSC, 65°C)
and exposure was carried out overnight at -80°C with intensifying screens. SC in
the lanes with diminazene selected clone 2 represents the curious molecule absent
from the unselected CP 547 clone. As verified from panel A and B, this curious
molecule exhibits pulse time-dependent mobility and a migration path slightly
displaced from the consensus "track" of the linear DNAs. In panel A the curious
molecule has a relative size of approximately 600 kbp whereas it is approximately
750 kbp in panel B. Such unusual mobility properties are characteristic of
circular DNAs (Garvey and Santi, 1986; Hightower eta!., 1987; Beverley, 1988).
(C) PFGE analysis of gamma-irradiated DNA from the dim inazene-selected
CP 547 clone 2. Embedded DNA prepared from the diminazene selected CP 547
clone 2 was subjected to gamma irradiation from a caesium source. The different
lanes contain (1) un-irradiated CP 547, whereas lanes 2-7 contain DNA irradiated
with doses of 10, 30, 60, 100, 150 and 180 Gray. The position of the curious
molecular species displaying mobility characteristics of a circular DNA molecule
is indicated by SC, and the position of the apparently linearised SC molecule by
L. The pulse times used were 250 sec for 40 h, 150 sec for 20 h, 60 sec for 20 h
and finally 50 sec for 10 h. The Southern blot of this gel was hybridised with a
32P-labelled N/a III repeat probe. The washing conditions were of high
stringency (0.1 X SSC, 65°C) and exposure was carried out overnight at -80°C
with intensifying screens.
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circular form. The appearance of a new molecule is therefore diagnostic for circular
DNA (Beverley, 1989).
Titrations of gamma irradiation were performed using an irradiator which
employs a caesium source. CP 547 DNA embedded in agarose sample plugs were placed
in a standard 1.5 ml polypropylene microcentrifuge tube and then irradiated at ambient
temperatures for different times. Samples then remained at room temperature for at least
30 mm prior to separating the chromosomes by pulsed-field electrophoresis (Figure 30c).
Southern blots of these gels were generated, and hybridised with the 32P-labelled Nia ifi
repeat. The increasing doses of gamma irradiation resulted in successive decreases in
hybridisation intensity of the molecule migrating as a 750 kbp DNA molecule (marked as
SC in Figure 30c), and the successive increase of a new component of about 400 kbp
(Figure 30c marked as "L"). The appearance of this new molecule is likely to be the
result of linearisation of the curious circular molecule of 750 kbp. A specific probe for
this molecule would verify this result. A dose of 60-100 Gray converted about 50% of
the circular DNA to linear forms, while 100-150 Gray results in complete conversion to
the linear form. Therefore, from these gamma irradiation experiments and experiments
showing its pulse-time dependent mobility, it is established that the intermediate
chromosome-sized curious molecule in the CP 547 clone is a circular molecule. One of
the physical properties of circular DNA molecules is aberrantly slow migration through
pulsed field gels, leading to a larger apparent size than is deduced from either sequence
analysis or from migration of the same DNA when linearised (Beverley, 1989). This
offers a possible explanation for the lack of staining of the 750 kbp molecule by
ethidium-bromide. Since it is approximately 400 kbp in size, and migrated at 750 kbp in
PFGs, its relative staining is expected to be much fainter in comparison to a larger, linear
DNA molecule migrating at the 750 kbp position in a gel (Figure 30c). The curious, N/a
III repeat-containing elements in the GUTat 3.1 sub-clones (Figure 29c) may also be a
circular molecule migrating among molecules larger in size, explaining its lack of
staining by ethidium-bromide. This result therefore shows that in addition to the drug
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resistant CP 547 isolate, other Trypanozoon populations may also contain large circular
Nia Ill repeat containing extrachromosomal elements.

3.6.3 Copy number of the N/a ifi repeats
The revelation that N/a III restricted once within the N/a Ill repeat, and that
pCAIS insert contains 3.4 copies of the N/a ifi repeat, provided a means to estimate the
copy number of this newly identified repeat family in three different T. b. bruce!
populations; the multidrug-resistant CP 547 clone 2, the drug-sensitive ILTat 1.4 clone
and the GUTat 3.1 clone. To estimate the copy number, 1 gig and 2 pg aliquots of total
genomic DNA from the three T. b. bruce! populations and different concentrations of
pCA15 control DNA, accounting for approximately 9,500 to 71,000 copies of genomic
equivalents of the N/a III repeats were digested with excess N/a ifi restriction enzyme.
The reactions were carried out overnight to ensure complete digestion. In order to
resolve the small-sized digestion products, all the digested samples were electrophoresed
slowly in 2% agarose gels at 40 volts for a period of 18 h. Southern blots of these gels
were generated and DNA was transferred onto nylon membranes for a minimum of 38 h
to ensure complete transfer. The blots were subsequently hybridised with 32P-labelled
N/a III repeat (Figure 31). The densitometric scanning of the hybridisation signals using
a Molecular Dynamics Laser Densitometer was used to compare the signal intensity
between the different concentrations of the pCAI5 DNA and the genomic DNA. Such
densitometric analyses allowed the determination of the number of copies of the Nia ifi
repeat in the different genomic DNA samples. These experiments established that in T. b.
bruce! the N/a III repeat is represented by approximately 40,000 copies per diploid
genome with no significant differences between the CP 547 drug-resistant and the ILTat
1.4 and GUTat 3.1 drug-sensitive populations. Since the T. b. bruce! diploid genome size
is estimated to be 8.6 x

bp (Borst el a/., 1982), the Nia III repeat sequence or the Nia

III repeat family could therefore account for about 5% of the parasite genome. Although
these experiments suggested that there are no significant differences between the drugresistant CP 547 clone in comparison to the drug-sensitive populations, direct
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Figure 31
Copy number of the Nia III repeat sequence in different T. b. bruce!
populations.
Digestion of tandem repeats of the 113 bp sequence (108 bp repeat and one of the
S bp flanking sequences) with Ma III generates fragments sized 41 bp and 72 bp.
If this restriction site is lost, a fragment of 113 bp is generated. Genomic DNA
(I and 2 pg each) from the drug-resistant CP 547 population and drug-sensitive
clones ILTat 1.4 and GUTat 3.1 was digested overnight with excess of Nla III
(Panel B). This was resolved in a 2.5% agarose gel alongside carefully
calibrated amounts of the purified cloned pCA 15 insert, also digested with Ma
III; the amount of DNA of the pCAI5 insert, lanes 1-13, was 0.4 to 3.0 pg in
increments of 0.2 pg (Panel A). These represented 9,500 to 71,000 copies of the
108 bp repeat relative to the T. brucei genome content. To ensure complete
transfer of the DNA, blotting onto nylon membranes was performed for a
minimum of 38 hours. The Southern blot was hybridised with a 32P-labelled
Ma III

repeat. The washing conditions were of high stringency (0.1 X SSC,

65°C) and exposure was carried out overnight at -80°C with intensifying screens.
Densitometric scanning of the area encompassing the hybridisation signals was
performed using a Molecular Dynamics Laser Densitometer to compare the
signal intensity between the different concentrations of the pCA 15 DNA and the
genomic DNAs. The area encompassing lane 7, representing approximately
40,000 copies, gave an equal signal intensity to that for I pg of each of the
genomic DNAs.
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comparisons between the copy number of different clones of CP 547 expressing varying
drug sensitivities was not carried out.

3.6.4 Transcription of the Ma 111 repeat sequence
To ascertain whether the N/a III repetitive sequence is transcribed, poly(A) RNA
was isolated from long slender and procyclic forms of the drug-resistant CP 547 and the
drug-sensitive ILTat 1.4 populations and analysed by Northern blot analysis as previously
explained in section 3.3.3. 32 P-labelled pCA4 was used as the hybridisation probe
because sequence analysis showed it to consist of only the N/a III repeats. Medium
stringency post-hybridisations did not reveal any transcriptional differences between the
long slender bloodstream forms of the drug-resistant CP 547 and drug-sensitive ILTat 1.4
clones (Figure 32a). Similarly, no differences were observed between the procyclic
forms of CP 547 and ILTat 1.4 (Figure 33b). For both these parasite popu(atios, both
long slender bloodstream forms and procyclic insect forms, the N/a ifi repetitive probe
did not hybridise to transcripts of any discrete size-class, but to a region constituting
heterogeneous transcripts ranging between 300 bp and over 10 kb (Figure 32a, b). To
test whether these hybridisations represented true transcripts, the poly(A) RNA was pretreated with 5 units of ribonuclease free DNase I for 1 hour at 37°C. Northern blot
hybridisations of the pre-treated samples showed that the heterogeneous RNA transcripts
contained DNA contamination only in the higher regions (Figure 32b). Similar
hybridisations of a Northern blot generated from poly(A) RNA isolated from the
different life-cycle stages of ILTat 1.1 (gift from Dr. Murphy) displayed that the Nia [II
repeat is differentially expressed. Heterogeneous transcripts were identified in the
actively dividing long slender and procyclic forms of the parasite. No hybridisation was
evident in the poly(A) 4 RNAs of short-stumpy and intermediate forms (Figure 33a).
Whether this is also true for the CP 547 clone was not determined because of the
difficulty in obtaining a uniform-stumpy form parasite population. Since most of the
Northern blot analyses were performed using poly(A) RNA, experiments were carried
out to determine if there were N/a Ill repeat transcripts that were not polyadenylated. To
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Figure 32
Northern blot analysis of the Nia 111 repeat.
(A) Approximately 3 tg of poly(A) enriched RNA from the long slender
bloodstream form of the drug-resistant CP 547 population and drug-sensitive
ILTat 1.4 clone was glyoxylated and separated on a 1.4% agarose gel. The RNA
was blotted onto a Nytran filter and hybridised with a 32 P-Iabelled Ma III repeat.
The integrity of the RNA preparation was verified by reprobing the stripped
filters with a 32P-labelled 13-tubulin hybridisation probe; the signals
corresponding to the B-tubulin are shown in the lower panels.
(B) The extent of DNA contamination in RNA preparations. An aliquot of about
10 jig of total RNA from the long slender bloodstream form of the drug-resistant
CP 547 population was untreated (U) and one aliquot was pre-treated with 5 units
of ribonuclease free DNase 1(D) for 1 hour at 37 °C. This RNA sas subjected to
Northern blotting and hybridisations as in panel A. The DNA contaminating the
preparation is indicated by the bracket.
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Figure 33
(A) Differential expression of the Nia III repeats. As outlined in Figure 12, a
Northern blot was generated from 3 pg of poly(A) RNA isolated from the
different life cycle stages of ILTat 1.1; the actively-dividing long slender (LS)
and procyclic forms (P) of the parasite and the non-dividing short-stumpy (SS)
and intermediate forms (1). The blot was hybridised at high stringency with a
32P-Iabelled Ma III repeat. Transcripts were only detected in the long slender
and procyclic actively-dividing forms. The integrity of the RNA preparations
was verified by reprobing the stripped filters with a 32P-labelled B-tubulin
hybridisation probe. The signals corresponding to the 13-tubulin are shown in the
lower panels.

(B) Expression of Nia III repeats in the diminazene selected CP 547 clone 2.
As in A, a Northern blot was generated from 3 pg poly(A) RNA isolated from
the two actively dividing life-cycle stages of CP 547 clone 2; the long slender
(LS) and procyclic forms (F). The hybridisations were performed as in panel A.
(C) Only some Nia III transcripts are polyaden) lated. In this gel, 10 pg of
total RNA (T) and 2 pg po1y(A) RNA (A k) purified from long slender
bloodstream forms of CP 547 were resolved. The hybridisations were performed
as in panel A. The stronger hybridisation signal with 13-tubulin in lane A
indicates the enrichment of the polyadenylated RNA in this lane in comparison to
the total RNA.
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establish this, 10 g of total RNA and 2 jig poly(A) RNA purified from long slender
bloodstream forms of CP 547 was size separated in an agarose gel, blotted onto a
nitrocellulose filter and probed with 32P-labelled pCA4. Hybridisations revealed a strong
signal in the track with total KNA in comparison to the track with the poly(A) RNA.
Hybridisation of the same Northern filter with control a 13-tubulin probe (Figure 33c)
showed stronger hybridisation in the track with the poly(A) RNA, confirming its
enrichment. This experiment therefore indicated that the majority of the transcripts
specific for the Nia III repeat are not polyadenylated. For all the Northern blots, the
integrity of the RNA preparation was verified by Teptob%\, te tcippd tThets with a
labelled 13-tubulin probe.
An attempt was also made to establish whether the transcripts of the Ma III
repeats have a miniexon or spliced leader sequence, as has been reported for all protein
coding genes in trypanosomes (Borst, 1986). Single stranded cDNA was generated by
reverse transcribing CP 547 RNA using a cDNA synthesis kit (Stratagene). To amplify
transcripts specific for the N/a III repeat, 5 ng of the single stranded cDNA was used as
the target DNA in a PCR-amplification using miniexon-specific primers and N/a Ill
repeat-specific primers. To control the PCR, oligo(dT) and miniexon-specific primers
were used to amplify full length transcripts from the CP 547 cDNA. The PCR products
were size separated by gel electrophoresis and the Southern blot generated was probed
with the 32P-labelled pCA4 (Figure 34a, b). At high stringency washes, no hybridisation
was evident with the N/a III repeat. To ensure and verify that the PCR amplification had
indeed worked 1 the same Southern blot was re-probed with the 13-tubulin probe which
hybridised to a DNA band of 1.5 kb in the control PCR sample (Figure 34b). This
confirmed that the miniexon and oligo(dT) primers amplified full length cDNA
molecules, among which the tubulin transcripts were represented (Figure 34b).
Therefore, the lack of hybridisation with the N/a III repeat probe indicates that transcripts
specific for the N/a 111 repeat sequence were not amplified and most likely do not have a
5' miniexon sequence. This experiment therefore suggests that the Nia ifi repeats are
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Figure 34
Determining whether the Nia III repeat transcripts contain a miniexon
sequence by PCR analysis.
(A) 5 ng of single stranded cDNA generated from total CP 547 RNA was used as

the target DNA in a PCR-amplification using miniexon-specific primers (ILO
2235) together with primers specific for the Ma III repeat, ILO 1148 (2) and ILO
1148 (3). To control the PCR, oligo(dT) and miniexon-specific primers were
used to amplify full-length transcripts from 5 ng of single stranded (1) and 5 ng
of double stranded (4) CP 547 cDNA. The PCR products were separated on a
1% agarose gel and stained with ethidium-bromide.

(B) A Southern blot of the gel in panel A was hybridised with a 32 P-labelled Ma
III repeat, but revealed no signals. To ensure and verify that the PCR
amplification had indeed worked, the same Southern blot was re-probed with the
32P-labelled 13-tubulin probe. At high stringency ashing conditions (0.1 X
SSC, 65°C) and overnight exposure at -80°C with intensifying screens, a DNA
band of 1.5 kbp corresponding to full length B-tubulin cDNA was detected.
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most likely not translated, as was also suggested by the lack of an open reading frame in
the DNA sequence.

3.7

Search for unique "non-repetitive" sequences within the 6.6 kbp element
It is conceivable that the 6.6 kbp element is made up entirely of the Nla HI repeats

since it was completely digested by only Nia III. However, this possibility became
questionable because when using two different probes generated from the 6.6 kbp region,
both the gel-purified 6.6 kbp DNA and the random-primed PCR product (generated from
membrane-bound 6.6 kbp) gave identical profiles of hybridisation to many restriction
enzyme digested DNA fragments (Section 3.1.2 and 3.3.2). The identical profiles
strongly suggested that the 6.6 kbp element contains within it copies of genomic
sequences other than the Nia III repeats. Yet, when some of these hybridising restriction
fragments were gel purified and used as radioactive probes, none hybridised back to the
6.6 kbp element, although some hybridised to the >40 kbp element (section 3.1.2 and
3.4.1). The likely explanation for the lack of a hybridisation signal to the 6.6 kbp element
is that these sequences are probably represented in only some species of the 6.6 kbp
element which are present at a copy number that is below the level of detection by
hybridisation. Thereafter, a further search for such unique "non-repetitive" sequences on
the 6.6 kbp element was carried out since such sequences could contribute to discerning
the function of the 6.6 kbp element and possibly the larger elements. In order to ampIif'
these putative unique sequences, an approach using arbitrary primers (AP) in a PCR
amplification was used. DNA fingerprints of three different target DNAs (total genomic
CP 547 DNA, the alkaline lysis DNA preparation from CP 547 trypanosomes, and the
gel-purified 6.6 DNA) were generated in a PCR amplification using arbitrary primers.
The arbitrary primers were expected to prime, and thus amplify, many sequences in the
total genomic DNA. However, it was anticipated that some sequences specific for the 6.6
kbp element would also be amplified. Similarly, in the alkaline lysis DNA preparation,
which is enriched for circular DNA molecules including the 6.6 kbp and the higher
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hybridising elements, amplification of sequences specific for the 6.6 kbp element were
expected along with amplification of other sequences like those from intact rninicircles
and maxicircles that should theoretically also be enriched for. However, in the gelpurified 6.6 kbp DNA, sequences specific for the 6.6 kbp element 'ere mainly expected
to be amplified with a low level of amplification of contaminating genomic DNA. The
AP-PCRs were performed simultaneously, as outlined in section 2.7, using 2 ng of each
of the three target DNAs. The DNA fingerprints were analysed in parallel by size
separating the products on agarose gels. By ethidium-bromide staining of the agarose
gels, fragments that could contain the 'putative unique' sequences were identified. These
fragments were those that amplified in the 6.6 kbp target DNA and simultaneously
amplified as the same-sized products in the other two target DNAs. In order to eliminate
both the N/a III repeat and other possible repetitive sequences, Southern blots of these
gels were generated and hybridised with these sequences. Firstly, the Southern blots
were probed with 32P-labelled gel-purified 6.6 kbp DNA. A note was made of the same
sized fragments which hybridised for all three target DNAs. These Southern blots were
stripped and reprobed with the 32P-labelled N/a III repeat. Fragments that hybridised to
the N/a III repeat were not pursued further. The Southern blots were again stripped and
reprobed with 32P-labelled total genomic CP 547 DNA in order to identify and then
eliminate other repetitive sequences that may have been amplified in the PCRs.
Subsequently, through this screening strategy, putative unique and non-repetitive
sequences specific for the 6.6 kbp element were identified and gel-purified for further
analysis.
With this approach, 80 arbitrary primers were tested in the AP-PCR using the 3
target DNAs. However, it became apparent that the major set-back of using the AP-PCR
technique was that the target DNA had to be purified away from any contaminating
DNA. As was evident from previous experiences, when purifying the 6.6 kbp element
from the agarose gels, some level of co-migrating contaminating DNA sequences was
inevitable even when great care was exercised. Such sequences contributed to the many
false positives in the AP-PCR amplifications. Another frequent readily amplified

129

cctmin.nt In the gcl-purilled 6.6 kbp target DNA was sequences that did not hybridise
b ek to the 66kbp element, but to the size markers. However, these concentrations were
rc tly rcduccd on cxteasivc washing of the commonly used electrophoretic tanks (the
r*c.bte scIrcc of this contaminant) prior to electrophoresis.
Representative examples of two of the AP-PCR amplification experiments are
shown in Figure 35 where different arbitrary primers were tested. The ethidium-bromide

stined gels disclosed that not all arbitrary primers could prime and amplify sequences
from the target DNAS. The Southern blots of such gels were then hybridised with gelpurified 6.6 kbp probe. From the resulting autoradiograms, sequences amplified in the
gel-purified 6.6 kbp DNA were identified (Figure 35 a, b and c, blot 2). To eliminate
sequences hybridising to the N/a III repeat, the blots were stripped and re-probed with
this probe (Figure 35 a, b and c blot 4). It could not be discounted that the 6.6 kbp
element has other repetitive sequences besides the N/a lU repeat, and in order to avoid
picking another repetitive sequence, the blots were stripped once again and probed with
total genomic CP 547 DNA (Figure 35a, b and c blot 3) which would give strong
hybridisation signals for repetitive sequences. Finally, in order to eliminate at least some
of the false positives, the stripped blots were re-probed with 32P-labelled DNA size
markers. From this hybridisation screening, amplified sequences that hybridised to the
gel-purified 6.6 kbp probe and not to the N/a III repeat, total genomic DNA or the size
markers were selected for further analysis. These fragments were excised from agarose
gels and used as 32P-labelled probes on test Southern blots containing lanes of undigested
CP 547 DNA. Of the 80 arbitrary primers tested, only nineteen primers gave
amplification of sequences from the gel-purified 6.6 kbp target DNA. Of these, two PCR
amplification products hybridised to the N/a III repeat and were thus not analysed further.
Eleven samples were amplification products of contaminating genomic DNA, as these
did not hybridise to the 6.6 kbp element but to other trypanosome sequences. Five
samples were amplification products of spurious DNA that did not give any hybridisation
to trypanosome DNA. Of the examples in Figure 35, only the 870 bp sequence
amplification product of one primer, ILRAD oligonucleotide (ILO) 878 (Figure 35a blot
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Figure 35
Search for non-repetitive sequences in the 6.6 kbp element using arbitrary
primers (AP) in a PCR amplification (AP-PCR).
(A, B & C) These represent examples of DNA fingerprints generated using three
different arbitrary primers (ILO 878, 868 and 1071, respectively) in each panel.
In each panel (1) represents the ethidium-bromide stained gel together with the
Southern blots of these gels (2, 3 & 4). As outlined in section 2.7, DNA
fingerprints of three different target DNAs were generated in each panel. From
left to right, these are represented by the alkaline lysis DNA preparation from CP
547 trypanosomes, total genomic CP 547 DNA and the gel purified 6.6 kbp
DNA, respectively. Lanes 2 to 4 represent the hybridisation results with 32.
labelled gel-purified 6.6 kbp DNA, (2) 32 P-labelled total genomic DNA isolated
from CP 547 population, and (3) a 32 P-Iabelled Ma III repeat. The washing
conditions for all the blots were of high stringency (0.1 X SSC, 65°C) and
overnight exposure at -80°C with intensifying screens. The arrows in panels A,
B and C indicate the fragments that hybridised to the 6.6 Lbp element, but not to
the total DNA and the Nia Ill repeat probe.
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2), hybridised faintly to the 6.6 kbp and the higher hybridising elements, but not the Ma
III repeat (Figure 36a). The presence of this unique sequence was verified by repeated
amplifications with the ILO 878 primer using different 6.6 kbp isolations as the target
DNA.

3.7.1 Analysis of the ILO 878-870 bp product generated by AP-PCR.
In most AP-PCR reactions using the ILO 878, the fragment specific to the 6.6 kbp
element was approximately 870 bp. The 870 bp fragment could not be gel purified easily
since it migrated closely with other amplified sequences (Figure 35abot 1 ,lane3.
Attempts at excising this fragment and reamplifying it to enrich and separate it from
other fragments were unsuccessful as the same profiles were obtained. Therefore, the
region encompassing the 870 bp fragment was carefully gel purified by geneclean®
method, 32P-labelled by random priming and used as a probe in Southern blot analysis.
High post-stringency washes showed a hybridisation signal corresponding to the 6.6 kbp
and the higher hybridising elements, and some restriction enzyme fragments (Figure 36).
In order to rule out the presence of a possible N/a III repeat-containing fragment in the
gel-purified DNA that may be responsible for the hybridisations, it was necessary to
identify genomic clones specific for the ILO 878-870 bp PCR product. Therefore, about
15,000 recombinant clones from the CP 547 genomic library were plated at a density of
5,000 plaques per 150 cm2. Of the duplicate library lifts, one set was hybridised with the
gel-purified region encompassing ILO 878-870 bp and the second set was probed with a
32P-Iabelled N/a III repeat. The screening of these identical lifts with the two different
probes revealed that some of the genomic clones hybridising to the ILO 878-870 bp PCR
probe also hybridised to the Nia III repeat (Figure 37, indicated by the asterisks), whereas
some genomic clones hybridised only to the ILO 878-870 bp PCR product (Figure 37,
marked by arrow head). To rule out the possibility that the gel-purified 110 878-870 bp
PCR sequence may be contaminated with some N/a III repeat repetitive sequences that
had escaped detection, 11 clones hybridising to the ILO 878-870 bp PCR probe, but not
the N/a III repeat, were picked and the DNAs prepared from them were used as
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Figure 36
Southern blot analysis of DNA from the diminazene-resistant CP 547 clone 2
with ILO 878-870 bp as a hybridisation probe.
2 .ig of total DNA from CP 547 diminazene-selected clone 2 was resolved on a
1.4% agarose gel as (U) undigested total genomic DNA, (1) Nia III digested, (2)
Alu 1, (3) Sau3A I, (4) Taq I, (5) BarnH I and (6) EcoR I digested DNA.
(A) The Southern blot of this gel was hybridised at high stringency conditions
with the 32P-labelled gel-purified ILO 878-870 bp fragment.
(B) A Southern blot similar to the one in panel A was hybridised with a
labelled Ma III repeat probe. The washing conditions were of high stringency
(0.1 X SSC, 65°C) and exposure was carried out overnight at -80°C with
intensifying screens. The brackets indicate the position of the 6.6 kbp element.
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Figure 37
The ILO 878-870 bp sequence is linked to some copies of the Nia III repeat
sequence in T. b. brucei.
This figure shows the comparative screening of clones from a genomic library
generated from 7'. b. brucei CP 547. About 15,000 recombinant clones from the
genomic library were plated at a density of 5,000 plaques per 150 cm 2 . Of the
duplicate library lifts, one set was hybridised with 32 P-labelled gel purified ILO
878-870 bp fragment (panel A) and the second set was probed with a
labelled Nia III repeat (panel B). The arrow heads in panel A indicate some
clones clearly specific for the ILO 878-870 bp probe; the asterisks in panels A
and B indicate some clones clearly hybridising to both the ILO 878-870 bp probe
and the Nia III repeat probe. The arrows in panel B point to some clones specific
for the Nia III repeat probe only. The washing conditions were of high
stringency (0.1 X SSC, 65°C) and exposure was carried out overnight at -80°C
with intensifying screens.
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hybridisation probes on test Southern blots. Four clones hybridised to the 6.6 kbp
element and the higher hybridising elements. One of these, pILOl8, was selected for
further analysis and was subcloned into plasmid Bluescript. A test Southern blot of
undigested and restricted CP 547 DNA probed with 32P-labelled pILO18 displayed a
hybridisation profile identical to the one obtained with the gel-purified ILO 878-870 bp
PCR probe (Figure 36), suggesting that the 870 bp sequence amplified by ILO 878 from
gel-purified 6 6 kbp DNA is indeed present in the 6.6 kbp region and most likely on some
species of the 6 6 kbp element However, this sequence is not unique to the 6.6 kbp
element as hybridisation to the higher hybridizing elements was also evident. On
rescreening the genomic library with 32P-labelled DNA purified from plLOl8 it became
apparent that some of the positive clones also hybridised to the N/a III repeat, confirming
the close proximity of the two sequences within the genome. Due to the limitations on
time, the 870 bp is yet to be characterised.
It is thus hoped that future characterisation of these sequences will possibly
unlock the purpose and function(s) of the 6.6 kbp element and the higher hybridising
elements in the multidrug-resistant CP 547 clone and other isolates in which
extrachromosomal elements have been identified.

132

CHAPTER 4

DISCUSSION

4.1

Background
African trypanosomes form a homogeneous group of unicellular flagellates that

frequently cause severe diseases in tropical and subtropical Africa. Most of the salivarian
trypanosomes are cyclically transmitted by several tsetse fly species in which they
undergo a complex life cycle. The diseases caused by salivarian trypanosomes have
proven to be particularly difficult to prevent or to effectively treat due to specific features
of both the trypanosome and the insect vector, the tsetse fly. Attempts to develop a
vaccine against African try panosomes have also been thwarted by the parasites ability to
change the composition of its exposed surface antigens. This process of antigenic
variation allows the parasite to avoid the host's immune responses and presents the host
with a seemingly endless antigenic repertoire. Chemotherapy has remained the most
effective means of controlling trypanosome infections. However, the continued use over
the last 30 years of a limited and chemically related set of chemotherapeutic agents has
resulted in the appearance of drug resistance An increase in the incidence of drugresistant infections in recent years and the occurrence of multidrug-resistant parasites
particularly threaten the future of chemotherapeutic control in humans and livestock
(ROttcher and Schillinger, 1985; Mbwambo eta!., 1988; Zweygarth and Rottcher, 1989;
Codjia eta!, 1993).
In view of the difficulties and expenses involved in the development and
introduction of new trypanocides, it is important to maintain the efficacy of the currently
used compounds. This can be carried out both in terms of modifying them andlor using
them in improved combinations. However, in order to design better chemotherapeutic
strategies or improve on those presently used, both the mode of action of the present

133

drugs and studies on the molecular mechanisms responsible for drug resistance require
investigation.
At the onset of the work presented here no data addressing molecular mechanisms
of drug resistance had been obtained for African trypanosomes. Hence, the initial
objective of this study was to determine if gene amplification, one common mechanism
by which cells become resistant to the action of selective agents (Cowell, 1982; Schimke,
1982), was employed as a mechanism of resistance in a multidrug-resistant T. b. brucei
CP 547 field isolate Table 8 outlines the different tested drugs to which the CP 547
population was found to be resistant.
In experiments designed to detect amplified DNA, an extrachromosomal element
of 6 6 kbp was identified in this population. This element represents the first
extrachromosomal element identified in African trypanosomes, thus warranting its
characterisation The identification of the element suggested a form of amplification in
the drug-resistant isolate analogous to that found in drug-resistant Leishmania spp.
(Beverley eta!., 1988) In Leishmania spp., DNA amplification was first shown to occur
after selection with methotrexate (MTX) a dihydrofol ate reductase inhibitor. It has also
been observed to occur sometimes spontaneously in wild-type populations (Beverley et
a!, 1988) These amplified DNAs generally exist as extrachromosomal circles, most of
which appear to have an involvement in drug resistance. The two best characterised
amplified elements include the R and H circles Beverley, 1991). In many lines ofL.
major, R circles arise by circularisation and amplification of an approximately 30 kb
region of chromosomal DNA in response to selection with either MTX, or CB3717, a
thymidylate synthase inhibitor. The R circles contain the bifunctional thymidylate
synthase-dihydrofolate reductase gene, and the production of these circles results in
elevated levels of the enzyme, which confers resistance to antifolates. The H circles are
approximately 70 kb in size. These elements are found in different lines of Leishmania
spp. obtained by selection with MTX or drugs unrelated to antifolates (Karakiura and
Chang, 1989) and are believed to encode a novel mode of resistance. Finally, a
homologue of the P-glycoprotein or multiple-drug resistance (MDR) gene has been
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identified on H circles of L. tare,zioIae (Ouellette eta!., 1991). However, the role of the
gene product does not appear comparable to MDR genes found in higher eukaryotes
(Callahan and Beverley, 1991)
The aforementioned 6 6 kbp extrachromosomal element was initially identified in
only the multidrug-resistant T b. brucei CP 547. It was therefore tempting to conclude
that the 6 6 kbp element played a role in drug resistance. Therefore, to ascertain the
possible function of the element, its characterisation was necessary. A further reason for
characteri sing the element was that its small size could make it a suitable candidate for
the development of a shuttle vector for the genetic manipulation of T. b. brucei.

4.2

Summary of results
For the analysis of the 6 6 kbp extrachromosomal element, attempts to isolate

pure and sufficient quantities of the element by standard techniques posed many
difficulties Several different approaches were attempted before a sequence which
hybridised to the 6 6 kbp element was finally isolated. This sequence is represented by
monomers of 108 bp which form long arrays of tandem repeats. N/a III is the sole
restriction enzyme that cuts within these repeats. In most of the sequenced clones, the
tandem 108 bp repeat units are interspersed by a 5 bp spacer sequence. A unique 5 bp
direct repeat flanks two complete copies and one partial copy of the 108 bp repeat. The
possible significance of these 5 bp interspersed sequences will be discussed later with
respect to transposition. In Southern blots generated from undigested total genomic
DNA of CP 547, hybridisation with the N/a III repeat revealed extrachromosomal
elements larger than the 6.6 kbp element. These elements were subsequently referred to
as the 'higher' hybridising elements. The 6.6 kbp element and the 'higher' hybridising
elements appear to be predominantly composed of long tandem arrays of N/a III repeats,
since in the many restriction enzyme digests carried out, only N/a III appeared to cut
these elements. Some results indicate that in addition to the N/a ifi tandem repeats, there
are also other sequences on the 6.6 kbp element. One such sequence identified by the
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PCR using arbitrary primers (AP-PCR) is the ILO 878-870 bp product, and, like the N/a
III repeat, this appears to be present on the 6 6 kbp and the 'higher' hybri di sing elements.
The 6 6 kbp element and some of the 'higher' hybridising elements display
features of circular DNA molecules The 6.6 kbp element also displays some level of
size and sequence heterogeneity. Whether this heterogeneity is because of the presence
of different species of the 6 6 kbp element will be discussed later. The copy number of
the 6 6 kbp element is also not stable, and appears to be directly affected by the
application of selective drug pressure. However, from the data presently available, the
6 6 kbp element can not be unequivocally correlated directly to drug resistance. This is
discussed more extensively in later sections.
The N/a III repeat family represents a newly identified repetitive family specific
to members of the Jr)pano:oo?z subgenus This repeat family of approximately 40,000
copies, represents about 500 of the diploid parasite genome. Pulsed field gelelectrophoresis analysis of the drug-resistant CP 547 population revealed that the N/a III
repeat sequence is dispersed through all size classes of chromosomes, and is also present
on etrachromosomal elements such as the 6.6 kbp element and the 'higher' hybridising
elements identified by conventional agarose gel electrophoresis. There is also evidence
to suggest that extrachromosomal elements containing N/a III repeats are also present in
some drug-sensitive populations The N/a III repeat is arranged in tandem arrays, is
dispersed throughout the genome, and is represented by a high copy number. These
properties define the N/a III repeat as a dispersed highly repetitive sequence.
Transcriptional studies of the N/a III repeats have revealed that at least some of
the copies are actively transcribed and their transcription is developmentally regulated. A
heterogeneous array of transcripts ranging from greater than 10 kb to smaller than 300 bp
are detected in the actively dividing long slender bloodstream and insect stage procyclic
forms of the parasite but not intermediate or non-dividing stumpy bloodstream forms.
The N/a III repeat lacks an open reading frame and transcripts do not appear to have a
spliced leader sequence at the 5' end. Furthermore, there is almost an equal
representation of polyadenylated and non-polyadenlyated transcripts.
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4.3

Limitation of the parasite material
One of the problems in this project was the lack of an appropriate drug-sensitive

control population. Ideally, the drug-resistant material should have been derived from a
known, well characterised, drug-sensitive clone. However, such a control was
unavailable as the CP 547 population was a field isolate which was resistant to the
highest tolerated dose of diminazene aceturate in mice. Hence, since CP 547 was a drugresistant population, the best available drug-sensitive control was the well characterised

T. b. brucei clone, ILTat 1 4. During the course of this study, CP 547 clones showing
reduced levels of resistance to diminazene were also produced, but in comparison to
ILTat 1 4, these CP 547 clones still expressed high levels of resistance to dimina.zene
aceturate and isometamidium chloride

4.4

Technical difficulties
The discovery of the 6 6 kbp extrachromosomal DNA suggested that an

expeditious means for generating hybridisation probes was available. This probe was to
be useful for identifying sequences specific to this element by screening recombinant
libraries, and hybridising Southern blots. However, the major obstacle for such analysis
and characterisation was that the 6.6 kbp element is present in very low quantities,
estimated at approximately one copy per genome. Since these small quantities are not
visible in ethidium-bromide stained gels, purification of the 6.6 kbp element from
agarose gels presented many problems. Firstly, in order to visualise the element, a
Southern blot was required for each experiment. Secondly, enrichment of the low
amounts of the 6.6 kbp element from agarose gels to generate enough material for one
labelling experiment required approximately 500 ig of total DNA; equivalent to
approximately 6 x

trypanosomes. Both these steps were time consuming and

relatively expensive to carry out.

137

In initiai isolations of the element, the agarose gel slices corresponding to the 6.6
khp r&on were localised with the use of linear size markers. In order to avoid missing

the 6 6 kbp element, wide agarose slices were excised and DNA was then extracted either
by gcnvden® or electroelution. However, major losses of DNA were incurred with both
techniques since the large volumes of the gel slice contained low quantities of DNA; the
DNA was so dilute that its precipitation was inefficient. In addition, the presence of
relatively large quantities of agarose resulted in co-precipitation of agarose components
with the 6 6 kbp DNA. Consequently, the labelling of small quantities of agarosecontaminated 6 6 kbp DNA resulted in poor hybridisation probes. An additional problem
encountered was that not all attempted gel purifications of the 6.6 kbp region contained
DNA. This led to the realisation that the 6.6 kbp element had differential mobility in
different percentage agarose gels, a property of circular DNA molecules As discussed in
a later section, a further problem resulting in low 6.6 kbp yields was brought about by the
continuous passage of the CP 547 population This resulted in a significant decrease in
the copy number of the 6 6 kbp element and eventual loss of the element.
Since there was a suspicion that the 6 6 kbp element was a circular element,
alternative techniques such as caesium chloride banding to enrich for circular elements
were attempted. However, using this technique, enrichment of the 6.6 kbp element and
the 'higher' hybridising elements was unsuccessful. The most likely reason for this was
that the copy number of the extrachromosomal elements was probably too low to be
visualised as a distinct band When Southern blots containing the fractions of the CsC1
gradient were hybridised with a probe generated from the gel-purified 6.6 kbp DNA
probe, hybridisation was evident to all the fractions, and no distinct bands were revealed.
These results were explicable with further investigations.
When the different gel-purified 6.6 kbp DNA probes were used in Southern blot
analyses, clear hybridisation occurred to a consistent set of restriction fragments, believed
to be genomic copies of the 6.6 kbp element. However, there was very faint or no
hybridisation to the 6.6 kbp element in lanes containing undigested and digested CP 547
DNA. Due to the weak hybridisation signal, it was virtually impossible to determine the
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restriction enzymes that cut the 6 6 kbp element. Longer exposures of autoradiography
only promoted higher background signals. Furthermore, depending on the 6.6 kbp probe
used, there were inconsistencies in some of the hybridising fragments These variations
in the Southern blot profiles were originally attributed to the differing concentrations of
genomic contaminants co-migrating with the 6.6 kbp probe, and to variations in the
transfer efficiency of DNA in the different blots. In conclusion, the problems with
isolating even small quantities of the 6.6 kbp DNA, and the difficulties in interpreting the
DNA hybridisation results, indicated that alternative approaches were required.

4.5

Overcoming the problems

One option to overcome the encountered technical difficulties was to directly clone
sequences from the 6 6 kbp element by a 'shotgun' cloning approach. Gel-purified 6.6
kbp DNA was digested with selected restriction enzymes and attempts were made to
clone sequences from it in a plasmid restricted with the same enzymes. The clones
obtained using this approach did not hybridise back to the 6.6 kbp element. The
explanations for this were that either the 6.6 kbp element was resistant to digestion with
the restriction enzymes used, or that the gel-purified 6.6 kbp DNA occurred in too small a
quantity to be cloned The cloned sequences were therefore believed to be contaminating
genomic DNA that was co-purified from the 6.6 kbp region. Lack of success prompted
attempts to clone the putative genomic copies of the 6.6 kbp element. However, this
approach was also subsequently abandoned as sequences specific for the 6.6 kbp element
could not be unequivocally identified.
The lack of apparent success with the different approaches prompted the
following alternative strategies:
1) Purification of the 6.6 kbp element after localisation of the element by Southern blot
analysis. This approach improved the level of recovery of the element to some degree
and highlighted that the mobility of the 6.6 kbp element varied in different percentage
agarose gels. This unusual mobility property, relative to that of linear DNA-size markers,
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is characteristic of circular DNAs (Beverley, personal communication) and was the first
indication that the 6 6 kbp element had properties of a circular DNA element. This
observation also provided an explanation for the curious lack of radiolabelling of 6.6 kbp
DNA from some gel isolations; cutting out a gel slice as determined by the linear size
markers meant that the 6 6 kbp element was not localised properly, and in some cases
none or only a small proportion of the DNA was recovered. With this purification
method it also became apparent that with successive passage of the CP 547 population in
vivo, in the absence of drug pressure, hybridisation signals to the 6.6 kbp element became
increasingly less intense and eventually were not detected. Therefore, isolations were
being made from the 6 6 kbp region, but with increasing passages, decreasing amounts of
6 6 kbp DNA were present in the purified material.

2) Generation of CP 547 clones Recognition of the instability of the 6.6 kbp element in
the CP 547 population prompted the generation of clones of CP 547 that were derived
with and without drug pressure Analyses of these clones established a correlation
between the presence of the 6 6 kbp element and the application of drug pressure.
Subsequently, regular and reliable isolations of the 6.6 kbp element were made from
cloned populations of CP 547 that were maintained in mice under a selective pressure of
55 mg/kg body weight of diminazene aceturate.

3) Abundant quantities of probe were generated directly from the 6.6 kbp element using
PCR. By exploiting the PCR, direct amplification of sequences from membrane-bound
6.6 kbp element was achieved using random hexanucleotides. This approach helped to
generate abundant quantities of the random hexanucleotide-primed PCR probe with a
sequence specificity essentially identical to the probe generated from the gel-purified 6.6
kbp DNA. However, as with the gel-purified 6.6 kbp DNA, this probe also hybridised
weakly to the 6.6 kbp DNA. The specificity of the PCR probe endorsed the earlier results
obtained with the probes generated from gel-purified 6.6 kbp DNA. The necessity to
produce large quantities of parasites for generation of total genomic DNA from which
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only low quantities of the 6 6 kbp element could be recovered was therefore overcome.
Furthermore, with the availability of sufficient quantities of the PCR probe, a genomic
library was screened to select clones which would hybridise strongly to the 6.6 kbp
element.

Despite improving on the procedures to obtain purer and more abundant
quantities of the 6.6 kbp DNA probe, none of the probes generated or purified from the
6 6 kbp element region ever hybridised strongly back to the element itself. This emerged
as a major problem at the time, as no explanation was available for the lack of a strong
hybridisation signal. In all the different approaches used, the main emphasis had been to
identify sequences that hybridised strongly to the 6.6 kbp element. Since such a sequence
could not be unequivocally identified, a comparative analysis of all the results was made.
This involved a comparison of the hybridisation profiles obtained from Southern blots
hybridised with the gel-purified 6 6 kbp DNA probe, 32P-Iabelled putative genomic
copies of the 6 6 kbp element, the random hexanucleotide-primed PCR probe, and clones
selected with the PCR probe. A search for fragments that hybridised with the four
different probes led to the eventual identification of a second, strongly hybridising
element named as the> 40 kbp element. On using the gel-purified > 40 kbp element as a
probe on Southern blots of CP 547 DNA, strong hybridisation was evident to the 6.6 kbp
element, the 'higher' hybridising elements and the region of unresolved genomic DNA.
This indicated that sequences similar to those on the> 40 kbp element are present on the
6 6 kbp and the 'higher' hybridising elements. Subsequently, the> 40 kbp element was
used as a hybridisation probe to screen both genomic and cDNA libraries generated from
the CP 547 population to obtain sequences that are contained on the 6.6 kbp element. In
both the genomic and the cDNA libraries, since the average size of the fragments was less
than 6 kbp, the full length element was not expected to be represented. Furthermore,
since the sequences hybridising to the > 40 kbp element are repetitive, the chances of
picking a clone derived directly from the 6.6 kbp element were unlikely. Nevertheless,
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the availability of the > 40 kbp element offered an opportunity to identify and
characterise a repetitive sequence contained on the 6.6 kbp element.
The clones selected for further analysis hybridised to both the 6.6 kbp and 'higher'
hybridising extrachromosomal elements in the drug-resistant CP 547 population.
However, in the drug-sensitive T. b. brucei populations, no extrachromosomal elements
were apparent and hybridisation was only evident in the region of the gel comprising the
unresolved genomic DNA. Characterisation of these clones has led to the identification
and characterisation of a new family of repetitive DNA in T. b. brucei, named as the Nla
III repeat family. The availability of this sequence as a probe for hybridisations has
permitted further characterisation of the 6 6 kbp and the 'higher' extrachromosomal
elements identified in the drug-resistant CP 547 population.
In this discussion, the features of the N/a III repeat family are outlined in addition
to the features of the 6 6 kbp and the 'higher' hybridising elements. Secondly, the
possible role of the 6 6 kbp element and the N/a III repeat family in the genomic
organisation of trypanosomes is discussed.

4.6

The N/a III repeat family

Sequence analysis of selected clones hybridising to the 6.6 kbp element and the
'higher' extrachromosomal elements revealed the presence of a 108 bp tandem repeat
sequence interspersed by a 5 bp sequence. Each sequenced 108 bp repeat contained
overlapping copies of smaller repeats; these were represented by three copies of a 9 bp
repeat, two copies of a 10 bp repeat and two copies of a 27 bp repeat. The interspersing 5
bp spacer sequence in most cases is a region of the 9 bp repeat. It would be interesting to
know the events that might have given rise to such a curious repeated structure. It could
be possible that the different blocks have originated from different parts of the genome to
form a composite unit. This leads to the question as to what represents the active unit of
this sequence. The 108 bp repeat sequence has been referred to as a 'unit' based on its
tandem appearance and the presence of the N/a In sites. However, the active unit may be
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the 6 6 kbp element or even still, a much larger sequence In one of the sequenced clones,
two complete and a partial copy of the N/a III repeat were flanked by a unique 5 bp direct
repeat Sequences flanked by direct repeats are generally indicative of transposable DNA
elements (Singer and Berg, 1991) Whether the 108 bp sequences are transposable is
discussed later
Southern blots of agarose gels containing undigested and restriction enzymedigested CP 547 DNA when probed with the N/a III repeat revealed hybridisation to the
6 6 kbp, 'higher' hybridising elements and the 23 kbp main DNA region in these gels. In
the track with undigested ILTat 1 4 DNA, hybridisation was only evident to the region
corresponding to the 23 kbp main DNA region. Even frequently cutting enzymes such as
Sati3A I or A/u I did not cut the 6 6 kbp element and the 'higher' hybridising elements.
However, when total genomic DNA from either of the populations was digested with NIa
III, the entire hybridising sequences were cut resulting in a ladder of monomers, dimers
and trimers of approximately 113 bp repeat units, which represents the 108 bp repeat and
its 5 bp end The ladder was not a result of partial digestions, as the reactions were
carried Out overnight vith an excess of N/a III. These experiments suggest that the N/a
III family of repeats is made up of very long tandem arrays of the 108 bp sequence, since
digestion with the various enzymes other than N/a III did not result in any digestion
products Therefore, a stretch of 23 kbp would have more than 200 copies in tandem.
However, 200 copies in tandem represents the lower limit of tandem arrays in the
genome since hybridisation to digested or undigested CP 547 DNA is mostly to the> 23
kbp region The multimers of the 113 bp unit generated after digestion with N/a III, most
likely arise from repeats which have an altered or modified N/a III site, thus giving rise to
sub-families.
Presently it is not known whether the N/a III repeat family is associated with
sequences other than the interspersed 5 bp sequences, although one sequence named as
the ILO 878-870 bp product, hybridising weakly to the 6.6 kbp element and the 'higher'
hybridising elements, has been identified in close proximity to the N/a III repeat in some
genomic clones. However, in comparison to hybridisation with the N/a III repeats, the
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ILO 878-870 bp fragment hybridises only weakly to the extrachromosomal elements.
This suggests that if this sequence is present on the same elements containing the N/a III
repeats, it is not associated with every N/a III repeat present on these elements.
Sequence analysis has revealed that the N/a III repeat contains no open reading
frame, yet the G/C content of this repetitive sequence is 47.8 mol%, equivalent to the G/C
content of most protein coding sequences in the Trypanozoon. Structural analysis of the
Nia III repeat revealed that it can not form any stable secondary structures as is also true
for the Alu-satellite repeat sequence of T. b. brucei (Sloofet a!., 1983). A homology
search of the (Genl3ank database release 77) has revealed that the N/a lU repeat has the
highest homology (87 500 in a 40 bp overlap) with a subtelomeric sequence specific to a
subset of minichromosomes of 1'. b. brucei(Weiden eta!., 1991). By using
oligonucleotides generated to the different repeat blocks as hybridisation probes, it may
be possible to establish whether the source of homology is specific for telomeres other
than those of minichromosomes The possible significance of the homology between the
N/a III repeats on extrachromosomal elements to the subtelomeric region is discussed
later
PFGE and OFAGE revealed that on the basis of 12 trjpano-oon populations
examined, the N/a HI family of repeats is dispersed in all chromosome size classes ofT.
b. bruce, Although this family is highly repetitive, the lack of hybridisation to some
chromosomes of T. b. brucei indicates that the N/a III repeat is not an integral feature of
all the chromosomes. However, the repetitive nature and the dispersal of the N/a III
repeats suggests that this family may be able to undergo transposition. Furthermore,
hybridisation differences observed between the subclones ofT. b. brucei GUTat 3.1
suggests that either the N/a III repeat is rapidly reorganising within the parasite genome
or that transposition of the N/a III repeat may be occurring within short time durations.
PFGE of different T b. brucei DNA also disclosed the presence of some chromosome
sized, N/a III repeat containing DNA molecules that have been referred to as curious as
they are not visible on ethidium-bromide stained gels and do not hybridise to the
telomere probe. In the GUTat 3.1 subclones, the curious molecules were found in the
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mini-intermediate-chromosomes size range, whereas in the drug-resistant CP 547
population one curious molecule has an apparent size of approximately 750 kbp while
others are smaller than 50 kbp minichromosomes. Whereas haploid chromosomes in the
750 kbp size range are easily visualised in ethidium-bromide stained gels, these curious
molecules were only visualised by hybridisation with the Nia III repeat probe. There are
several possible reasons for the inability to detect the curious molecules in ethidiumbromide stained gels One possibility is that these molecules exist in copy numbers of
less than one per genome However, if this was the case, it would be difficult to explain
the persistent presence of the 6 6 kbp element in different populations expanded from one
CP 547 clone. A second possibility is that the molecules are actually much smaller than
is apparent from their migration in the gels. If this was the case, the relative staining by
ethidium-bromide of a smaller molecule would be much fainter in comparison to a larger
DNA molecule found at the same place in a gel. In this context one of the physical
properties of circular DNA molecules is aberrant slow migration through pulsed field
gels, leading to a larger apparent size than is deduced either from sequence analysis or
from migration of the same DNA vhen linearised (Beverley, 1988). Therefore, if the
curious molecules are circular, then the inability to visualise them in pulsed field gels can
be ration alised
A further feature of these curious molecules is that they did not hybridise to a
consensus telomeric sequence that hybridises to all the chromosomes apparent on the
ethidium-bromide stained gels This suggests that the curious molecules are either nonchromosomal elements with unconventional telomeric ends or that they are indeed
circular molecules The possible circular nature of some of these molecules is further
supported by the altered direction in migration of one curious molecule in the CP 547
population in both PFGE and OFAGE. PFGE of gamma irradiated CP 547 DNA also
verified that the 750 kbp curious molecule was indeed circular; treatment with gamma
irradiation resulted in nicking of this circular DNA to give an approximately 400 kbp
linear molecule. Molecules displaying such anomalous mobilities, characteristic of
circular molecules, were however not evident in the drug-sensitive T. b. brzicei
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populations that were examined From the evidence available, these large curious
molecules are most likely oligomeric forms of the extrachromosomal elements evident in
Southern blots of CP 547 DNA resolved on conventional agarose gels, analogous to the
oligomeric forms of H circles in Lez3hrnania spp. (White eta!., 1988).
Transcriptional studies of the Ma III repeats have revealed that their transcription
is developmentally regulated, heterogeneous transcripts ranging from greater than 10 kb
to smaller than 300 bp are present in actively-dividing long slender bloodstream forms
and the procylic insect form of ILTat 1.4 and CP 547, but were absent in the shortstumpy and the intermediate forms of liLTat 1.4. In bloodstream and procyclic forms of
T b. brucei, transcription of telomeric repeats located at chromosomal ends also appears
to result in generation of heterogeneously sized RNA (Rudenko eta!., 1989). It has been
postulated that transcription of telomere repeats results from read-through downstream of
telomeric genes The heterogeneous sized transcripts of the N/a III repeat may be a result
of tandem repeats of varying sizes from different genomic loci. Alternatively, transcripts
from the different loci could be hybrids with varying numbers of N/a III repeat units
together with sequences unique to each locus. Since the smallest transcripts are
approximately 300 bp, this indicates that even three units, or possibly less, of the N/a HI
repeats can be transcribed as single transcripts. An explanation for the smaller transcripts
could be the possible dispersal of copies from the N/a III repeat clusters to new
chromosornal locations, similar to dispersal by the ribosomal and histone genes away
from their long tandem clusters (Childs eta! 1980; Long and Dawid, 1980). However, by
Southern blot analysis the smallest array of the Nia III repeats that is detected is the 6.6
kbp element. Three possible explanations for the smaller transcripts that are observed on
Northern blots are as follows: firstly, transposition of the smallest possible unit of the Nla
III repeat might result in modification of bases at the recipient locus, whereby a large
area spanning the transposed unit is resistant to digestion by restriction enzymes.
Although there is no precedent for such base modifications in trypanosomes, it would
explain the lack of hybridisation of the N/a III repeat probe to fragments smaller in size
than the 6.6 kbp element. Secondly, it is possible that there are simple sequences with
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promoter activity interspersed among some of the N/a III repeat units that are responsible
for the generation of the smaller transcripts Thirdly, it is possible that the tandem N/a III
repeats encode their own internal promoter and that the differences in size of transcripts
are due to initiation of transcription from different copies. The differences in size could
also depend on the varying position of transcription termination signals among the N/a III
tandem arrays, at different loci.
Among fundamental processes that are carried out differently by trypanosomes
and mammalian cells, the method by which the parasites transcribe mRNA stands out
(Borst, 1986) The 5' end of all mature transcripts of genes coding proteins in
trypanosomes possess a 39 nucleotides capping sequence named the spliced leader (SL),
often improperly the 'miniexon', which is added to the RNA by trans-splicing Borst
(1986) In a PCR using CP 547 cDNA as target DNA, primers specific for the miniexon
and those specific for the N/a III repeat failed to amplify sequences specific for the N/a
III repeat This experiment indicated that the N/a III repeat transcripts lack the miniexon
sequence at their 5' ends However, in the control PCR using CP 547 cDNA as target
DNA, primers specific for oligo dT and the miniexon sequence resulted in amplification
products
Determination of the copy number of the N/a III repeats within different T b.
bruce, populations revealed that this family is present at up to approximately 40,000
copies in the diploid parasite genome, with no significant difference between the drugresistant and drug-sensitive populations. This family of repeats can therefore be broadly
classified as a 'highly' repetitive dispersed family (Singer and Berg, 1991), and represent
500

of the total parasite genorne. However, this family of repeats is restricted to the

subgenus Tr,xi,zo:oon, since even at low stringency, no hybridisation was apparent to T
congo/ense or T. vi'ax. The absence of the N/a III repeat family from closely related
kinetoplastida suggests its recent origin and amplification in the Tiypanozoon. However,
since the N/a III repeats are known to be involved in rapid genomic reorganisations, it is
also possible that this family may have an early origin, but that its rapid evolution
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resulted in significant divergence between Trypanozoon and other genus resulting in the
lack of hybridisation.
Despite its relatively small size, (six times that of Escherichia co/i) (Borst eta!.,
1982), the genome ofT. b. brucei contains an abundance of repeat sequences. In addition
to the large collection of variant surface glycoproteins (VSG) genes (up to 1000 copies),
which show local homologies (van der Ploeg eta!., 1982b), several copies of reiterated
sequences have been described; the spliced leader (SL) sequence (Boothroyd and Cross,
1982), the 76 bp repeat sequences found 5' to the VSG genes (Campbell eta!., 1984b),
and the telomeric repeat sequences (Blackburn and Challoner, 1984; van der Ploeg et a!.,
1984d) In addition to these sequences, families of retrotransposon-like reiterated
sequences have also been reported from a number of Trypanosoma species. For example,
the ribosomal mobile element (RIME) in the subgenus Trypanozoon represents a 'middle'
repetitive family of sequences (Hassan eta!., 1984). Two halves of a RIME element are
also found flanking the trypanosome repeated sequence TRS1 (Murphy eta!., 1987) or
'ingi' element (Kimmel eta!, 1987) which is closely related to mammalian
retrotransposons and is widely distributed in many genomic sites in T. bruce!. Both
RIME and TRS 1 ingi are present in about 400 copies in the T. b. brucei diploid genome,
representing about 1 500 of the genomic DNA content (Kimmel eta!., 1987; Murphy ci
a!., 1987). Therefore, thus far, apart from the homologous sequences surrounding VSG
genes (van der Ploeg ci a!., I 982a), TRS 1/ingi and RIME sequences have been
considered to be the most abundant dispersed repetitive sequences in the T b. brucei
genome (Kimmel et a!., 1987). However, it now appears that the Nia III repeat family
represents the most abundant class of repeats yet identified in trypanosomes. Finally, in
addition to the presence of these reiterated families, the first examples of satellite DNAs
in protozoa, the 177 bp Alu repeat were identified in T. b. brucei and T. cruzi (Sloofet
a!., 1983).
Considering that the N/a III repeat family represents almost 5% of the T. bruce!
genorne, it is surprising that this reiterated family has not been described previously. The
probable reason for the lack of detection is that theN!a Ill repeat family exists in long
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tandem arrays of N/a III repeats, generally greater than 20 kbp and lack sites for
restriction enzymes other than N/a III, which is an infrequently used enzyme.
Furthermore, in caesium chloride density gradients, unlike the T. b. brucei Mu-satellite
repeat family, the N/a III repeat family does not form a satellite band since the GIC
content of the family is equivalent to that of coding sequences which are known to
equilibrate at the main band position in the density gradient (Newton and Burnett, 1972).
Therefore, unlike satellite DNA, the N/a III repeat family most likely resolves with the
main band, making this family quite inconspicuous.
In the work described here, a newly identified NIa 111 repeat 1amTiy'hasoeen
characterised The involvement of the N/a III repeats in genomic reorganisation, their
transcriptional characteristics, and their presence on an extrachromosomal 6.6 kbp
element and 'higher' hybridising elements, in a drug-resistant stock of T b. bnicei and
clones derived from it, differentiates this repeat family from other families of
Tr)pano:oon repeat sequences

4.7

The 6.6 kbp element and the 'higher' hybridising elements
Screening of the CP 547 genornic library with the >40 kbp element led to the

selection of genomic clones, all ofhich contained N/a III repeats in tandem arrays,
interspersed with variable 5 bp sequences. The N/a III repeat sequence probe
subsequently allowed partial characterisation of the 6.6 kbp and the 'higher' hybridising
extrachromosomal elements in the CP 547 population.
High stringency hybridisations with the N/a III repeat revealed that the 6.6 kbp
element and the 'higher' extrachromosomal elements contain sequences homologous to
the N/a III repeats. Since Nia III is the only enzyme that cuts these elements, this
suggests that the N/a III repeats exist as long tandem arrays on these elements. This was
further established in PCRs in which primers designed from theN/a III repeat unit
enabled amplification of sequences from the gel-purified 6.6 kbp when used as the target
DNA. This PCR amplification product hybridised back to the 6.6 kbp and the 'higher'
hybridising elements, and on agarose gels the PCR product resulted in a ladder
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suggesting that the N/a III repeats are arranged in tandem on the 6.6 kbp element. The
presence of heterogeneous sequences interspersed between the N/a III repeat would have
resulted in gaps in the ladder of the PCR products. However, under the PCR conditions
used, gaps in the ladder were not apparent, suggesting that the 6.6 kbp element is
composed of the N/a III repeats Data from hybridisations with the N/a III repeat probe
and the PCR analysis does not exclude the occurrence of randomly placed heterogeneous
simple-sequence elements either between or at the ends of the N/a III repeats. However,
in AP-PCR analysis, the ILO 878-870 bp sequence was amplified from the gel-purified
6 6 kbp DNA Hybridisation of the ILO 878-870 bp sequence to the 6.6 kbp element and
the 'higher' extrachromosomal elements suggests that besides the presence of the N/a III
repeats, these extrachromosomal elements may also contain other sequences. Further
evidence for this is available from the identification of genomic clones which contain
both the N/a III repeat and the ILO 878-870 bp sequence. Since the 6.6 kbp element and
the 'higher' extrachromosomal elements are only digested by N/a III, it is likely that, as
for the N/a III tandem repeats, the interspersed sequences present on these elements are
also simple repeats, lacking sites for the restriction enzymes that were used. It is,
however, worth noting that when a PCR was carried out that used primers designed from
the N/a III repeat, there was no indication of the presence of any additional sequences on
the 6 6 kbp element A likely explanation for this could be that the 6.6 kbp element is
made up of many tandem repeats of the N/a III repeat followed by one ILO 878-870 bp
sequence In such a situation, the majority of the products would represent the N/a III
repeat and its multimers, the ILO 878-870 bp sequence would be under-represented.
Since the ladder ran into a smear, the under-represented ILO 878-870 bp sequence may
have been masked by the more abundant N/a III repeats. However, hybridisation with
1L0878-870 bp would have resolved this. Another possible explanation is that the 6.6
kbp element may occur as a heterogeneous population in which the majority of 6.6 kbp
species are made up entirely of the N/a III repeats. In this situation, the minority of the
6.6 kbp element species would contain other sequences like the ILO 878-870 bp product
in addition to the N/a Ill repeat sequence. Finally, there may also be some species which
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do not contain the N/a III repeat at all The presence of a heterogeneous 6.6 kbp
population is supported by the evidence that is discussed in the next section.
As previously mentioned, the 6 6 kbp element and some of the 'higher'
hybridising elements are most likely circular DNA molecules. Evidence to support this
was obtained firstly, from their aberrant mobility in different percentage gels and in
PFGE and OFAGE Secondly, evidence to support this was also obtained from results of
Ba! 31 exonuclease digestions of total CP 547 DNA. In these experiments the resistance
of the > 40 kbp and some 'higher' hybridising elements in the 23 kbp region to
exonuclease activity indicated their circular nature. From the Ba! 31 experiments it was
difficult to determine whether the 6 6 kbp element is circular in nature as it was
continuously masked by the larger sequences that were sensitive to digestion by Ba! 3 1.
Thirdly, an oligonucleotide specifically designed from a consensus telomeric sequence
which hybridised to all the T. b. bruce, chromosomes resolved by PFGE did not hybridise
to the 6 6 kbp element, the 'higher' hybridising elements and the curious molecules
identified in PFGs These results indicate that the curious molecules are probably larger
extrachromosomal circular elements and that, like the 6.6 kbp element and the 'higher'
hybridising elements, these molecules either lack conventional telomeric ends or are
circular in nature Finally, the 6 6 kbp element and the 'higher' hbridising elements are
greatly enriched by the alkaline lysis protocol used in the isolation of circular plasmid
DNA, suggesting their circular nature.
At present, it is not known whether the 6.6 kbp and 'higher' hybridi sing elements
are specifically transcribed. From the transcriptional studies of theN/a III repeat, it is
evident that it is highly transcribed. However, whether the N/a III repeats present on the
extrachromosomal elements are also transcribed cannot be easily ascertained due to the
repetitive nature and genomic distribution, of this sequence. For a meaningful
transcriptional analysis of these extrachromosomal elements, either sufficient quantities
of the cloned elements, or unique markers need to be identified on the elements to be
used as hybridising probes. It may also be possible to specifically target exogenous
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selectable marker genes such as the izeo gene (Jiminez and Davies, 1980) to these
elements by transfection

4.8

Size heterogeneity in the 6.6 kbp element
From various Southern blots of different preparations of undigested CP 547

DNA, it became apparent that the 6 6 kbp element also displays size heterogeneity. The
reasons for this are undetermined However, to explain the size heterogeneity, the
following possibilities are considered
1) If the 6 6 kbp element is made up entirely of N/a III repeats, some of these repeats may
be deleted or added during repeated rounds of replication. The size variability could also
be due to expansion and contraction of the region containing tandem copies of the Nia III
repeat by intercistronic or intra-element recombinational events.
In T b. bruce,, fluctuations in sequence sizes have been observed in the 5' limit of
transposition of VSG genes within the 76 bp tandem repeat units (van der Ploeg et a!.,
1982b) These fluctuations are also believed to be due to expansion and contraction of
the region containing the 76 bp repeats by intercistronic recombination events such as
gene conversion (van der Ploeg eta!, 1982b).
2) The size heterogeneity might be due to the presence of different species of the 6.6 kbp
elements comprised of heterogeneous sequences. Evidence to support this is presented in
the following section entitled 'sequence heterogeneity'.

4.9

Sequence heterogeneity in the 6.6 kbp element
As mentioned earlier, the different gel-purified 6.6 kbp probes hybridised

consistently to a number of genomic restriction fragments but inconsistently to others. It
was possible that hybridisation to the 'inconsistent' fragments was due to contaminating
genomic sequences in the 6.6 kbp probe. However, this did not appear to be the case
since the gel-purified 6.6 kbp probes did not hybridise to any of the abundant, highly

152

repetitive, trypanosome sequences, as would be expected from contamination with total
genomic DNA Further, when random hexanuckotide primers were used to generate
PCR probes from the gel-purified element, they were consistently specific for the
restriction fragments that hybridised to the gel-purified 6.6 kbp DNA. It is curious that
both the PCR probe and the N/a III repeat probe originate from the 6.6 kbp element, and
yet the hybridisation profiles obtained using the PCR probe and the N/a III repeat probe
are completely different. The differences in the two probes suggests, as previously
mentioned, that there may be different populations of the 6.6 kbp element containing
different sequences The random hexanucleotide-primed PCR product is posfby a resu\
of selective amplification of sequences from one or more populations of elements which
do not contain the N/a III repeat Although the random hexanucleotide-primed PCR
probes gave hybridisation profiles essentially similar to the gel-purified 6.6 kbp DNAs,
there was a problem in explaining why they did not hybridise strongly to the 6.6 kbp
region In view of the possible occurrence of a heterogeneous population of 6.6 kbp
elements, it is possible that the sequences contained within the PCR probe are derived
from species of the 6 6 kbp elements that are present in copy numbers below the level of
detection by hybridisation In order to validate these speculations, the different species of
the 6 6 kbp element would have to be identified and characterised individually.
However, it is difficult to envisage that in the random hexanucleotide-primed PCR there
was selective amplification of sequences from some 6.6 kbp elements, whereas sequences
specific to the N/a III repeat were not amplified. One possible explanation is that
secondary structures may inhibit their amplification in PCR. However, from sequence
analysis there is no evidence of stable secondaiy structures in the Nia III repeat which
could rationalise its lack of amplification. In conclusion, the reasons for the lack of
amplification of sequences specific for the N/a III repeat are as yet unclear.
The lack of hybridisation of the gel-purified putative genomic copies of the 6.6
kbp element back to the element can possibly be explained in a similar manner. The
putative genomic copies possibly occur in only some members of the heterogeneous 6.6
kbp population, which are below the limits of detection by hybridisation. However, both

153

the putative genomic copies and the random hexanucleotide-primed PCR probe
hybridised strongly to fragments in restriction enzyme digests of total genomic DNA.
These fragments are most likely genomic copies of these sequences, with each
hybridi sing band representing one or more copies of that sequence in the genome.
Further evidence for heterogeneity within the 6.6 kbp population was evident
from the selection of a CP 547 population found to contain a unique species of the 6.6
kbp element This 6 6 kbp element contained sites for many restriction enzymes which
are absent in all other 6 6 kbp elements. However, this unique species of the 6.6 kbp

element changed to the form of'the element that cou)d not be digesteâ wth moss
restriction enzymes after the parasite population that contained it had been expanded in
mice This suggested that sequences on the 6.6 kbp element vary in different populations
of the same clone of 7'. b. bruce,. Further evidence of heterogeneity was also obtained
from hybridisations with the N/a III repeat probe to Southern blots containing digests of
total CP 547 DNA with different restriction enzymes. These blots revealed that Alit I and

ApaL I caused a reduction in hybridisation signal intensity to the 6.6 kbp element, but no
alteration in its size No such differences were apparent between the hybridisation signal
of the 6 6 kbp element in other restriction enzyme digests when compared to the signal
for the undigested DNA samples. However, in some DNA samples isolated from other
populations of CP 547, no such differences in the signal intensity of the 6.6 kbp element
were apparent after A/it I orApaL I digestion. These experiments therefore showed
variations in the 6 6 kbp element in different CP 547 populations.
Some possibilities that could offer an explanation for the sequence heterogeneity
observed in the 6.6 kbp element are as follows:
1) It is possible that the N/a III repeat probe hybridises to one population of elements
whereas other populations in this size range are not detected by the probe. During
expansion of the CP 547 parasite population in mice, selection for different 6.6 kbp
species from a heterogeneous 6.6 kbp population may occur for undetermined reasons,
resulting in variable 6.6 kbp DNA isolations. Some of the variable results may have
occurred due to isolation of DNA for the probe from one population and hybridising the
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probe to a second population The proposed heterogeneous probes could therefore have
contributed to the inconsistencies observed in hybridisation to restriction fragments in
Southern blots The presence of mixed species of 6.6 kbp elements also offers an
explanation for the reduction in hybridisation signal intensity to the 6.6 kbp element that
was observed when one isolation of total CP 547 DNA was digested with A/u I orApaL I
and not others. The simplest explanation for this latter observation is that only some N/a
III containing 6 6 kbp species have the restriction site for these enzymes. As a result,
digestion resulted in loss of only these species, accounting for the reduction in signal
intensity. Similarly, one of the reasons for the earlier mentioned weaker hybridisation of
the ILO 878-870 bp product in comparison to N/a III repeat probe to both the 6.6 kbp and
the 'higher' hybridising elements, may be due to only some species containing the ILO
878-870 bp sequence
2) Some circular DNAs are thought to be derived from chromosomal tandem repeats as a
result of homologous recombination (Schmoolder Reis eta!, 1983). It is clear that the
N/a III repeated units, can also give rise to circular molecules. Dispersed N/a III repeats
could carry 'passenger' sequences originally located between them. This would be
analogous to, but distinct from, 'true' transposition according to bacterial models
(Shapiro, 1979, Carlos and Muller, 1980). The variability could also be analogous to the
unique variable arrangements of the Cruhidia retrotransposable element 1 (CRE1)
(Gabriel eta!, 1990) identified in individual cells from the same population, the CRE1
element interrupts the tandemly arrayed miniexon genes of C.fascicu/ata. Although the
specific genetic mechanisms underlying the frequent rearrangements of CREI are yet
unknown, it has suggested that unequal crossing over between the flanking tandem arrays
of miniexon genes may be responsible for the observed rearrangements (Gabriel eta!.,
1990). If one assumes that there are unique sequences flanked by the N/a III repeat
tandem arrays in the 6.6 kbp element, this organisation would then be analogous to the
organisation of CRE1s within long tandem arrays of miniexon genes. It would also be
similar to the situation in transgenic mice which contain a single copy of a Moloney
murine leukemia virus proviral genome integrated into highly repetitive tandem
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sequences on the sex chromosomes (Habers eta!., 1986). In both the CRE1 and Moloney
murine leukemia virus proviral genome, the high frequency of rearrangements is thought
to be due to unequal crossing over within the tandem arrays flanking the respective
sequences.
In conclusion, it is possible that the observed sequence heterogeneity in the 6.6
kbp element may be a result of rearrangements within the 6.6 kbp element due to unequal
crossing over within the tandem N/a III repeat units flanking unique sequences. Such a
phenomenon could result in heterogeneous sequences among different 6.6 kbp element
species Which species are detected will depend on: (i) The frequency with which these
events occur, (ii) Whether there are 'hot spots' for these events; (iii) Whether these are
produced by recombination or through duplication; (iv) The replication efficiency of
these circular molecules whereby, some may replicate more efficiently than others
becoming the dominant species

4.10 Is the 6.6 kbp element responsible for mediating drug resistance?

The aim of the present study was to try to determine if gene amplification is one
of the mechanisms used by trypanosomes to overcome the lethal effects of trypanocidal
drugs. The identification of an extrachromosomal 6.6 kbp element in the drug-resistant
CP 547 population raised these expectations and encouraged its characterisation. As
mentioned previously, the element suggested a form of amplification in the drug-resistant
isolate analogous to that found in drug-resistant Le/shrnania spp. (Beverley eta!., 1988).
The following section therefore discusses the possible biological significance of the 6.6
kbp and the 'higher' hybridi sing elements with respect to drug resistance.
Work in several laboratories has demonstrated that when the activity of an
essential gene product becomes insufficient, either by mutation or because of the
presence of a specific inhibitor, mutants that overcome the deficiency can often be found.
Some mutants survive by at least one mechanism of resistance, that of gene
amplification; an important step in the development of drug resistance in vivo. Gene
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amplification may result in the over-production of the target gene product, a mechanism
found in many drug resistant mammalian cells (Stark and WahI, 1984) and Leishmania
spp (Beverley, 1991, Segovia, 1994). Essentially the effects of the inhibitor are diluted
by over-production of the target gene product through gene amplification. Multiple
tandem repeats of the targeted gene are acquired, and the multiple gene copies produce a
superabundance of mRNA and of the corresponding polypeptide. Sometimes, in
response to drug pressure, amplification of genes from loci distant to the target gene can
also occur (Stark eta!, 1989). Mariani and Schimke (1984) have established that
cytotoxic agents which enhance gene amplification are inhibitors of DNA synthesis. In
Lei/,mania spp , the amplified DNAs exist primarily as extrachromosomal circular forms
which can be easily visualised following electrophoresis under appropriate conditions
(Beverley eta!, 1988, Beverley, 1991). The 6.6 kbp element was identified in the
multidrug-resistant CP 547 stock. When Southern blots containing undigested DNA
were probed with the gel-purified 6 6 kbp element, in the lane with DNA from CP 547
stock, hybridisation was evident to both the 6.6 kbp extrachromosomal element and the
total genomic DNA In the lane with DNA from the drug-sensitive ILTat 1.4 population,
hybridisation was evident only to the total genomic DNA. It was therefore evident that
sequences homologous to the 6 6 kbp element were present in the total genomic DNA of
both CP 547 and ILTat 1.4. This suggested that the 6.6 kbp element arose from the
genome and was most likely a product of gene amplification. Such an occurrence was
not unlikely since trypanocides are also inhibitors of DNA synthesis, and may result in
gene amplification as do mammalian cytotoxic agents inhibiting DNA synthesis. During
the initial handling of CP 547 stock, the parasites were expanded from a CP 547
population that was maintained in mice by continuous passage. When Southern blots
were generated from DNA purified from different passaged CP 547 populations,
instability in the copy number of the 6.6 kbp element was revealed. With reference to
Figure 21, if the drug pressure is withdrawn, the copy number of the 6.6 kbp element
reduces and the element eventually becomes unnoticeable. The response of the 6.6 kbp
element to selective drug pressure, its extrachromosomal and circular characteristics, and
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its presence in the multi drug-resi stant CP 547 stock and not the drug-sensitive reference
clone, ILTat I 4, raised the expectation that the 6.6 kbp element was analogous to the
circular extrachromosomal elements mediating drug resistance in methotrexate-resistant
L.eishmania spp (Beverley, 1991) and methotrexate-resistant cultured mammalian cells
(Schimke, 1984) In Leishmania spp and cultured mammalian cells the copy number of
the extrachromosomal elements is also unstable in the absence of selective drug pressure.
With reference to Table 8, four clones referred to as the 'unselected' clones were
generated from the CP 547 stock passaged in the absence of drug pressure. All the
unselected clones displayed reduced levels of resistance to both dimina.zene and
isometamidium in comparison to the parental CP 547 stock. Furthermore, the values for
resistance differed between each of the four unselected clones. It therefore appears that
the continuous passage of the parental CP 547 stock in the absence of drug pressure
resulted in the selection of sub-populations that expressed lower levels of resistance to
diminazene and isometamidium In three of the four unselected CP 547 clones, the
reduction in resistance was also accompanied by the loss of the 6.6 kbp element. These
observations suggested a correlation between the 6.6 kbp element and drug resistance.
The variations in the drug-resistance profiles and the copy number of the 6.6 kbp element
in the four 'unselected' clones emphasised the need for a uniform CP 547 population for
the further characterisation of the 6 6 kbp element. Therefore, four additional clones
were derived from the parental CP 547 stock after it had relapsed following treatment
with the maximum tolerated dose of diminazene aceturate in mice (ie, 60 mg/kg body
weight). These clones were referred to as the 'selected' clones. The four selected clones
all displayed resistance to the maximum tolerated dose of 60 mg/kg of diminazene
aceturate in mice and therefore their absolute level of resistance could not be established

in vivo. All the four selected clones showed the presence of the 6.6 kbp element,
suggesting a strong correlation between the presence of the 6.6 kbp element and drug
resistance. However, this possibility became questionable since one of the unselected CP
547 clones (clone 3) contained the 6.6 kbp element, and yet was more sensitive to
diminazene than the unselected clone I which did not have the element. This result alone
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indicates that there is no direct correlation between the presence of the 6.6 kbp element
and expression of resistance to diminazene. However the presence of the element in all
the selected clones makes it difficult to discount a possible correlation between drug
resistance and the presence of the element. Although the unselected clones were more
sensitive to diaminazene than the selected clones, in comparison to the drug-sensitive
control, ILTat 1 4, the unselected clones express higher levels of resistance to aceturate
and isometamidium (Table 8)
From the limited data available on the different CP 547 clones, all evidence
suggests that the 6 6 kbp element does not mediate drug resistance directly. This is
apparent from the observation that the element is absent from the more resistant,
unselected clone I but present in less resistant, unselected clone 3 In support of this,
sequence analysis of the N/a III repeat, known to be present on the 6 6 kbp element and
the 'higher' extrachromosomal elements, revealed no open reading frames which might
encode a possible drug target Also, transcriptional analysis of the N/a III repeat did not
reveal any differences in hybridisation between the drug-resistant CP 547 population and
the drug-sensitive reference clone used, ILTat 1.4. Furthermore, no significant difference
in copy numbers of the N/a III repeat was detected between CP 547, ILTat 1.4 and
another drug sensitive-clone, GUTat 3 1 However, it should be noted that these copy
number estimates are relatively inaccurate and an alteration of 1000, equivalent to about
4,000 copies, would not be detected Therefore, small differences in the copy number of
the N/a III repeats between the drug-resistant and the drug-sensitive populations would
probably be difficult to detect due to the limitations in the accuracy of the estimates. The
combined results obtained from drug-sensitivity profiles, sequence analysis,
transcriptional analysis, and determination of the copy number of N/a III repeats
indicates that the N/a III repeat does not mediate drug resistance. However, in view of
the suggestion that the 6.6 kbp element is composed of a heterogeneous population, it
would be more appropriate to say that the 6.6 kbp elements containing only the N/a III
repeats do not appear to mediate drug resistance. Since the 'higher' extrachromosomal
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elements have not been analysed in detail, their possible involvement in mediating drug
resistance cannot be ruled out
Although the 6 6 kbp element does not appear to mediate drug resistance, the
maintenance of the element on application of 55 mg/kg diminazene aceturate indicates
that it is generated or amplified as a direct consequence of drug pressure The response
of the 6 6 kbp element to drug pressure may also be a general response of the CP 547 cell
line, or even all T. b. brucei populations, to other external stresses The element may be
an inherent or integral property which the population evolved to ensure its continued
existence in a hostile environment As a follow up in this investigation, it would be
useful to determine whether application of methotrexate-pressure generates such
elements in trypanosomes It would also be useful to determine whether application of
diminazene pressure would produce extrachromosomal elements in liLTat 1 4 or GTJTat
3 1 Furthermore, it would useful to determine the drug resistance profiles of the other
tr panosome isolates found containing similar extrachromosomal elements If all these
isolates are resistant, then there may be a real correlation between the presence of the
elements and drug resistance However, if even one of these isolates is drug sensitive,
then there is no correlation and the elements must be produced in response to as et
unknown factors
To date, no data have been published on the molecular basis of resistance to
diminazene in trypanosomes As shown in Table 8, the continuous passage of the
parental CP 547 population in the absence of dirninazene pressure led to the selection of
clones displaying reduced levels of resistance in comparison to the parental CP 547 stock
These results show that the resistance to diminazene is not stable and contradict previous
results by Kaminsky and Zweygarth (1989b) and Gray and Roberts (1971a) who claimed
that resistance to diminazene is stable The reason for the discrepancy is most likely due
to fact that Gray and Roberts and Kaminsky and Zweygarth used parasite stocks
However, in the light of the instability of resistance to diminazene aceturate that has been
observed in the CP 547 clones, conclusions about stability of diminazene aceturate in
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studies by Gray and Roberts and Kaminsky and Zweygarth require clarification.
Quantitative rather than qualitative assays for drug resistance are required before
definitive statements about the stability of resistance can be made (Peregrine, 1994).

4.11

Are the 'higher' hybridising elements multimers of the 6.6 kbp element?
Digestion of total CP 547 DNA with Ba/31 exonuclease, and the subsequent

hybridisation of the resolved DNA with the N/a III repeat probe revealed that there are
additional 'higher' hybridising elements containing N/a III repeats than is apparent from
just resolving of undigested DNA on standard agarose gels and hybridising with the
repeat Some of the 'higher' hybridising elements appeared tobe resistant toBal3l
exonuclease digestion, while others appeared sensitive. This indicated that the 'higher'
hybridising elements contain a mixture of circular and linear molecules.
Both the 6 6 kbp and the 'higher' hybridising elements were resistant to digestion
by a series of restriction enzymes; N/a III was the only enzyme identified that digested
them to completion Therefore, it is likely that the 'higher' extrachromosomal elements
also contain tandem arrays of the N/a III repeat similar to the 6.6 kbp element. ApaL I
digestion of one of the preparations of total CP 547 DNA resulted in the concurrent loss
of signal intensity of both the 6.6 kbp element and one of the 'higher' hybridising
elements, the 13 kbp element. The likely interpretation of these results is that in that
population of CP 547, only some species of the 6.6 kbp and the 13 kbp element have an
ApaL I site. These results indicate that the 6.6 kbp element and the 13 kbp element
probably have a similar structural organisation. Furthermore, the hybridisation signals of
the 6.6 kbp, the 13 kbp, and the elements between 20 kbp and >40 kbp display a level of
periodicity in their sizes which may be expected for a multimeric series of
extrachromosomal DNAs with size increments roughly corresponding to 6.6 kbp. These
observations suggest that the sequence organisation of some of the 'higher' hybridising
elements is likely to be similar to that of the 6.6 kbp element. Thus, at least some of the
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Ma Ill repeat-containing elements may represent multimeric forms of the 6.6 kbp
element
From experiments performed to verify the chemical nature of the 6.6 kbp
element, it is apparent that not all the 'higher' hybridi sing elements are similar. Results of
such an experiment showed that some of the 'higher' hybridising elements are resistant to
digestion by RNase A and RNace 'It', but fully sensitive to digestion by RNase H,
suggesting that these element may be DNA-RNA hybrid molecules. As is discussed in
later sections, DNA-RNA hybrid molecules may represent intermediate products of
reverse transcriptase.
Since the N/a III repeats are present on chromosomes of both the drug-resistant
and the drug-sensitive populations, it is most likely that the extrachromosomal elements
hybridising to the N/a III repeat are of chromosomal origin. The production of these
extrachromosomal elements appears to be a directed phenomenon because if it had been
random one would expect them to also contain some other highly repetitive T. b. brucei
sequences in addition to the N/a III repeats. However, high stringency hybridisations
using some of the well characterised highly repetitive T. b. briicei sequences such as the
177 bp Alu-satellite repeat, TRSI ingi, minicircle DNA, the telomere consensus
sequence, the miniexon sequence and RIME as hybridisation probes revealed that the 6.6
kbp element and its 'higher' forms do not contain any of these sequences. Irrespective of
the true mechanism(s) of their production, there is a defined size range within which the
6.6 kbp element and the 'higher' hybridising elements appear. The 6.6 kbp element
appears to be the lower size limit as no elements smaller than this size were detected.
This indicates that these molecules are generated by a precise, non-random process. This
observation is suggestive that the 6.6 kbp element and the 'higher' hybridising elements
may play an important role in the genetic make-up of the parasites.
The instabilities displayed by the 6.6 kbp element are indicative of the occurrence
of an active biological phenomenon involving genetic rearrangements. Thus,
extrachromosomal elements displaying such instabilities could represent by-products or
intermediates of events such as deletions, gene amplifications or transpositions.
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4.12 Classification of the Nia III repeat family
Two general classes of repetitive elements occur in eukaryotic genomes. The first
class Contain clustered repeats, while the second is arranged as dispersed repetitive
sequences.
The clustered repeat family may be composed of simple sequences with repeats
no more than 6 bp long, repeated as many as 106107 times per genome (Gall eta!.,
1973), while others can be up to hundreds of base pairs long (Brutlag, 1980; Mikios,
1985). Because of their sequence content, many of these repeated sequence clusters have
buoyant densities in caesium chloride density gradients that are different from the
majority of an organism's DNA, and can be observed as 'satellites' to the main DNA
band, and hence their name Satellite DNA is mainly found at the ends and centres of
chromosomes However, more recently, the term 'satellite DNA' has encompassed any
tandemly repeated sequence (Willard and Wayne, 1987). 'Minisatellites' for instance, are
similar to satellites but are shorter while microsatellites are even shorter comprising only
a few tandem repeats of a simple sequence that are dispersed through the genome of
eukaryotes (Jeffreys eta!, 1985). The number of tandem repeats at a given locus in the
DNA from one individual may contain a short minisatellite while another may contain a
long minisatellite. Polymorphisms in minisatellites can be used to make an individual
specific DNA fingerprint that can be used to follow chromosomes in genetic analysis
(Jeffreys eta!., 1985). Furthermore, defects in minisatellites and microsatellites are now
associated with some cancers (Nowak, 1994)
Trypanosomes are the only known members of protozoans and lower eukaryotes
to contain satellite DNA sequences (Sloof eta!., 1983). There are some features of the

Nia III family which would indicate that it is similar to the 177 bp Alu-satellite repeat
family present in the subgenus trypano:oon:
1)

From the digestion profile of the 6.6 kbp and 'higher' hybridising elements it was

apparent that these elements appear to be made up of very large numbers of tandem
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arrays of the N/a III repeat These long tandem arrays of simple repeat units are typical
of satellite DNA (Brutlag, 1980, Miklos, 1985). The previously identified T. b. brucei
satellite DNA referred to as the 177 bp Alu-satellite repeat family, is made up of long
tandem arrays of a 177 bp repeat (Sloof eta!., 1983). This repeat contains two copies a
19 bp sequence and several additional copies of part of this sequence. Similarly, the N/a
III family exists as long tandem arrays of the 108 bp N/a HI repeat which as previously
mentioned is also made up of different sub-repeats. The satellites of higher eukaryotes
are believed to have arisen by duplication of a simpler sequence (Brutlag, 1980; Miklos,
1985) Therefore, it is possible that the N/a III may also have arisen from multiple events
bringing the different sub-repeats together to form one active unit. However, unlike the
N/a III repeat family in which some of the 108 bp units are interspersed with a 5 bp
sequence, there is no published data indicating the presence of interspersed sequences
within the 177 bp Alu-satellite DNAs
2)

Satellite DNA is highly species specific, whereby even closely related species

appear to have completely distinct satellite DNAs (Brutlag, 1980; Dover, 1986). Like the
177 bp Alu-satellite repeat DNA, the N/a III repeat family is also specific for the
subgenus Tr)pano:oon This is apparent from its lack of hybridisation, even at low
stringency, to DNA generated from T. congolense and T vivax.
3)

Most satellite DNAs show a limited sequence difference between repeats within

one organism Restriction enzyme digestion of most satellites shows that either they are
completely resistant to specific enzymes or they are digested into very regular patterns of
DNA fragment sizes (Brutlag, 1980; Miklos, 1985). After digestion of total T. b. brucei
DNA with A/i, I, 99°o of the 177 bp Alu-satellite repeat can be isolated in a fraction
containing oligomeric series of DNA fragments whose lengths are multiples of the
monomer unit (Sloof et a/., 1983). Similarly, for the N/a III repeat family, when
genomic T b. brucci DNA is digested with N/a III, almost 100% of the family can be
isolated in a fraction containing oligomeric series of DNA fragments whose lengths are
multiples of the 113 bp monomer unit.
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4)

In higher eukaryotes, satellite DNAs tend to be restricted to specific loci such as

centromeres, telomeres and nucleolar organising regions (Warburton and Willard, 1992).
It is now recognised that satellite DNA in primates is organised in higher-order,
chromosome-specific repeat units which may form arrays as large as several thousand kb
(Willard and Wayne, 1987) Each chromosome in primates is characterised by a
multimeric higher-order repeat unit whose organisation and nucleotide sequence is
specific for the particular chromosome. The chromosome-specific subsets are in general
greater than 95°o identical (Warburton and Willard, 1992). Similarly, the N/a III repeat
family is also dispersed in the genome of 7'. b. bruce! in chromosomes of all size-classes,
in addition to being present on extrachromosomal elements. However, whether these
elements have a particular arrangement which identifies as being derived from specific
chromosomes can only be established if the sequence organisation of tandem arrays
between these elements, between chromosomes and within chromosomes is elucidated.
Unlike the N/a III repeat, the 177 bp Alu-satellite repeat DNA sequence is localised
specifically in the minichromosome size-class (van der Ploeg eta!., 1984b).
The aforementioned four characteristics displayed by the N/a III repeat family
also apply to the highly repeated satellite DNAs of animals and plants (Miklos, 1985).
However, some features of the N/a III family separate it from the 7'. b. bruce! satellite
DNA family and those of higher eukaryotes. Like most satellite DNAs, the 177 bp Musatellite repeat is easily visualised as a classical satellite peak well separated from the
main band of nuclear DNA in buoyant density gradient, since its G±C content is 29 mol%
(Sloofet a!., 1983). However, the N/a III repeat family does not separate after
equilibrium centrifugation of total CP 547 DNA in a CsC1 density gradient since its G+C
content is 47.8 mol° o. Furthermore, unlike the 177 bp Mu-satellite repeat DNA family
and most other satellite DNAs, the N/a III repeat family is transcriptionally active,
resulting in abundant heterogeneous transcripts. Nontranscribed, highly repetitive DNA,
in a functional sense is 'dead' (Miklos, 1985). The transcription of satellite DNA in
amphibian (Diaz eta!., 1981) and cultured mouse and rat cells (Sealy eta!., 1981) is
considered as transcription by 'default' because it is yet to be proven that these transcripts

165

are not just adventitious products of a small cluster of repetitive DNA sequences that
have been transposed to transcriptionally active regions of the genome, or due to
transcription initiation sequences that have been transposed into a tandem satellite family.
The second family of repetitive sequences in eukaryotes represents the dispersed
repetitive sequences Dispersed repetitive sequence are characteristic of most higher
eukaryotic genomes. However, no single unifying description of their arrangement can
be applied to them (Goldberg eta!, 1975; Davidson eta!., 1985). Generally, dispersed
repetitive DNA sequences are considered to be mobile DNA (Young, 1979) and are
believed to have arisen either by DNA-mediated or by RNA-mediated transposition
(Potter eta!, 1979, Young, 1979). Because of lack of a structural similarity among the
different dispersed repetitive sequences, it is clear that there is more than one mechanism
for their generation Among these are DNA transposition events, gene duplications,
chromosomal rearrangements and the integration of viral genomes. Although many of
the above mechanisms may play a role in the formation and evolution of repetitive DNA
sequences, the process of retroposition appears to be the dominant mechanism in forming
the major mammalian repetitive DNA families (Weiner eta!., 1986). Each type of
mobile element occurs many times in the genome. Thus, the elements constitute families
of dispersed repeated sequences which foster further genomic rearrangements because
they provide sites for nonallelic, homologous recombinations.
Several different mobile DNA elements are distinguishable in eukaryotes (Singer
and Berg, 1991). Classifications primarily based on common structural features have led
to the identification of three main families (Singer and Berg, 1991): the transposable
elements, the retrotransposons and the retroposons. The former two elements transpose
because they have the coding capacity for enzymes such as reverse transcriptase and
integrase, required for their transposition. The retroposons include a very diverse group
of sequences that, notably, do not necessarily themselves encode functions required for
transposition. The evidence that retroposons are mobile is largely indirect. It includes:
(1) the dispersal of family members to different genomic loci, (2) the presence of target
site duplications, and (3) the existence of alleles that differ by the presence or absence of
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a retroposon Although the mechanism of their transposition is unproven, they appear to
transpose by what is believed to be a passive process, through an RNA intermediate
(Singer and Berg, 1991)
Several features of the N/a III repeat family indicate that it may be able to
undergo transposition Firstly, it is repetitive and dispersed throughout the T. b. brucei
genome in all chromosome size-classes Secondly, members of the family are present on
extrachromosomal elements, dispersed repetitive DNAs present on extrachromosomal
elements are believed to represent intermediates in transposition (Krolewski eta!., 1984;
Rogers, 1985). Therefore, the extrachromosomal elements comprised of N/a III repeats
may also represent intermediates in transposition. Thirdly, the alteration in location of
some of the N/a III repeats, a typical property of mobile DNAs (Wichman eta!, 1992).
This was evident in the chromosome profiles of GUTat 3.1, with reference to Figure 29,
whereby additional minichromosome-sized molecules that hybridised to the N/a III
repeat sequence were revealed in only two out of four GUTat 3.1 subclones. This
indicates that the N/a III repeat sequence may be rapidly translocating, although it is
possible that such chromosomal rearrangements occur as a result of VSG-gene switching
(Myler eta!, 1988) Furthermore, it is also possible that the minichromosome-sized
curious molecules in GUTat 3 1 represents extrachromosomal elements. Fourthly, one
cDNA clone revealed two complete and one partial copy of the N/a III repeat flanked by
direct repeats, which could represent a target-site duplication.
Since sequence analysis of the N/a III repeat revealed no open reading frames, the
dispersal of the N/a III repeat family may be similar to the dispersal of retroposons,
which, in a similar manner to the N/a III repeats, do not encode enzymes required for
transposition (Weiner elal., 1986; Singer and Berg, 1991).
Singer and Berg (1991) and Weiner eta!. (1986) have further classified
retroposons into two subfamilies containing firstly, the processed polypeptide
pseudogenes, and secondly, the processed RNA pseudogenes. The general structural
features of some of these retroposon families are: (1) the absence of terminally redundant
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sequences, either direct or inverted, (2) the presence at the 3' end of one strand of a
segment that is rich in A residues, and (3) variable sized target site duplications.
The best charactensed sequences of retroposons and retrotransposons families are
the short and long interspersed DNAs (SINEs and LINEs, respectively, in the
terminology of Singer [1982]) Although these sequences represent the major
mammalian repetitive DNA families (Singer and Berg, 1991), very little is known about
their functions The A/u family of SINEs, found within the genomes of primates, is the
best studied of all The A/u family represents one of the most successful classes of
mobile elements, having amplified to copy numbers which approximate 5-6% of the
primate genome by mass (Deininger and Daniels, 1986). A/u elements are distributed, on
average, every 5 kbp within the human genome, but also exist as clusters within specific
genomic loci (Lee et a!, 1984, Flemington c/al., 1987). They are retropseudogenes that
are ancestrally derived from 7SL RNA (Ullu and Tschudi, 1984), while other families of
SINEs are derived from tRNAs (Daniel and Deininger, 1985). A/u family members
contain an internal RNA polymerase III promoter, and their mobilisation is thought to
occur via a polymerase 111-derived transcript and retroposition (Schmid eta!., 1989).
LINE family members appear to be directly diverged from a RNA polymerase IItranscribed protein coding gene of unknown function (Singer and Skowronski, 1985;
Singer and Berg, 1991).
The existence of retroposition in trypanosomes was implied by the discovery of
the ribosomal mobile element (RIME), which was found inserted into a rRNA gene in
one T. b. brucei stock (Hasan elal., 1984). The IRS 1/ingi element (Kimmel eta!., 1987;
Murphy et a!, 1987) identified in T. b. brucei shares all the features described for
mammalian LINEs, the most important, having the potential to encode reverse
transcriptase. It was found that these trypanosome LINEs are flanked by separate
different halves of RIME (Kimmel c/aL, 1987). However, to date, no SINEs have been
reported in trypanosomes.
Dispersal of genetic information from one locus to another is known to be either
RNA-mediated or DNA-mediated. Therefore, the question arises as to how the N/a III
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repeat sequence is dispersed in the T b. brucei genome From restriction enzyme
analysis it is evident that in the T. b. bruce' genome, the N/a III repeats are found as long
tandem arrays Therefore, dispersal would most likely involve mobilisation of clusters of
these repeats The smallest array of such clusters appears to be the 6.6 kbp
extrachromosomal element Therefore, the 6 6 kbp extrachromosomal element may be
the progenitor or intermediate for transposition and dispersal of the repeat clusters. From
the transcriptional studies, the smallest Nla III transcript is approximately 300 bp, which
could represent the smallest Nia III repeat dispersal unit.
Tandem, highly repetitive DNA sequences appear only rarely to undergo
translocations to other parts of the genome (Miklos, 1985). On the contrary, the N/a 111
repeat family may be undergoing active translocation, as evident by PFGE of GUTat 31
subclones and the presence of direct repeats flanking some N/a III repeat units. It has
been postulated that in a dispersed family, clusters of repeats may represent an early stage
in the growth of the dispersed repeat family (Anderson eta!., 1981). Anderson eta!.
(1981) also proposed that a DNA-mediated mechanism operates in which individual
member units of the repeat family originate by the sequential excision from the tandem
arrays of the repeat, the excised fragments are subsequently dispersed by a variety of
mechanisms The DNA-mediated mechanisms involve transposition, chromosomal
translocation betveen non-homologous chromosomes and unequal crossing over. It is
therefore possible that as in 2034 repeat family in Strongyloceiiirolzispurpziratus species
of sea urchins (Anderson et a!, 1981), the N/a III repeat family is also at an early stage in
dispersal, whereby its repeats are transposed. The 2034 repeat family is believed to
represent a sequence family that is still dispersing, because, in addition to dispersed
clusters of the repeat in tandem, there are also a few singly dispersed members. Clustered
arrangements of theA/u elements have also been found within specific genomic loci of
the human genome Thus, the dispersed individual members of the family are believed
by some investigators to have originated and dispersed from such clusters (Calabretta et
a!., 1981).
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Over the past few years, RNA-mediated transposition has emerged as a major
evolutionary force contributing to continuous sequence duplication, dispersion, and
rearrangements that maintain the remarkable fluidity of eukaryotic genomes (Rogers,
1985, Singer and Berg, 1991) In light of the dispersal of repetitive sequences such as the
primate A/u repeats, the N/a III repeats may also be dispersed by retroposition. Since at
least some of the N/a III repeats are transcribed, its retroposition is theoretically possible
according to demonstrations that any mRNA can be inserted as cDNA into the genome if
reverse transcription is active in a cell (Lania el a/, 1987).
There are several features of the N/a III repeat family that place it amongst
retroposon-like sequences
1)

Evidence of possible target-site duplications. Insertion of nonviral retroposons

usually generates a target site duplication of varying direct repeats (Soares el a/, 1985).
There is evidence showing that some N/a III repeat units are flanked by direct repeats In
the cDNA pCA 15, tvo complete and one partial N/a Ill repeat are flanked by a 5 bp
direct repeat, this suggests that these N/a III repeats may have transposed as one unit It
has in fact been noted that retroposons have a tendency to integrate either adjacent to one
another, or directly into each others' tails (Rogers, 1985), giving rise to clusters of
members which can subsequently be mobilised as a single unit Such an explanation
could explain the 5 bp direct repeat flanking two complete and one partial copy of the
N/a III repeat among tandem arrays of the N/a III repeat units It is hoeer worth

noting that non-viral retroposons which do not generate a target site duplication have also
been identified (Deninson and Weiner, 1982, Bernstein eta!, 1983) Similarly, almost
20 to 3 O o of chromosomal mammalian A/u repeats are not flanked by direct repeats
(Krolewski eta!, 1982)
2)

Retroposons usually have a 3' terminal poly (A) tract Hovever, since the ends of

the genomic copies of the N/a III repeat units were not characterised in the present stud),
it is not known whether this is also true for the N/a III repeat units There are, however,
indications that the N/a III repeat units in the genome are in the 'icInity of A nch
sequences This is evident from the screening of the CP 547 genomic librar), whereby
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some genomic clones hybndising to the N/a III repeat also hybridised to oligo d(T).
However, just as the presence of direct repeats is not obligatory for retroposition, most of
the small nuclear (sn) RNA pseudogenes and all characterised artiodactyl SiNEs that are
retroposons do not have poly(A) tails (Weiner eta!, 1986; Singer and Berg, 1991).
3)

Non-viral retroposons such as the mammalian A/u-repeat are known to be co-

transcnbed along with adjacent chromosomal sequences, and thereby mobilise them
along side (Roger, 1985) IftheNla III repeats are a family of non-viral retroposon-like
molecules, then co-transcription of adjacent chromosomal sequences from different
genomic locations would contribute to heterogeneous transposition intermediates. This
could offer an explanation for the size and sequence heterogeneity observed in the 6.6
kbp element
4)

A transpositionally active retroposon should be transcriptionally active. Thus, the

extent of amplification of a retroposon correlates with its transcriptional competence
(Daniels and Deininger, 1991) Both RNA polymerase II and III transcripts are known to
gi'e nse to retroposons and retrotransposons, named class II and class III, respectively
(\ einer eta!, 1986, Singer and Berg, 1991) In general, processed pseudogenes of
snRNA genes are class II genes ith external promoters whereas almost all small
cytoplasmic RNA genes are class III vith internal promoter elements (Singer and Berg,
1991) A/u family members are actively transcribed in vitro (Ullu and Weiner, 1985).
However, studies on transposed 7SL pseudogenes, close sequence relatives of Ahi, show
that the internal promoter is not sufficient for in vivo transcription (Weiner eta!., 1986).
In the case of 7SL, the authentic gene requires upstream control sequences The N/a III
repeat family is transcriptionally active, but presently it is not known which class of RNA
polyrnerase is responsible for its transcription However, since the N/a III repeat
sequence is a small sequence lacking an open reading frame, it could be transcribed by
RNA polymerase III Most identified trypanosome mRNAs transcribed by RNA
polymerase II have the SL sequence at theirS' ends, independent of their coding sequence
(Parsons eta!, 1984, Walder eta!., 1986). The absence of the SL sequence from the 5'
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region of the cDNAs of the N/a Ill repeats suggests that their transcription may be
mediated by RNA polymerase III
If the N/a III repeat is a retropson-like sequence, then some of its transcriptional
properties can be explained on the basis of transcription of other retroposons. The
observed heterogeneous-sized transcripts may be a result of tandem repeats of varying
sizes from different genomic loci Alternatively, transcripts from different loci could be
hybrids with varying numbers of N/a III repeat units, together with sequences unique to
each locus Heterogeneous transcripts have been observed as a transcriptional feature of
some non-viral retroposons which are active transpositionally (Matera el at, 1990).
Unlike other RNA polymerase Ill-dependent genes, transposed A/u elements lack d(T)4
termination signals and therefore rely on 3' flanking DNA for transcription termination.
As a result, A/u sequences interspersed at different loci geneiae tetogtoxs
transcnpts vhose lengths and 3' sequences are variable and dependent on the position and
eficiency of the termination signals encountered by RNA polymerase III (Jelinek and
Schmid 1982, Maraia el a!, 1992) Transcripts ofBl, a murine homolog of the human
A/u, are also heterogeneous in size This heterogeneity is mainly due to the variable 3'
sequences as B 1 also lacks transcription termination signals (Weiner et a!, 1986, Maraia,
199 1)
The N/a III repeat is actively transcribed in the long slender and procyclic forms
ofT b. hrzce, These forms represent the proliferating and acively-dividing))fc-siages
of trypanosomes Retroposition is believed to be pronounced in such actively dividing
cells (Carey t.i a/, 1986, Vhite ci a/, 1989) As for the N/a III repeats, the murine
SINEs, WI and B2, are known to be transcribed actively in early stages of development
and states of proliferation and transformation (White eia/., 1989; 1990). This kind of
transcriptional control appears to apply not only to particular families of SINEs, but also
to many, and conceivably all genes transcribed by RNA polymerase III (White et a!.,
1990) This gives rise to the question asto whether the N/a III repeat sequences are
abundant because they are transcribed during the stage in development when
retroposition is occurring more efficiently. Alternatively, the N/a III repeat and its
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uncharactensed adjacent sequences contain sequences which make it a particularly
efficient substrate for retroposition The transcription of both TRSI and RIME is also
developmentally regulated TRSI is preferentially transcribed in bloodstream forms of
(he parasite (Murphy et a!, 1987), but significantly less so in actively dividing procyclic
forms

4.13 The 6.6 kbp extrachromosomal element and the 'higher' hybridising
elements as intermediates of genomic rearrangements analogous to small
poly disperse circular DNA
Many eukaryotic cells, derived from both tissue and culture, have been shown to
contain small polydisperse circular DNAs (spc DNA) (Krolewski eta!., 1982, 1984;
Stanfield and 1-Iellinski, 1984, Schindler and Rush, 1985). These molecules range from a
few hundred to a few thousand base-pairs per cell and are present at levels from less than
I to more than 100 copies Such molecules are believed to be derived from, or related
to, chromosornal DNA, whereby their buoyant density is virtually indistinguishable from
that of total genornic DNA A variety of mechanisms have been proposed to explain the
generation of spc DNAs since they are known to contain heterogeneous sequences
ranging from unique to repetitive chromosomal sequences (Riabowol eta!., 1985).
Among the repetitive chromosomal elements identified are the short interspersed A/u
retroposons (Krole ski eta!, 1982), the long interspersed nucleotide sequence known as
Kpn-I (Schindler and Rush, 1985) and the tandemly repeated 172 bp sequence known as
a-satellite (Bertelsen eta!, 1982) Presently, the biological function(s) and significance
of the spc DNAs remains mostly speculative. However, the most optimistic speculation
is that they are intermediates and/or by products of gene rearrangements (including
transpositions) Such rearrangements are thought to occur commonly in such apparently
disparate phenomena as development (Lewis eta!., 1982), ageing (Shmookler Reis eta!.,
1983) and cancer (Cal abretta eta!., 1982). Certain species of spc DNAs are characterised
by a relatively reproducible size and structure. These characteristics indicate that precise
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mechanisms are responsible for their synthesis, and contrast markedly with the structures
of other spc DNAs that probably arise from more or less random andlor non-reproducible
events It is therefore possible that the 6 6 kbp extrachromosomal element, and some of
the 'higher' hybridising elements, are analogous to the A/u-containing spc DNAs. Since
there is as yet no unifying characteristic feature of the family of spc DNAs, the
hypothesis that the N/a III repeat containing-extrachromosomal elements are analogues
of the spc DNAs of higher eukaryotes is based on similarities between the features
displayed by the spc DNAs and the 6 6 kbp element. These include: 1) The 6.6 kbp
element and some of the 'higher' hybridising elements are circular DNA molecules
containing the highly repetitive N/a III sequences, which are also present in chromosomal
DNA sequences, suggesting a chromosomal origin of these elements. Furthermore, since
the 6 6 kbp element and the 'higher' hybridising elements cannot be distinguished as a
distinct band on CsCl gradients, this suggests that these elements, in a similar manner to
spc DNAs, may have a buoyant density which is indistinguishable from that of
chromosomal DNA
2)

The 6 6 kbp element dispIas size and sequence heterogeneity, as discussed

earlier, in which the N/a III repeat-containing elements may represent one particular
species with a distinct size range Similarly, the spc DNA exist as heterogeneous
populations However, within these populations, there are distinct-sized species of the
spc DNAs, such as the A/u 1-containing and the Kpn 1-containing subspecies of discrete
size classes (Krolewski cia!, 1982, Schindler and Rush, 1985).
What, if any, is the significance of the 6 6 kbp element and the 'higher'
hybridising elements" The instability of copy number, sequence and size heterogeneity
of the 6 6 kbp and the larger elements suggests that these elements, like the spc DNAs of
higher eukaryotes, are possibly intermediates or by-products (or both) of genetic events
such as transposition and extrachromosomal amplification.
The presence of potentially mobile dispersed genetic elements such asAlu
retroposons (Jelinek and Schmid, 1982) on some discrete-sized spc DNAs has led to
speculations that, like some other eukaryotic elements, A/u repeats may have the ability to
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move from one chromosomal site to another by means of an intermediate molecule such
as the spc DNAs (Krolewski and Rush, 1984). Although more than one model can
explain the generation of circular molecules, there has been some speculation that genetic
elements such as A/u-containing spc DNAs are generated by reverse transcription of A/u
specific RNA (Jagdeeswaran eta!., 1981; Sharp, 1983), It is also believed that such A/ucontaining circles disperse further by recombining with other A/u sequences elsewhere in
the genome. Although only limited, there is some evidence to suggest that at least some
of the N/a III repeat-containing extrachromosomal elements may also be products of
reverse transcription-mediated transposition, when CP 547 total genomic DNA was
subjected to digestion with RNase H, it became apparent on Southern blots that two
regions among the 'higher' hybridising elements were sensitive to R.NAse H digestion.
Although these molecules were not characterised further, their sensitivity to RNAse H
indicates that they may represent DNA-RNA hybrids. In Drosophila melanogasier
DNA-RNA complexes have been detected in cells grown in vitro (Flavell and IshHorowicz, 198 1, Arkhipova ci al, 1984). The properties of such complexes are
consistent with those expected from the model of a reverse transcription pathway of
transposition and amplification of dispersed genetic elements.
On theoretical grounds, several authors have proposed a relationship between the
processes of gene amplification and the generation of spc DNAs (Lambert ci al., 1983;
Fujimoto ci al, 1985). In Leish,na,na spp (Garvey and Santi, 1986) and human cells
(Maurer et a!, 1987) extrachromosomal elements containing sequences encoding
dihydrofolate reductase have been interpreted as polydisperse circles representing
intermediates in gene amplification. In a given cell type, the amount of spc DNA varies
in response to certain influences. Thus, protein synthesis inhibitors such as purornycin or
cycloheximide greatly increase spc DNA levels in all cells studied (Sunnerhagen ci a!.,
1986, 1989). This response to inhibitors is very similar to the changes in the 6.6 kbp
element that are observed when trypanosomes are exposed to diminazene aceturate. In
view of these similarities, the 6.6 kbp and the 'higher' hybridising extrachromosomal
elements are probably analogous to spc DNA and therefore represent intermediates of
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gene amplification generated by reverse transcription. Selective drug pressure might act
by enhancing this process; as mentioned earlier, such a phenomenon could be tested by
applying drug pressure on drug sensitive ILTat 1.4 and GUTat 3.1 clones.
The newly identified Nia III repeat family appears to be the most abundant set of
dispersed repetitive sequences in the T b. brucei genome, contributing up to
approximately 5% of the nuclear DNA. The copy number and dispersion of members of
this family make it unlikely that they are without influence on the organisation of the
genome. The function, if any, of highly repetitive DNAs in eukaryotic genomes has been
difficult to define. It is generally believed that most of it represents the so-called 'selfish
DNA', contributing nothing to the organisms whose genomes they occupy (Doolittle and
Sapienza, 1980; Orgel and Crick, 1980). Their transposition does, however, have
mutagenic effects, disrupting genes into which they are transposed, or altering the
expression of genes in their proximity. They may therefore be of some advantage in the
evolution of the host organism (Rogers, 1985). One obvious influence of the dispersed
sequences would be to provide many dispersed sites of homology, where pairing and
recombination can occur. One may therefore expect translocations or chromosome
fusions to occur as a result of recombinations between elements located on different
chromosomes or between circular elements and chromosomal loci. Such a situation can
be found in Drosophila in recombinations between the long interspersed 'Doc' elements
(Schneuwly eta!., 1987). In tumour cells, amplification of specific genes, such as DI-IFR,
have been implicated in a variety of adaptive responses to environmental stress (Schimke,
1984). However, concomitant with the amplification, DNA sequences acquire an
increased mobility in the genome with extrachromosomal intermediates transposing and
translocating to other chromosomal segments (Stark and Wahi, 1984). Events of these
kinds have been shown to occur in the smaller chromosomes of T b. brucei (van der
Ploeg and Cornelissen, 1984; Bernards ci a!., 1986) and may play significant roles in the
processes of antigenic variation and evolution of VSG-gene repertoires (Bishop, 1983;
van der Ploeg and Cornelissen, 1984; Pays, 1988a, b). In these instances, DNA
rearrangements are instrumental in producing changes in gene expression. However, in
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trypanosomes these events differ from the transposition mentioned above in that they are
non-random.
Estimates of the frequency of putative N/a III transpositions under different
conditions would be informative in establishing the degree of plasticity as a result of this
repeat sequence. Differences found in chromosome distribution of the N/a III
hybridising sequences between the GUTat 3 1 subclones could help identify newly
transposed N/a Ill-containing elements, confirm the occurrence of transposition, and give
estimates on the frequency of transposition
Retroposon sequences have been considered rare outside mammals and only there
have they become predominant dispersed repetitive sequences. ThereIore, i t'he 1aTfl
repeats represent a retroposon-like family, it would be unusual that trypanosomes contain
them A possible explanation for their presence is that such sequences were acquired
prior to divergence early in evolution, but were mostly lost from the genomes of most
lower eukaryotes except trypanosomes. It is also possible that these sequences were
acquired after their divergence, for example, through gene transfer of viral genomes. The
identification of RIME, TRS 1 and SLACS, and now the N/a III repeat family, suggests
that transposable elements may be more videly distributed among trypanosome genomes
than has previously been apparent The presence of these elements suggests that a
considerable proportion of the trypanosome genome is represented by "selfish DNA"
sequences This is somewhat surprising when one considers that the genome size of
trypanosomes is only six times that of E. co/i It is also surprising since trypanosomes
undergo a complex life cycle, involving both an insect and mammalian hosts. A
considerable proportion of the coding capacity is probably employed for survival in the
hostile environment of the mammalian bloodstream. However, it should be remembered
that the genome of trypanosomes is continuously undergoing rearrangements,
particularly with regards to the VSG genes It is therefore probable that rather than
selfishly self-propagating, the N/a III repeats and the extrachromosomal elements
containing N/a III are indeed functional in the trypanosome genome. In this respect, it is
possible that there is an enhancement of retroposition by selective drug pressure, with the
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various elements constituting intermediates. The N/a HI repeats and probably sequences
associated with it thus, via extrachromosomal intermediates, may be actively dispersing
in the T. b brucci genome, generating mutagenic effects such as switching on new genes,
destroying o(control elements and promoting plasticity by insertions of the N/a III
repeats The insertion or excision of such elements has probably confirmed a selective
advantage and drug pressure probably acts to preserve such an insertion or excision.
Therefore, such events could have resulted in generation of populations with novel
properties, including the multidrug-resistant phenotype of the CP 547 population.
As discussed earlier, the N/a III repeat family has some features typical of satellite
DNAs It is therefore important that these concluding remarks consider this characteristic
in relation to T. b. brucei. In complex eukaryotes, as mentioned earlier, satellite DNA is
localised mainly in the heterochromatin in apparently genetically inert and compact parts
of the chromosomes, at both centromeric and telomeric regions (Warburton and Willard,
1992) Simple protists like trypanosomes have a primitive mitotic apparatus; the
chromosomes do not condense in any phase of the mitotic cycle (Vickerman and Preston,
1970), therefore making it difficult to use microscopy to obtain reliable information on
the chromosonial location of specific DNA sequences (van der Ploeg eta!, 1984b).
Homology searches have revealed the highest homology of the N/a III repeat to part of a
subtelomeric sequence that is specik for sot

ccvosowts of r 6. 6nces

Although the significance of this sequence is unclear, Weiden etal. (1991) have shown
that the organisation of A + land G + C rich blocks in subtetomeres of some T. b. brucei
minichromosomes is similar to some subtelomeric domains of the distantly related P.

berghei (Dore ci al, 1990) and the X and Y elements in Sacc/zaromj'ces cerei'isiae
(Horowitz and Haber, 1985) The X and Y elements in yeast cells can function as
autonomous replicating sequences and have also been identified as mobile genetic
elements, with a circular episomal intermediate form (Horowitz and Haber, 1985). The

P. berg/ei subtelomeric elements are also mobile and can be transferred to subtelomeres
of other chromosomes by an as yet unknown mechanism (Dore cia!., 1990). It is
therefore possible that the N/a III repeat family represents subtelomeres of some
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trypanosome chromosomes, and that the circular N/a III repeat-containing elements
represent the episomal subtelomeres found in yeast cells. In T b. brucei
minichromosornes the 177 bp Alu repeat was the only satellite sequence to be identified
(Weiden eta!, 1991), leading to the suggestion that it may be a candidate for a
trypanosome centromere. However, the N/a III repeat family, represented as tandem
repeats, is a more reasonable candidate for the centromere since, unlike the 177 bp
repeats, it is present on chromosomes of all size-classes, although not on all
chromosomes. Its presence on circular elements may represent a mobile form of a
centromere, providing 'services' to chromosomes where these tandem arrays are absent
The increase in copy number of the 6 6 kbp element in response to selective drug
pressure may therefore be a mechanism used by the parasite to increase its number of
mobile centromeres This may allow for more effective parasite replication when under
stress e g, drug pressure
Reviewing the two major classes of repetitive DNA has revealed that the N/a III
repeat family cannot be assigned completely to either one of the two above-mentioned
general families, the N/a III repeat family displays some features which are characteristic
of dispersed repetitive families and some features which are characteristic of satellite
DNA families
The biological significance of the N/a III repeat and the 6.6 kbp and the higher
hybridising elements is unclear at present Nevertheless, in view of the possible
transposition of N/a III repeats, and in view of the instability of the 6 6 kbp
extrachromosomal element containing the N/a III repeats, the N/a III repeat family
reported here may provide a unique system in which one can study the mechanism of
chromosornal instability If a unique marker could be inserted into the extrachromosomal
DNA, the element may be used as a convenient marker in analysing the dynamic state of
chromosomal and etrachromosomal elements Such analyses could contribute to the
better understanding of the plasticity of the parasite genome. Taking into consideration
that VSG expression occurs, in part, through genomic rearrangements (Roth eta!., 1991),
such analysis may consequently give a better insight into regulation of gene expression.
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The repetitive DNA sequence may also be used as a diagnostic probe specific for

Trypanozoon. In conclusion however, from the identification and the partial
characterisation of the 6 6 kbp and the higher hybridising elements many questions have
arisen (i) What is the structure of the active portion of this repeat that may be transposed,
and what is the complete structure of the extrachromosomal elements? (ii) How may
these structures have been constituted? (iii) Is this repeat sequence still proliferating in
the Trpano:ooiz genome? If yes, how may it be doing so? (iv) What RNA polymerase is
responsible for it transcription 9 (v) Can this repeat shed light on the organisation and
functions of'Selfish' DNA in higher eukaryotes 9 The answers to these may shed light on
the function(s) of this repeat sequence and the extrachromosomal elements containing
them
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